Top Banner
Adrenoceptor Antagonists and Haemodynamics Contemporary Concepts A c t a U n i v e r s i t a t i s T a m p e r e n s i s 1093 ACADEMIC DISSERTATION To be presented, with the permission of the Faculty of Medicine of the University of Tampere, for public discussion in the small auditorium of Building B, Medical School of the University of Tampere, Medisiinarinkatu 3, Tampere, on August 19th, 2005, at 12 o’clock. TUOMO NIEMINEN
108

Adrenoceptor Antagonists and Haemodynamics - Trepo

Apr 03, 2023

Download

Documents

Khang Minh
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Adrenoceptor Antagonists and Haemodynamics - Trepo

Adrenoceptor Antagonistsand Haemodynamics

Contemporary Concepts

A c t a U n i v e r s i t a t i s T a m p e r e n s i s 1093

ACADEMIC DISSERTATIONTo be presented, with the permission of

the Faculty of Medicine of the University of Tampere,

for public discussion in the small auditorium of Building B,

Medical School of the University of Tampere,

Medisiinarinkatu 3, Tampere, on August 19th, 2005, at 12 o’clock.

TUOMO NIEMINEN

Page 2: Adrenoceptor Antagonists and Haemodynamics - Trepo

DistributionBookshop TAJUP.O. Box 61733014 University of TampereFinland

Cover design byJuha Siro

Printed dissertationActa Universitatis Tamperensis 1093ISBN 951-44-6346-3ISSN 1455-1616

Tampereen Yliopistopaino Oy – Juvenes PrintTampere 2005

Tel. +358 3 3551 6055Fax +358 3 3551 [email protected]/tajuhttp://granum.uta.fi

Electronic dissertationActa Electronica Universitatis Tamperensis 452ISBN 951-44-6347-1ISSN 1456-954Xhttp://acta.uta.fi

ACADEMIC DISSERTATIONUniversity of Tampere, Medical School, Departments of Pharmacological Sciences andClinical PhysiologyTampere University Hospital, Department of Clinical PhysiologyFinland

Supervised byProfessor (fixed term) Mika KähönenUniversity of TampereProfessor Pauli YlitaloUniversity of Tampere

Reviewed byProfessor Risto HuupponenUniversity of KuopioDocent Ari LindqvistUniversity of Helsinki

Page 3: Adrenoceptor Antagonists and Haemodynamics - Trepo
Page 4: Adrenoceptor Antagonists and Haemodynamics - Trepo

!"#$% &

1.1.2.3 α ##!"% '

β ##!"%(

)* +*,

-) ,*. .)* &

!" #

$% & '

() *

+ ,

-

-+/%#"0#"1-

-/"%!12-

--0!##$!12-

2.1 α * +, 3*-

2.1.1 α&.

2.1.2 α& '

β * +, 3* -'

-&/β β0β& '+!//-'

$0//(

β&

- *α *β * +, 3*

1

2"

*, )+(

Page 5: Adrenoceptor Antagonists and Haemodynamics - Trepo

!"

#$%"%&'(%

)'*+"$$+& %!&+*(,

!",

+& "!$(" -.%&(+'%"+' $ /

) !"

)+0* #*&%%$%#

))* &%'&1+"2&$ *&%%$%#

)+"+# +"$+& +$+%"%' $'+&'"

)#+'+ '%#%#$%"$"&+ %")

!"

2&+$ %"+"!"%* "!%.!"#$+"%&!

)'(")'(%%#%!

) 3 3 3

44 45 4 664 456 478

554543 4 4 4 7189/

)554534:33634543434 4 7689

4 45434343768 9)

934 44 454 9

93 53 4543 4 4 4 9,

9)44 ;: 34:3363454343 4

94 45434343 )

93 334 54 9

Page 6: Adrenoceptor Antagonists and Haemodynamics - Trepo

:

Page 7: Adrenoceptor Antagonists and Haemodynamics - Trepo

&

1$%"1#%$%$%>%#"1#7//?$$$/00$"$%8?1$1##7##"$"1#"#9">2

"1#00#/% @

$#0$#83AA>$B0;(((<@ %"#C/0#$"!"

>##"#0$##/$>/2$"$/" ">/#"#%"%$"1#!/%#"0#"1D /$+12%$/

(@'' 5

$#0$# 8 /$"/ 8 3AA>$ 8 /$"/ +8 3E1A# ;((<@ 77#"% 7

##!" /$ *% $C%/ #%!%$C##%% " +%%$C#

"1%"%$% !/#> "//# >/# >/$ %"2 F#$0$""#/7%1G*

#%#1@(

$#0$# 8 /$"/ 8 3AA>$ 8 /$"/ +8 3E1A# ;((<@ 1# C%$/"2

#77#"7/7F%$"0%/%$$!%%$C#"1%"%$%0$%#8>/# >/$8

!/#> "//#%"2/&@-( -

$#0$#8%$"/)8B08BE1//8)##%"A0)8E#!EEH8!

8 )#$$/E +8 3E1A# ;((<@ %%$"$ >#"?## /? !/%0 /#C#/% 7

!1"1/0$ "$0//1#020$% $/0!"$#"%H /$+10/

:@-:5 -&

$#0$#8%$"/)8E#!EE H8 B08#8,# 8!8

"8,#1"$0E$83E1A#+/20!1$%0%7##%14$586

7-$!10$#"$%%2%"#0$#77#"%7!1"1/0$"$0//>0$""#

$"$8%0#!>/$%1#"$%!#%#"#

Page 8: Adrenoceptor Antagonists and Haemodynamics - Trepo

'

#/$#

1 #"2/1/$#

* ###$"1#β ##$##!"

"0$#C%%2%"#0

###""$$!/%0C#%%"$0#C#

"$C#"$/

+ /!#%%#

+) #$!%""#12!#!/%$

$$#9I$"!"$C$#>2>2%7##

09 9$0/!/%0#""$

#"/#C%%2%"#0

$"!"

+ 2"10#+(#F20#%

*+ *$%"/$"#$/!#%%#

/#"$!12

9"#%$C#0#">/$%#

. .##9!$"2C/0#$#%#I0#%#7!/027"$

*+ %$#$!1%!1"#

###$"1#α %>$"7 !"#$

+ !"#$!/###!"%

+ %$#"$!1%!1"#

) )#""#

0!##$!12

= =1/# >2$0!##$!12

"#0#$"#0#">/$%#

+ "/!#%%#

"$%$%20!"10$0#"$"$C$"2

, ,?#$2""%20!"0%

Page 9: Adrenoceptor Antagonists and Haemodynamics - Trepo

5

+ #"#$/!#%%#8*+JK;+ *+<

#/$#

+* +1%!1$#%"#%#"2!#

+. +##9!$"27/?I0#%#7!/027"$

+ +0#">/$%#

+$"#C/ "#C/>#"?##"1#!#97+?C#"1#!#I !0#"#

+= +/%#?C#C#/$"2

4$"#C/ $0#>#"?##"1#>#$$74?C#""1##7?C#I !0#"#

4$"#C/ 4$"#C/#"#7)

* 6#"7"1#0#%6#$77###%7%#%%$C#%I0#%#7)

C$>$/$"2

"#C/>#"?##B#"40!/#9#%

$"$/

+ 2%"/$"#$/!#%%#

* "#C$"$

"#70#

"#$#9I%"#C/0#$C$#>2>2%7##

+ $/#/#"$#!/20!1$%0

"#C/0#

2%"#0$C%/#%$%"#I""/#%$%"#$!#$!1#/$/"$

2%"#0$C%/#%$%"#$#9I"1#!"7>2%7##

L /$0$"$1/7 /$7#

09 $0#"#1 09

Page 10: Adrenoceptor Antagonists and Haemodynamics - Trepo

(

1##77#"%7"1#%20!"1#"$#C%%2%"#0

# 0#$"# >2 ##$ ##!"%

##!"%*%>/$"1#%###!"%8

α β "$%"%8 # ?$#/2 %# "

$0$$%1#9#%%$C#%20!"1#"$"$C$"2$#

1#" C%/"# # 0B /"$% 7

##!"%8 α β "$%"% #9#"

C$#"2 7 1#020$ #77#"% "1" 1C#

>## %"$# 6$"# #9"#%$C#/2 >" " 2#"

%"$%7"$/2 1$% $%%#""$ ?% $0# "

0!/#0#" "1# ?/## >" "1#

1#020$ $7/## 7 ##!"

"$%"%

#C#/ $C%$C# 0#"1% 1C# >##

$"# 7%%#%%0#"71#020$%

=1/# >2$0!##$!12; =<

1% >## %1? " ## ?#// ?$"1 $C%$C#

0#"1% $ 02 !"$#" !% #

$77##" %"2 %#""$% .$# !#%%# !/%#

"0$1">##C##%$#"%#0#

#$/2 C$/>/# "1 =8 >" "1#

#/$>$/$"27"1#!/%#"0#"11%"

>## #6"#/2 0#"# "1# "2 8

"1# !$# %"# C/0# ;< $

"!" ; < C/#% >2 "1# !/%# "

=?##0!#$(!"$#"%%>B#"#

"1# !"$/" "#%"1#!/%#"0#"1

"# "1# 1#% $ #/"$C#/2

?#//8 >" $" ?% " #/$>/# $ %%#%%$

>%/"# /#C#/% = ?% %# $ "1# /"#

%"$#% "%%#%% "1#1#020$ $7/##

7"1###!""$%"%

1# #77#"% 7 !!//8 C#$//8

"0%/%$ /7F%$ ?## %%#%%# $

"$#% ?$"1 & - 1#/"12

C/"##%8 #%!#"$C#/28 %>B#"# " 1# !

"$/" !C"$ 0%/%$ /7F%$

$# $70 #77#"%@ %2%"#0$ C%/

Page 11: Adrenoceptor Antagonists and Haemodynamics - Trepo

! " #

$$ $# %

&'(

#&#

# $

) &! $# $

# # # *+

!# , #&

&

# "

!! !

&

' " "& "&

# "

#

#

# # & -&# .(*/0

&## !

#1 $$ 1 &#

$$ $ ) # # 2

&"&3# ##

"

! # $$ !

" $ $# # # "

!$#(4

"#54!&$

!&##

! 6

7 $ 8

" " $$

#&# $ # #

2&" 9!#

$-#

"& $$ ! &

&"α!

α1!$$$#α6

!"

" ! $$

$# " β! (4 $ "

! # 54

# " $ #

" #&# $$ (4

#&#&#""

$#54

Page 12: Adrenoceptor Antagonists and Haemodynamics - Trepo

##$##!"%##!"%0#$"#

"1##77#"%7#/$#;<#/$#

;<#/#%#>2 "1##/0#// "1#

%20!"1#"$ #C% %2%"#0 !$

#C#/!0#" 7 ##!" "$%"%

%""# $ "1# 5(O%8 % "1# #9$%"## 7

$%"$" N M ##!"% ?% #/$%#

/$ 7 %20!"1#"$ %"$0/"$ $%

>##7$$/ $ 0/"$"# 7 $%#%#%

%20!"0%8 8 %#6#"/28 "1#?$#!

7##!""$%"%$%0"1#0%"

00 !10#"$/% ##!"

"$%"% %# 02 1#% $ "1#

$C%/ %2%"#0 1#020$%

1# ? $C%/ $% 7"# #%"

?/28 C#$1#" "# ;)< >/

!#%%#%;+<8?1$/#"1#"#01#020$%

1% ># 0#$ #%$>#% "1#

!12%$/ 7"% C#$ >/ 7/? ?$"1$

"1# $/"2 %2%"#08 $# "1# 7"%

"//$ "#$/ !#%%#% %2%"#0$

C%/ #%$%"# ;< 02 %#%8

1?#C#8 "1# ?% $C%/

1#020$#$"#1#>/#

C$#"2 7 "#1$/ !!1#% 1C# >##

#C#/!# " %%#%% "1# 1#020$ %""%

$ #"$/ #"1% ##%%$""$ !/02

"#2"1#"##/27#%$>/#$$"$//2$//

!"$#"%8 # " >"1 "#1$/ #"1$/

7"%1##7#8"1##$%##70#"1

"1" #>/#% %#0$ $C%$C# #C#

$C%$C# 0#%#0#" 7 %"# C/0#

;<8$"!"; <88"#$/!/%#

?C# C#/$"2 ;+=< #" . $C%$C#

"$%>#" " >#"0#%#0#"%?$"1"

># 7 !#" #!##28 "1## #

"? "#1$6#% C$/>/#@ !/%# "

0#"1$0!##$!12; <

?1/# >20$7$"$7 ; =<1%

Page 13: Adrenoceptor Antagonists and Haemodynamics - Trepo

-

>## 0!>/# ?$"1 / %" $C%$C#

0#"1% $ %#C#/ %"$#% 0!# ?$"1

8 "1# %# 7 "1# !/%# " 0#"1

/!%%$>/2>##C##%$#0##$/2

C$/>/#8 >" $"% !!/$>$/$"2 # $ 1# !

"$/""#%"$1%">##!C#

1#1#020$#77#"%7!!//8"1#

7$%" /$$//2 %# β "$%"8 1C# >##

#90$##9"#%$C#/28$"$%7"#%#%

"1#"1#β >/$%#0!#

?$"1 "1# %#/#"$C# β "$%"8

"$0//8 $% #"/2 0$/2 %# % "!$/

"#"0#" 7 / 12!#"#%$

/0 *#%!$"# "1# !1"1/0$

0$$%""$8 "$0// $% >%># " "1#

%2%"#0$ $/"$ ?$"1 %#6#" β

>/#C#%##77#"%$"1#$/"2

!/02 %2%"#0% 1#%# #77#"% 1C# >##

1"#$%# " %0# #9"#"8 >" "1#

%%$"$ >#"?## "1#0 "1# !/%0

#""$ 7 "$0// 1% " >##

#%">/$%1# $0// $% 0#">/$%# "11

2"10# +( #F20# +*:8?1$1 $%

? " #9!#%% 0# ##"$ C$"$%

)?#C#8"1##!###7!10$#"$%

!1020$%7!1"1/0$ "$0//

"1# 14$5 #"2!#% $% " /#

C#$//$%0>$#α β "$%"

?$#/2 %# $ "1# "#"0#" 7 12!#"#%$

#%"$C#1#"$%#%#8>" "1###

!>/$%1#"$"%#77#"%%1C#

1#020$ !0#"#% %

1# #%!%#% ""1%"%$%$C#$//

"#"0#"#/%?

1# α >/$ % /7F%$

"0%/%$# %/#/2%# $ "1# "#"0#"7

/?# $2 "" %20!"0% ;,< # "

>#$ !%""$ 12!#!/%$ ;+)< 1#

1#020$#77#"%7 "1#%#α "$%"%

1C# " >## %"$# !!#/2@ /2 "1#

#%!%#%7)+#?

1#!#%#"%"2?%#%$#"#

" 0!/#0#" "1# ?/## "1#

1#020$ #77#"% 7 "1# ##!"

"$%"% !!//8 C#$//8 "$0//8

/7F%$ "0%/%$ +$ " #%"$0"$

"1# #77#"%8 "1# #/$>$/$"2 7 "1# !/%#

"0#"1?%#C/"#

Page 14: Adrenoceptor Antagonists and Haemodynamics - Trepo

#$%

&%'(')*+(,$-'&../.%,)

-,$-*,0

1#"0$#C%%2%"#0;<$%#2

#/" 7 !12%$/$/ 10#%"%$%I $"

"/% )8 >2 "#0!#"#8 +8

0#">/$%08 $/"$8 #%!$"$8

$#%"$ $%>%#1$"#"#7

#7/#9 1 ?$"1 #77##" 7$>#% "%0$""$

$0!/%#% 70 "1# #"/ #C% %2%"#0

; < " #/"# "1# 7"$% 7 !#$!1#/

%8 77##" 7$>#% $C$ 7##>

$70"$ "1" 0/"#% "1# #77##"

%2%"#0 "0$//28 "1# #77##" $%

$C$# $" "1## 0!#"%@ "1#

%20!"1#"$ !%20!"1#"$ $C$%$%

"1">"100$"#?$"1"1#"1$$C$%$8

#"#$ #C% %2%"#0 ;.#%% %"

5'(8$F$,>%558$1#%((-<

%" # % # $#C"# ?$"1 "1#

%2#$%"$7"#!!%$#77#"%7>"1

%20!"1#"$!%20!"1#"$%2%"#0%

+%20!"1#"$ %20!"1#"$ $C$%$%

1C# %2!%#% $ !#$!1#/ /$ >#"?##

"1# #% $$"$ $ "1# "1#

!%"/$$ #77##"% $#C"$ "1# #

%I "1# #"%0$%%$ % ?$"1

#"2/1/$# ; 1< C$ $"$$ 1

##!"%"1#!%20!"1#"$$C$%$8"1#

!%"/$$#"%0$""# 1"$C"#%

0%$$ 1##!"%1#!%"/$$

#77##"% 7 "1# %20!"1#"$ $C$%$ #/#%#

#/$# ;< "1" "% "11

##$ ##!"% ?$"1 "1# #9#!"$ 7

%?#" /% C%$/"2 #% $ "1#

%#/#"/0%/#8?1##"1#%20!"1#"$%2%"#0

#/#%#% 1 #%$# "1# "/

Page 15: Adrenoceptor Antagonists and Haemodynamics - Trepo

#"%0$""#%8 >"1 %20!"1#"$

!%20!"1#"$ %2%"#0% #0!%% C$#"2

7"%0$""#%#0/"%%1%

!0$#8 #%$# "$!1%!1"# ;+<8

$"#%$ 8 #!#!"$# 8 ##!1/$8

%0"%""$ C%"$C# $"#%"$/ !#!"$#

;,># 55:8 # $1#/ 5558

/#C#"/(((8$1#%((-<

1# 1/$#$ #C# #$% "$ 1$1

#""$% 7 2"2/1/$#%"#%#8 8

%#6#"/28 "1# "%0$""# 1 #% "

$77%#$""1#>/%"#01%8"1##77#"%

7 //$%# 1/$#$$%1# #$%#"#

/%" 7>%"77#?0$//$%#%"

"$0#;,#C255&8((-<1$%#>/#%

%?$7" "# #/"$ >2 "1#

!%20!"1#"$#C%%2%"#08#7/#"##

% >#" " >#" #/"$ 7) ;,#C2 5&8

55&< "1# "1# 18 70 "1#

##$ #C# #$% %!#% $" "1#

#$1>$ #//% $/"$ 1# "1#

"? ##% "#1/0$#%8 #/$#

;<!0$#8#/%!#%#"$!/%0

%#6#"/28 "1# %20!"1#"$ $C$%$ 1%

0# !/# $77%# #77#"% "1 "1#

!%20!"1#"$ %2%"#0 ;## ,#C2

55->8,#C255&<

1 1% 7 !$02 #77#"% "1#

$C%/ %2%"#0@ C%$/"$ $

#%%#"$//2 // C%/ >#% ;.#$/ 55'<8

#"$C# 1"!12 ;*$.#% 55-8

# $1#/ 555<8 ##/#"$ $

"$ C#/$"2 #"$C# 0"!12

$ "1# %$"$/ ;< #8 "$C#"$/

;< # )$% +$B# %2%"#0 ;3#" #"

/ 5&8 ,#C2 1?"F 55<8

#"$C# $"!12 #%!#$//2 $ "$/0%/#

;)$$% #" / 5&-8 =$0 /!10

558 #2 #" / 55&< 1# "#" #//

#%!%#% " "1# $#C"$ >2 #

#!##" "1# #%$"$#% 7 $# "2!#% 7

##!"% ;.$ < 7$C# "2!#% 7

0%$$ 1 ##!"% ; /7$#/

$%// 55'8 */$% $1"# 5558

$0#%((<

/)1#%2,%*+(,$-'&../.%,)

68

1##//>$#%7"1#%20!"1#"$$C$%$#

/"# $ "1# $"#0#$/"#/ /0 7

"1$ /0> %!$/ >#"?## "1#

/#C#/% ,- 7"# /#C$ "1# %

!"7 "1$ /0> %!$/#C#%8 "1#

!#/$$ #77##" 7$>#% %2!%#?$"1 "1#

!%"/$$#%$%20!"1#"$/$

%" 7 "1# %2!%#% # $ "1# !C#"#>/

/$1$%B#"""1#C#"#>//0

//"1#?270"1#!!#!"7"1##"

"1# 29 =$"1 7#? #9#!"$%8 "1#

#0$$ %20!"1#"$ /$ # $ "1#

#/ 0#// "1# !#C#"#>/ !/#9%

/"#$7"7"1#"/$"%0B

"#$/ >1#% ;/#C #" / (((8

$1#%((-<

Page 16: Adrenoceptor Antagonists and Haemodynamics - Trepo

:

1# # #77#"% 7 "1# %20!"1#"$

#C% %2%"#0 ;>/# < # 0#$"# >2

##!"% "1" %"$""# 70$/2 7

%""//2 7"$//2 #/"# !"#$%

1#2 >#/ " !"#$ !/# ##!"%

;+ <"1"#?$#!7##!"%7

1#% 7 10#% #"%0$""#%8

# 0%$$ #"2/1/$# ##!"%8

%#"#$ ) ##!"%8 1!%$

!$"# ##!"% // "1# + % %$%" 7

%$/# !/2!#!"$# 1$ ?$"1 ! " ((

0$ $ #%$#% "1" 70 %#C#

"%0#0># α 1#/$#% # 7 "1#

$"#////!%$%/#"1"1#"1#%

$"#"% ?$"1 "1# !"#$ ;=#%% 55'8

)7#/" #" / (((< 1# ##!"% #

$C$# $" "1## /%%#% "1" # // 7"1#

$C$#$""1##%>/%%#%;.$<

#34, #%!%#% 7 $C%/ !/02 #77#" % " %20!"1#"$ #C# $0!/%#% $/"$

"#1/0$#% 1# $#"$ %"#"1 7 "1# #%!%#% # $$"# >2 "1# 0># $#"$ 7 ?%

;)7702/((>8$1#%((-><

55,+%'$'$6#( αααα αααα ββββ ββββ

# )↑↑ )↑ "$ ""$/$"2"$

C#/$"2↑↑ ""$/$"2"$C#/$"2↑

# "$C#/$"2↑↑ "$C#/$"2↑ )$% +$B#%2%"#0 "$C#/$"2↑↑↑ "$C#/$"2↑ #"$/#% ""$/$"28"$

C#/$"28"0"$$"28"#7$$C#"$/!#0#%↑↑↑

""$/$"28"$C#/$"28"0"$$"28"#7$$C#"$/!#0#%↑↑↑

2 *$0#"#↓ *$0#"#↑ *$0#"#↑↑ $0% *$0#"#↓↓↓ *$0#"#↑ #/#"/0%/# *$0#"#↓↓ *$0#"#↑ *$0#"#↑↑ ##>/ *$0#"#↓ +/02 *$0#"#↓ *$0#"#↑ #/ *$0#"#↓↓↓ *$0#"#↑ *$0#"#↑↑

*$0#"#↓↓ *$0#"#↑ *$0#"#↑↑

1#/>1$/0%/# #/9"$↑

1$//% ##"$↓ ##"$↑

#$ ##"$↓ ##"$↑↑

Page 17: Adrenoceptor Antagonists and Haemodynamics - Trepo

&

α

α

β

α

α

α

α

α

α

β

β

β

*6##!"%>"2!#%

#/0#//$%/%"%20!"1#"$

/$@ $" $% $#C"# >2 !#/$$

%20!"1#"$ #% "1" "$C"# $"$$

1##!"%"1#!%"%2!"$"#"#//%

;1077$ #//%< ;$1#% ((-< =1#

%"$0/"#8"1#1077$#//%#/#%#$"

"1#>/%"#08"1$%$%"1#%/#%#7

7 $ !/%0 1%8 #/ 0#//

%#C#% % #$# 0!#" 7

%20!"1#"$ "7/?8 >#$ $/ $ "1#

#/"2$"#!/2>#"?##"1#"1#

#$# %2%"#0 ;$//# P //1

((8#""((-8,#/ ##"/((-<

7&

1# !"#$% # 0#0># !"#$%

$C/C# $ "%0#0># %$//$ 1#2

%$%" 7 "1## %>$"%@ α8 β γ "1#

#%"$ %""#8 !"#$ #9$%"% % αβγ "$0#8 ?$"1 %$# $!1%!1"# ;*+<

""1#""1#α %>$"%$%">$%

" + 8 70"$/ 1# $ "1#

2"!/%0$ 0$ 7 "1# ##!" #"/2

$#%#% "1# 77$$"2 7 "1# + " "1#

!"#$αβγ "$0#%%$"$7+ ?$"1

!"#$ %#% "1# > 7 α %>$" "

*+ " $%%$"# " ># #!/# ?$"1

%$# "$!1%!1"# ;+< 1$%8 $ "8

%#% βγ $0# " %#!"# 70 α +

1#%#"?0!/#9#%#"1#"$C#70%7

!"#$I "1#2 $77%# $ "1# 0#0>#

%%$"# ?$"1 C$% >$1#0$/ #77#"%8

0$/2 #F20#% $ 1#/%8 ?1$1

#%/"% $ "1# "$C"$ $"$C"$ 7

C$% %#% 1# 2/# $% 0!/#"# %

+$%12/2%#"*+?$"1"1#1#/!7"1#

+%# 7 "1# α %>$"8 ?1##! "1# α

*+ 0!/#9 $%%$"#% 70 "1# #77#"

#$"#% ?$"1 βγ $0# ; /$

# 55-8 /!10## 55&8=#%%

55'<

Page 18: Adrenoceptor Antagonists and Haemodynamics - Trepo

'

#34,##!"%8$77##" !"#$%"1##/"#%#0#%%##%, "2!#1#/%#C/"#

!#"#/$01#/%#2/2/2/%#"/2%#%"1#70"$72/$#$#0!1%!1"#;+<1#

$#"$%7"1##77#"%#$$"#>2"1#?%;0$7$#70)7702/((><

7$,('+,1%'$ 81$'%,*( *'+2,)*+#4,55,+%'$.

β % ↑#2/2/2/%#8↑, "2!# J1#/%

β % ↑#2/2/2/%#

β- % ↑#2/2/2/%#

α 6 ↑!1%!1/$!%# *

68$G ↑!1%!1/$!%#

6 ↑ J1#/%D

α $8- ↓#2/2/2/%#

$ ↑3J1#/%

↓ J1#/%;, "2!#<

D ↑!1%!1/$!%#

1## # ( ? 70% 7 "1# α %>$"

;α α(<8%$97"1#β %>$";β β:<7

"1# γ %>$" ;γ γ< 1# %!#$7$$"2 7

$"#/// + #77#"% $% >%# "1$%

C$"$ ?$"1$ "1# !"#$ ;=#%% 55'<8

0%"/2α %>$"C$"$ !"#$%

># /%%$7$# $ " "1# $C/C#

0>$"$ 7 "1# "1## %>$"% $" 7

0$ "#$#%@%8$86 ;)770

2/((80((-<1"2!#7

!"#$%%1?%%!#$7$$"2 ">"1##!"%

"1# #77#"% ?$"1 ?1$1 "1#2 !/#

;>/#<

#C#/ !/20!1$%0% 1C# >## $%C##

$ "1# %>$"% 7 !"#$% %$/#

/#"$# !/20!1$%0 ;+< 7 "1# β-

%>$" 1% >## %%$"# ?$"1 /? !/%0

#$ "$C$"28 "1$% + 02 $#"$72

$$C$/% ?$"1 %$0 %#%$"$C#

12!#"#%$ #%!%$C# " $#"$%

;1#"#"/55'8##"/((<

"1###7-#$α %>$"8"1##$%

%$/#"+">%#/%-5-8?1##"120$#$%

#!/# >2 2"%$# ;-5- < 1$% + $%

%%$"#?$"1"1#!#%##;J<>%##; <

7 #%"$"$ %$"# 7 98 %$

!"$#"%?$"198J//#/##%!>#""#""1#

"$12!#"#%$C##%% 7 β "$%"% "1

!"$#"%?$"198 //#/#;H$#"/555<

1.1.2.3 α& α ##!"%

Page 19: Adrenoceptor Antagonists and Haemodynamics - Trepo

5

/"11 %""//2 /%#/2 #/"#8 "1#

$77##" ##!"% "/ %2"1#%$%

#/#%# 7 C$% %# 0#%%##% ;>/#

<8 "1% #/"# $%"$" !12%$/$/

%#% 3?/## 7 "1# !!#"$#%

$%"$>"$% 7 "1# α β ##!"

%>"2!#% $ #1 #// "2!# $%

##%%2 " #%" "1#$C#%# #77#"% 7

"#1/0$#% "1# % ?$"1

%20!"10$0#"$%20!"1/2"$#77#"%

)0α ##!"%##"/2$C$#

$""1##%>"2!#%;.$<@α8αα*8

?1$1 # ## $ $77##" ##% $

10%0#%'8(8#%!#"$C#/2;)$#>/#

#" / 558 # $1#/ 555< 1##

# %#C#/ %!/$# C$"% 7 %>"2!# α

$77#$$/#"1"1#%#6##7"1#$

"#0$/0$%;)$%?#"/558 1

#" / 55'<8 >"8 $0!""/28

!10/$/%$//$$77###%1C#

>##>%#C#; 1#"/55'<

1#α ##!"%0#$"#02"$%7

##% "#1/0$#%8 "1# 0$

#%!%#% >#$ ""$ 7 "#$/

C#% %0"1 0%/# ;>/# < %/

%0"10%/#"$%%#%#9!#%%0$9"#%7α

##!" %>"2!#% ;# #" / 555<

1#C%%"$"2#77#"$10%02>#

!$0$/2 0#$"# >2 "1# %>"2!# α8 >"

0%" !>>/2 %#C#/ %>"2!#% # $C/C#

; # 7 #" / 55:8 Q1

$#055582/# "1 (((<

α $% "1# 0%" >" α %>"2!# $ "1#

1#"8 >" "1# C#// $"!1$

1"!1$ #77#"% 0#$"# >2 α

##!"% # %0// 0!# ?$"1 "1#

#77#"%0#$"#>2β ##!"%;"#$7"1

#"/558"#$7"1#"/55>8#

$1#/555<

1# α ##!"% $ "1# /?# $2

"" "$>"# " "1# "7/? #%$%"# 7

$# ;=/# #" / 5558 #1>

1?$ ((< %"0 !%/# 7 "1#

!%""#8 $ "$# 7 "1# >/#8 α

%>"2!# C#?1#/0$/2 !#0$"#% ?$"1

α* ##!"% !#%#" " /#%%# #9"#"

;=/# #" / 5558 *#>2# (((< α*

%>"2!# $% "1# 0B ##!" $ "1#

>/# #"% 0%/# ;//2 #" / 55'8

)0!#/ #" / ((< 1# 0$ /"$% 7

α ##!"% # 8 %!/## /%

;+$##"/558,#555<

1# /2 #"/2 ? %220%

!/20!1$%0 $ α ##!"% $% "1#

*1 $ α ##!"

%>%"$""$ 7 $$# >2 2%"#$# " 0$

$ !%$"$ 5 >" $" #% " %##0 "

!#%#" 2 "#?"12 !12%$/$

!10/$ C$"$ ;,$#"" ((-8

7?#"/((<

Page 20: Adrenoceptor Antagonists and Haemodynamics - Trepo

(

α ##!"%

+#%2!"$ α ##!"% 0$/2 "1#

%2>"2!#α # !>>/2 !#%#" $ // "1#

"#$#% C#$%8 ?1## "1#2 0#$"#

#"$C#7##>""1##/#%#7;"#

5'&8 $0#% #" / 55&8 ,# 55&8

*1#"2 55'8 ) #" / 55'< "1#

#"1#/$0 7 /# "#$#%

0$$/"$8 "$C"$ 7 α

##!"% %"$0/"#% "1# #/#%# 7 $"$

9$# ;<8 "1% 0#$"#% #"1#/$0

#!##" #/9"$ ;% #" / 5':8

$1 #" / 55(8 0 #" / 55-<

1#%# α #77#"% "# " ""#"#

C%%"$"$ !# >2 "$C"$ 7

!%"%2!"$ C%/ α ##!"%

;$0#%((<

1# !%"%2!"$ α ##!"% # 7

0$/2 $ C#$%8 >" /% $ #"$ "#$#%

?$"1 C%%"$"2 $7/## ;C$ #" /

55&8 $0#% #" / 55&8 )#

55'8$0#%((8*$##"

/ ((8 *$# #" / ((>< /%8

%"$0/"$7!%"B"$/α ##!"%

$ "1# /?# >$%"#0 #$ $% %%$"#

?$"1 ## %20!"1#"$ "7/? 70 "1#

8 "1$% 1% >## !!%# " ># "1#

0#1$%0 7 "1# "$12!#"#%$C# #77#" 7

/$$# ;)770 ((< +#"$ α

##!"% $1$>$" $%/$ %##"$

;0F$ #" / 5'8*#>2%# #" / 558

+/"#"/55<

1 7 "1# α ##!" %>"2!#% %1?

%220%!/20!1$%08%0#7"1#0

>#$70B/$$/$0!";,$#""((-<

#/#"$ 7 0$ #%$#% - - $

α ##!" %#% %>%""$//2

!/# ##!" 1% >## #!"# "

1C# 7$C#7/ $#%# $ "1# $% 7

#C#/!$1#"7$/#;0//#"/((<

$"$8 0>$"$ 7 "1$% //#/# ?$"1 "1#

'*707β ##!">$%>"

"#7/ $% 7 1#" 7$/# ;0// #" /

((<

β& β ##!"%

1## β ##!" %>"2!#% 1C# >##

/#%7@β8ββ-8#$%#!"#

##% $ 10%0#% (8 '8

#%!#"$C#/2 ;2/ #" / 55<β β

##!"% 0#$"# 0$/2 $C%/

!/02 #%!%#% " $/"$ "

"1# #/#%# 70 %20!"1#"$ #C#

"#0$/% ;,% #" / 5:&8 ,% #" /

5:&>< "1# 1#"8 "1# "$ βGβ $% >"

:( &(G-( ($"1#"$&( '(G( -($"1#

C#"$/#% ;# 55<8 >"1 7 "1#%#

%>"2!#% # $C/C# $ "1# !%$"$C#

1"!$8 $"!$8 /%$"!$ ;#/9"<

Page 21: Adrenoceptor Antagonists and Haemodynamics - Trepo

0"!$ #77#"% "1# $#%#

"0"$$"27!#0# "$%%#% ;#?"#"

/ 5558 +C$# *#7# ((< "1#

$0!""β 0#$"##77#" $% "1# $#%$

#/#%#7#$70"1##/B9"/0#/

!!"% ;*#%//#% #" / 5&'8 "#% #" /

5&'8 =#># #" / 5'-< #

#6//2 !"#" "1# β ##!"

;)770#"/((<

? +% 1C# >## $%C## $ "1# β

##!" ## 6@ '*7 "1"

%#%%>%"$""$7$$#>2/2$#"

0$ $ !%$"$ -'58 *7 "1"

#!/#% %#$# ?$"1 /2$# " !%$"$ 5

;,$#""((-80//#"/((-<+8"1#

?$/ "2!# '* 70 ;&- R 7#6#2 $

%$%< 7 "1# '*7 !/20!1$%0

!#% $#%# 1$1 77$$"2 $%"

>$$#1##2/2/%#"$C$"$#%

0!#?$"1"1#707 '*8?1$11%"1#

7#6#27"1##0$$&R;%#"/

5558,$#""((-80//#"/((-<1#)

#9!#$0#"%10"$/!#!"$%

1C# 2$#/# C2$ #%/"%@ #$"1# "1#

'*7 !/20!1$%01%"#9#"#2

#77#"% ;/# #" / ((8 %# #" /

((-<8"1#'*C$"1%#0%""#

#"# $"!$ 2/$ #$#

0!1%!1"#;+<#%!%#%""1

"1#7 '*C$";$/%#"/((-<

/$$/ %"$#%8 $77###% $ )8

""$/$"2!/%0#$"$C$"2#%!%#%

" >$2/# #9#$%# >#"?## "1# '*

7 '*1C#>##7;%1##"/((8

7?#"/((-8,#$#?#>##"/((<

'* 10F2"#% # " $#%# $% 7

#C#/!$ 12!#"#%$ ;#"%% #" /

((< "1# "1# 18 "1# %0# !"$#"%

1C# %1? #"# #"$ 7 $%"/$

"#$/ !#%%# ;*+< $ 0#"!//

"#// "#"0#" 0!# ?$"1 "1# C$"

//#/# $%0#;H1%#"/((-87?

#" / ((-< "11 " // %"$#%

;P11#%%2#"/(((<

1# 7 * //#/# ; R 7#6#2 $

%$%<7 "1#*7 !/20!1$%0$%

%%$"# ?$"1 #"# $%" !0"#

? #/"$ /"## /2%2/"$ 7

"1#β ##!"$10%"#7$>>/%"%;,#C$#"

/((8"1F#"/((<1#+1%"

12#77#"%$"1##9!#$0#"%?$"110

"$/ !#!"$% ;%# #" / ((-<

/$$/ %#""$%8 "1# %>B#"% ?$"1

10F2%$"2 7 "1#7 * //#/#1>!0

/?# #%"$ ) "1 "1# 0!$% !

;# #" / ((<8 "1## 1% >##

"# "? #"# + #%!%# "

0#"!// $ * 10F2"#% 0!#

?$"17 *$#%;H1%#"/((-<

β ##!"%

1#/#7β ##!"%$"1###$

$ #77#"% ;>/# < $% 0# !0$#"

Page 22: Adrenoceptor Antagonists and Haemodynamics - Trepo

"1 "1# %1## 6"$""$C# "$ βGβ ?/

B%"$72 1$% $% # " "1# 7" "1" β

##!"% !/# 0# #77#"$C#/2 "

#2/2/ 2/%# "1β ##!"% ;,#C2

#" / 55-8# $1#/ 555< 1#%#

#77#"% >#0# #C# 0# !# $

7$/$ # 1#"% ;# $1#/

555< $"$8 β ##!"% 0#$"#

>1$/"$8 $#%# %##"$ 70

>1$/ /% C%$/"$ $ 0%"

>/ C#%%#/% β ##!"% #91$>$" >"

- 7/ 1$1# 77$$"2 7 "1 7

;$1#/558)770#"/((<

1# "1## ? +% ?$"1$ β

##!"% # " 0$ $ !%$"$% :8

& : 1#%# %# 1#% $ $%"

!0"# ? #/"$8 1$1 77$$"2

$%">$$%!/$+5//#/#

1% >## #!"# " ># %%$"# ?$"1 '

7/ $% 7 0"/$"2 $ !"$#"% ?$"1 1#"

7$/# ;,$#""#"/55'<#$1"7/ $%

7 1C$ #!#%%# #9#$%# !$"2

;=##"/(((8=##"/((<

%"108 C$" //#/# $ "1# !%$"$ : $%

0#/2 %%$"#?$"1 "12!12/9$% " β

$%" ;%#/ #" / ((< 0>$"$% 7

#"$ !/20!1$%0% #/"# "

12!##"$C$"2 7 $?2% ;,$"B #" /

((<

β- ##!"%

1# 7$%" #/$"# /#% 7 "1# β-

##!" ?## !0"$ 7 /$!/2%$% $

$!%# "$%%# ;1 #" / 5'<

"1#0##%$% ;0$# #" / 558

%% #" / 55< ,"#8 %/$1" β-

0#$"# #"$C# 1"!$ ;"1$# #"

/ 55'8$""# #" / ((< $"!$

;"1$# #" / 55'< $7/## 1% >##

7 β- ##!"% # /% !#%#" $

>/C#%%#/%8?1##"1#20#$"#C%$/"$

$>"1!#$!1#/C#%%#/% ;#/#"/558

1##"/55<2"#$#%;*#%%2

#" / ((< 1# !10/2 7 β-

##!"$%/#/2$%"$"70"1"7β

β ##!"%@ "1# 7$%" $% " >/#

>2 !!// "1# C#"$/ β

"$%"%8 $" $% >" ( -( 7/ 0#

%#%$"$C# " "1 " ;,$#"" 558

$0#% ((8)770 #" /

((< +/20!1$%0 $ "1# β- ##!"

02># #/"# ">#%$"2 "2!#$>#"#%

$ %0# !!/"$%8 >" "1# #!"% # "

%$%"#";,$#""((-80//#"/((-<

#,)'7/(#)*+1#$#),%,$.#(7

$,6&4#%*'(

,5*(*%*'(.

1# $C%/ 1#020$

C$>/#% # $"#"?$# ?$"1 #1 "1#

"11 02 $"##!##$#% "1#

Page 23: Adrenoceptor Antagonists and Haemodynamics - Trepo

-

%$0/"#% !#"$ 7 0/"$"# 7

#/"$0#1$%0%;.$<

$% #7$# % "1# !" 7)

$% #"#0$#>202$/ ""$/$"28

!#/7"#/2$/""$/$"2

$% !#/2 $ 7" %$# $" $%

1"#$%"$ 7 $ "$%%#%8 #C# "11

0/"# >2 C$% #/ 10/

0#1$%0% $C# %"" ""$/$"28

"1# . "/$O% /? %""#% "1" "1#

09$00 "#%$ $ 0%/# #C#/!%

#!#% "1# %0## /#"1 B%" >#7#

%2%"/# ;,"" 55< $%"/$ C/0#

!#%%# # %"# !0#"#% 7

%0##/#"18//7"1#%##0#%#%

7 !#/ 1# "1$ $/ 7" $ %$F$

$% "1# 7# "1" "1# ""$022"#%

0%"C#0#1$%$%7"#%>%"$""#7

0# !"$/ !0#"#8 %2%"/$ "#$/

!#%%#;+<8>"17"1#%##0#%#%

7 7"#/ ;/!#! ((-< 0!""/28

!#/ 7"#/ #" 1#"

C%/"# $" "1# %0# #/"2

01$#28 "1#2 # //# !/$

7"% %$# "1#2 #8 $ $"$ " >#$

#"#0$"%7 8 /% 77#"#>2

#"$ "1# $C%/ 1"#$%"$%

;##,#C255-<

!

"

#

*6 1# "/ 7 $"#!/2 >#"?## 1#020$ !0#"#% 0# $"#"$% 7 0$ #77#" #

$# 1# "1$ /$#% #!#%#" %""$ !$"% 70B 7##> /!% / C/0# $% %%0# %"" 8

$"!"I)81#""#I+80#"#$/!#%%#I8%"#C/0#I8%2%"#0$C%/#%$%"#

Page 24: Adrenoceptor Antagonists and Haemodynamics - Trepo

8 ""/!#$!1#/ #%$%"#8 #!#%#"%

"1# %0 7 #%$%"#% $ 0/"$!/# !//#/

#$/ C%/ >#% 1# %$"# 7 "1#

#%$%"# $% !#0$"/2 $ "1# %0//

"#$#% "#$/#%8 $# "1# #%$%"#

C#%%#/%$%#7$#>2"1##6"$

[ ][ ]G'(G

0$GG

G<;

1:$

!1:$

1$:$3

⋅⋅=

⋅≅

−=

8 ;<

?1##"1#0#$1""$/!#%%#$>#

#/#"#%$#$"$%$0$"$C#0!#?$"1

"1# 0# "#$/ !#%%# ;+< 1# $"

2 $%G;% S 0<1#%""'( $ "1# /%"

0%" 7"# %# 70 7 "1# #6"$ $%

>1" / >2 "1# 1# 7 "1# $"% 7

+ ;%#5'-<

,6&4#%'$/),+2#(*.).

$/"2 B%"0#"% # ##%%2 "

%## #6"# !#7%$ !#%%# "1#

%>%#6#" >/ %!!/2 " "$C# "$%%#%8 %

?#//%"$#%###%#1#"/%%8

$ "$0#% 7 1//##% %1 % %#C##

1#01# "0$"$ "1# >/ 7/? "

"1# 1#" >$ 1#/"12 0"#%$C#

$$C$/%8 "1# $#2 $% #"/ $ %#""$

/ "#0 "#$/ !#%%# ;,10#$# ((8

=2%% /%((8*$((<8?1$/#

$% "11" " ># !$0$/2 %1" "#0

#/" 0$"$$ "1# "#$/ !#%%#

# "# 1//##% %1 % "1%"%$%8

%"#%%!12%$/#9#$%#;=2%% /%

((< 1# !#%%# %#%% "1" "$C"#

#"$C"# # %"#"1 ##!"% //#

>##!"% 1# 0%" $0!""

>##!"% /$# $ "1# C#"$"$ /2# 7

"$1"$%$%#%7+$%#%

"1# >##!"% %"#"18 "1# 7$$ >2 "1#

>##!"%""1#0#//>/"C$"1#

;5"1$/#C#<

;("1< $#%#% : "8

#%!#$//2 8 $% 7

!$02 $0!"# $ "1# $#%!$"2

#7/#9 $"#"$ #/"$ 7

%20!"1#"$ "$C$"2 ;#%# 3F#

558 /0>$#"/((<! $#%#

77##" "$C$"28 " #9$"#%

C/ $1$>$"% %20!"1#"$ $#C"$ "

"1# !#0# #//% 7 "1# 1#"8 C#"$/#8

#%$%"# "#$#% !$"2 C#%%#/%8

%$ >2$8 #$ $"!128

!$C%$/"$C#$/"$; 1

55<1#%#B%"0#"%##%#+>"

"1# %#" !$" 7 "1# >##!"

!"1/$/ %""#%8 "1# %#"!$"02># #%#"

" 1$1# !#%%# /#C#/8 12!#"#%$

7//?% ;/#$1" 558 %%$ #" / 55'8

"%%((<

%$/28 "1## # "?!0#"#% " B%" $

# " 0$"$ "#$/ !#%%#@

$0#"#7"1##%$%"#C#%%#/%;.$<

># C$# >2 1$) ) $%

0$/2 "//# >2 >"1 %20!"1#"$

!%20!"1#"$ $C$%$% 7 =1#

Page 25: Adrenoceptor Antagonists and Haemodynamics - Trepo

"1#%# "0$ %2%"#0% " 0$""/28

"1# $"#"$% # 0!/#98 " %$0!/2

$"$C#/#>$//2;,#C255&8!$#55'<

#%"$%""#8"1##$%"$$%1#70

>"1 $C$%$%8 >" "1# !%20!"1#"$

$0!/%#% !#C$/ ! "$C"$ 7

%20!"1#"$ $C$%$8 1/$#$ %"$0/"$

##%#%8>"17"1#%#1#%%?#//%

$/"$ "#1/0$#% 1C# !%$"$C#

1"!1$#77#"$#%#)

20!"1#"$ %"$0/$ %"#"1# "1#

""$% $#%# ""$/$"2 7

02$/ 0%/#8 #"# !"$ 7

"1#>/$%#9!#//#"7"1#C#"$/#%

$#%#%1$%!%$"$C#$"!1$#77#"$%

0#"# >2 $/"$ "#1/0$#%

#"$ !10#"$/%8 ?1$/#

!%20!"1#"$ %"$0/$ 1C# "1# !!%$"#

#77#";/!#!((-<

1# 0># #77#" 7 $ α

##!"% $% /?8 "1# $

%20!"1#"$#77#"%#0$/20#$"#>2β

β ##!"% )?#C#8 "1# α

##$ %"$0/"$ 1% /# $$#"

#77#"%8 %$# α ##!" 0#$"#

C#%"$"$#%/"%$$#%#C#%

#" "1" 7$/$""#% $ 7$//$

#1#% !#/8 "#$/ %"$"$

#%/"% $ $#%# "#$/ #%$%"# "1"

0#"%"#$/!#%%#7"#/

%"C%/>#%1C# $"$%$!!#"2

" B%" "1# /$># 7 "1# C#%%#/ % "1#

!#7%$ !#%%# 1#%8 !>>/2 " /#%"

!"/2 # " ""$/# #%!%# "

%"#"1$ 7 %0"1 0%/# $ "1# ?//% 7

>/ C#%%#/% "1# 0#"1% 7 //

#/"$ 0!$%# ///2 !#

C%$/" 0#">/$"#% %>%"#%

%##"# >2 #"1#/$0 ;#1#" F

((<1#%2%"#0$#/"$7"1#$0#"#

7 >/ C#%%#/% %$%"% 7 #/

10/ "/ "#$/#% "1#

#%$%"# C#%%#/% # "1# 0%" #%#/2

$#C"# #%8 >" // "1# >/ C#%%#/%

#9#!" !$//$#% C#/#% #0!%%

7$>#% 70 "1# %20!"1#"$ #C% %2%"#0

1# !%20!"1#"$ %2%"#0 #% "

$#C"# >/ C#%%#/% 1# C%$/"2

10#% $/#$$%8C%"$C# $"#%"$/

!#!"$# ;+< "$/ "$#"$ !#!"$#

;+<8 ?1$/# 8 8 C%!#%%$

$"#%$ %"$" >/ C#%%#/%

;#%# 3F# 558 %1// 558

/!#!((-<

$%,$*#4+')14*#(+,#(71&4.,0#-,

-,4'+*%/

"#$/0!/$#

3 $ 31 ∆∆≅= GG ;<

$%#"#0$"7"1#%"#!$"27"1#

"#$#% $ %2%"/# *$ $%"/#8 "1#

Page 26: Adrenoceptor Antagonists and Haemodynamics - Trepo

:

%"# >/ 7/?% 70 "1# "#$/ "##

7? " !#$!1#28 %#$ "$%

>/ %!!/2I "1$% #$/ $% //#=$#%%#/

#77#" 1#% $ 0!/$# $# >2

%8!12%$/$#%!%#%8$$%#%#

02 1C# %"$$ $0!"8 %$# "1#

#%$%"#""1#7/?$%$C#%#/2!!"$/

" "1# "1 !?# 7 "1# $0#"# 7 "1# ">#8

$ " "1# +$%#$//#O% /? ;/!#!

((->8,#=$"#%/((<

1# #/%"$$"2 7 !9$0/ /# "#$#% $%

%#6## 7 1$1 #/%"$ " //# "$

$"1#"#$/?//1#0%"!0$#"7"

#/"# " %"$77#C#%%#/% $%$8?1$1 /#%

" !#%%$C# ###"$ 7 "#$/ ?//

#/%"$ 7$>#% $#%# //# "#"

;C/$ #" / 55'< *##%# "#$/

0!/$# $# $#%# %"$77#%% $%

$0!"" #"#0$" 7 $C%/ $%

;/1# #" / 55'8 /1# #" / 5558

#$ #" / ((8 ,#" #" / ((8

"1 #" / ((8#> #" / ((8

"2$##"/((<1#0#"1%%#7

%%#%%0#" 7 "1# "#$/ 0!/$# #

0#%#0#" 7 "#$/ +=8 C/0#

%$//0#"2 0#"18 %$0/"#%

0#%#0#"7"#$/!/%#!#%%#"1#

%2%"/$ 1# $ "#$/ $0#"# %$

/"%;"#$!/%#"/558%0#"

/558"#$!/%#"/558,$#"/

55'84$#"/(((8=$$>#(((<

*$ #1 1#" >#" !/%# ?C# "C#/%

70 "1# 1#" ? "1# "#$/ ?// $

C# 7 >/ 7/? ;,"" 5'5< 1#

0#$$"1#?//7"1#"#28"1#7%"#"1#

?C#0C#% 1%8 += $% $C#%#/2 #/"#

""1#"#$/0!/$#=1#"1#?C#1$"%

"1#0B >1$ !$"%8 %1 % "1# #/

7#0/"#$#%8"1#%#?C#%##7/#"#

"1#2 "C#/ > " "1#$ !$" 7 $$

;+2"1#"/55:<0//28 "1# #7/#"#

?C# #"% > " "1# %""$ !$" 7"# "1#

"$C/C#$%/%#1$%0!/$7$#%*+

7$/$""#% >/ 7/? " "1# 2 "#$#%

;P# 558 , #$ 5558

$1/% ?% ((< )?#C#8 "1#

$#%# += 7 "1# $$"$/ ?C# "1#

%>%#6#"#7/#"#?C#02%#"1#?C#

"#"""1#"$C/C#>#7#"1$%/%#%

1$% #%/"% $ $#%# $+"1# "1

*+ ;$1/% ?% ((8 ##%

((<"/%##%#%"1#"$>"$7"1#

#7/#"# ?C# " "1# 7$//$ 7 "1# 2

"#$#%>%#6#"/28+=$%$#!##"

!#$" 7 $C%/ 0"/$"2 $ 1$1

$%$$C$/%@"1#7%"#"1#+=8"1#1$1#

"1# $% ;/1# #" / 5558 , #" /

((8$1/%?%((81B$#" /

((8 $%1 #" / ((8 7 #" /

((>8 /1# #" / ((-< += >#

#%"$0"# >2 C$#"2 7 0#"1%8 $/$

*!!/# /"%8 /2%$% 7 "1# !/%#

"8 0#"$ #%# "$

$0!## 0#"1% ;? #" / ((8

3AA>$#"/((-<

Page 27: Adrenoceptor Antagonists and Haemodynamics - Trepo

&

,.%.'(%2,+'(%$'4#(75&(+%*'(

'52#,)'7/(#)*+.

C$#"2 7 "#%"% 1C# >## #C#/!# 7

/$$/%%#%%0#"7""/"0$"$C$"2

$77##" %@ #)C$>$/$"28 1#"

"# ">/## ;F$ 10$" ((<8

>##!" %#%$"$C$"2 ;+"$ #" / (((<8

!%%$C# "1%"%$% "1# 7//?$8)

C$>$/$"2 !%%$C# "1%"%$% #

!#%#"#$0##"$/

,#$%$#%,-#$*#3*4*%/

$% "1#0%" $0!"" "//# 7)8

"1% %%#%%$ /2%$ "1#

7/""$% $ ) $% "#?2 " #%"$0"#

"0$ 7"$ ;%#/ #" / 5'8

+$ #" / 5':8 $/#2 #" / 55:8 %

.#55:<//"1#/2%#%7)C$>$/$"2

# >%# "1# $"#C/% ;< "1" #

$"#C/% >#"?## B#" 4 0!/#9#%

#%/"$ 70 %$% # #!/$%"$%

% ># /2%# $ #$"1# "$0#

7#6#2 0$ ;% .# 55:<

/$#"#1$6#%81%"1#2/2%$%7

7"/>#1C$1C#/%>##%#8>" "1#

!12%$/$/ $"#!#""$% 7 0%" 7 "1#%#

0#"1%#"2#"#%">/$%1#

$0# 0$ /2%$% 0!$%#% C$#"2 7

//"#$$#%1#%$0!/#%"0#%#$%"1#

%"#C$"$7"1#%;*<8>"$"

$% " ?#// #7$# >$"$/2 %#/#"#

%>#%#7$"%#!###"1#/#"1

7 #$ !#$ "1# !%%$>$/$"2 $% "

/2%# "1# $77###% >#"?## "1# B#"

%1#0%"/2%#7 "1#%#!0#"#% $%

%6#"7"1#0#%6#$77###%7

%#%%$C# % ;*<8 $" $% %$">/#

#%!#$//2 7 7$$ "1# %1" "#0

0!#"% 7 ) C$>$/$"2 ;% .#

55:<

.#6#20$ %!#"/ /2%$% 7)

C$>$/$"2 %#!"#% "1# $77##" 7/""$

7#6#$#% ?$"1$ "1# " 1# %1$7" 70

"$0# " 7#6#2 0$ $% 0%" 7"#

!#70#?$"1 7%" .$# "%70 ;..<8

>""##%%$C#0#/#%"$0"$%#0#

%$">/# $ #"$ %#% !#"/ /2%$% 7

) C$>$/$"2 ##%%$""#% %""$$"2 7 "1#

";//$$#"/558T$#"/55<

)?#C#80%"!12%$/$!1#0##"

%""$2 7 "#8 "1# " $% "2!$//2

!#!#%%# ?$"1 0"1#0"$/ "#1$6#%

/$# #"#$ 7$/"#$ $ # "

$#%#%""$$"2;+#F5&'<

!#"/ 0#"1% !# %!#"0 7 )

C$>$/$"28 $C$# $" 70B 7#6#2

>%@ 1$1 7#6#2 ;).< ( ()F8 /?

7#6#2 ;,.< (( ( )F8 C#2 /?

7#6#2;,.<(((- (()F/" /?

7#6#2 ;,.< U(((- )F 1#%#

0!#"% #!#%#" 7/""$% ?$"1

Page 28: Adrenoceptor Antagonists and Haemodynamics - Trepo

'

!#$$$"27 &%8& %8% :0$

V:0$8 #%!#"$C#/2*$77##" $$#%>#

//"#"#%$>#"1#>%/"##/"$C#

%$F# 7 #1 7 "1# 0!#"% //2

"//# #%!$"2 %$% 12"10$

;3"H$15&8>#5'-8((-<$%

?#// ? %# 7 ) C$>$/$"2

7/""$% $# >#"1$ 7#6#2 $%

1/2 ( )F ;#6/% " "$0#% !#

0$"#<8 "1$%0$"#% "1#).0!#"7

"1#)C$>$/$"2%!#"0; 1#%%#"/5&8

+$ #" / 5':8 $/#2 #" / 55:8 %

.# 55:< 1# //2 0$$%"## M

>/$ % "#//8 >$%!//

!!// # ? " $#%# "1# ).

0!#" # " ##%# %20!"1#"$

$#%# !%20!"1#"$ 0/"$

;+%%#"#"/55:8,$#"/5558,0!#"

#"/((-<

1# $"#!#""$ 7 "1# ,. 0!#" $%

"C#%$//"$C$"2 $%? ">#

0B"$>"; 1#%%#"/5&8%#/

#" / 5'8 %#/ #" / 5'<8 >" "1#

/$$/ #9!#$0#"/ %"$#% ?$"1

%20!"10$0#"$ %20!"1/2"$ #"%

1C# 2$#/# C$>/# #%/"% ; 1#%% #" /

5&8 %#/ #" / 5'8 %#/ #" /

5'8+0#F#"/5'8+$#"/5':8

###"/55-8C###"/55&<

#$"1# # "1# >% 7 "1# ,.

,.#%#6"#/2?/"$C$"2

%##0% " /#/2 0/"# /% "1#%# #%

;%#/ #" / 5'8 +$ #" / 5':8

2/ #" / 55'<8 ?1$/# #$ $"#%$

%2%"#0 ;%#/ #" / 5'8 2/ #" /

55'< "1#0#/"$ ;,$6C$%" #" /

5'58"%%((-<1C#%0//#/#%

##%# $ ) C$>$/$"2 1% /$$/

!%"$ C/#8 %$# $" 1% >## %%$"#

?$"1 $#%# 0"/$"2 $ !"$#"% ?$"1

1$ 1#" 7$/# ;/$$# #" / (((8

C##"/((8,C###"/((-<

2"#2$%#%#;3/#$##"/5'&<

#..*-,'$%2'.%#.*.92,#78&1%*4%

+10#%"%$%$%1//##>20C#0#""

!$1" !%$"$@ "1# >2 0%"

00"#""1##77#"%7C$"2"1""#

" %1$7" /# 0"% 7 >/ 70 #"/

C#$%">0#!#$!1#2."%%1

% "1# #$ $"#%$ /%"## %2%"#0

!/2/#C#/#!#$8>""1#"#

0!#%"$$%"//#>2

*# " "1# $#%# 12%""$ !#%%#8

C#% #" %$#>/2 ##%#% !

%%0$ "1#!$1"!%$"$1$% /#% "

##%# $ $ 7$//$ # $%"/$

C/0#8 " %#6#" ! 7 1/2

-( (R $ ;.$ -< $# +

#$#"/2!!"$/ "8#/$# $+

$00#$"#/2 "$C"#% "1# 0!#%"2

0#1$%0%;.$<>2 "1#>##!"%

% //# $!/02 ##!"% $ "$8

#"/ C#$% !/02 $/"$ 1#

Page 29: Adrenoceptor Antagonists and Haemodynamics - Trepo

5

#%/"$ !0!" ##%# $ "1#

!%20!"1#"$ "% "1# $#%# $ "1#

%20!"1#"$ "% #/#"#) >2 ( R

$#%# $"!12 "1" 0!#%"#%

##%# $ 7$//$ $0!""

$"$/0!#%"27"$%"1##1#

%20!"1#"$ "$C$"2 7 /# 0%/#% ?1$1

#%"$"% "1# C#% !/$ 7 >/ 7"#

%"$! ;/A7 =//$ 5&'8

?%# ((-< 1#%# 1#% 0>$#8

/2##%#%>2!!9$0"#/2 (R

% $#%#% " "1# %0# "$0#8 +

#0$% 1#8 ?1$/# *+ 02 #C#

%/$1"/2$#%#;1C$##"/((-<

*$%#% 7 #%/"$ $ %20!"1#"$

7$/#7"# %#"1%""$ $"/## "1"

C$#% 70 %20!"0"$ ##%# 7 +

"//!%##C# "%$#" %2%"/# ;

?%# ((-< $ $% %%$"# ?$"1

>"1 ## >$/$"2 " ?$"1? "1# C/

"$C$"2 ""#"# >##!" #7/#9#%

;1$0 #" / 5'8 0$"1 #" / 5'&8

1 #" / 55<8 ?1$1 #%/" $

$#%# $% 7 "1%""$ $"/## 1#

0#1$%0% $C/C# 7"# ># $%#

$7 "1# #"$/# 1#020$% $% 0$"#

$1# !"$/";*#1#"/5'83#2

#" / 5'&8/#2 #" / 5''8/06$%" #"

/ 5'58 $/%"#$ #" / 5'58 "1$% #" /

5583!555<

*6 #%!%#% $ %"# C/0# ;<8 1#" "#

;)<8 $ "!" ; <8 "#$/ >/ !#%%#

;+<8 %2%"#0$ C%/ #%$%"# $#9 ;<

!/%# ?C# C#/$"2 ;+=< " !%%$C# 1# ! "$/"

1# %>B#" $% "# 70 %!$# " :(W " "1# "$0#

!$"#"#>"%!$#!%$"$"1#

+?$? $/#% %2%"/$ ;!!#0%" /$#<80#

;0$/#<$%"/$;/?#0%"<!#%%#%

:,$+*.,%,.%

/$$/#9#$%#"#%"%1C#>###C#/!#"

#90$# "1# !12%$/ #%!#$//2

$#%!$"2 !$"28 "1# /#C#/

0#1$%0% 7 !#70# #%"$"$ 1#

#9#$%#"#%"$%0%"7"#!#70#>2%$

#/#"$//2>#>$2/#"#0$//

#0#"# 1# %" #9#$%# "#%" 7%#%

"1# #77#"%7 %"#%% %20!"0%8 /#

8 !/%# 9$0#"2 + % 7"$% 7

"$0# / 1# !!%# 7 "1$% "#%" $% "

$#"$72 $%1#0$8 ##//2 $" "

Page 30: Adrenoceptor Antagonists and Haemodynamics - Trepo

-(

#7$# "1# #/2$ !"1!12%$/2 $

!"$#"% ?$"1 #9#$%# $"/## 7

$%1#0$ $$ =1# ###

!!!$"#8 "1# $"$/ 0#%#0#"% 7

!/02 7"$ "#$/ >/ %#%

!C$# $0!"" $70"$ !/02

%#91#

1#0$>##7$"%7"1#>$2/##0#"##

"1#!%%$>$/$"2"6"$72#9"/2"1#/

/? /#C#/ 7 "#7"% 1# 09$00

92# %0!"$ ?$"1 "#0$//

#0#"#"#%">#%/$1"/21$1#"1"1"

?$"1 >$2/# #0#"# >#%# 7 "1#

$!"$ 7 0 0C#0#"

?#$1" >#$#77#"7%$""$"1#>$2/#

#0$//#0#"#02>#"#1$//2#%$#

"!#70

(-#.*-,),#.&$,),(%'5+#$7*#+

'&%1&%

2 "1# 0#% 7 !12%$/ %%#%%0#"

/$$/ 7$$% /#8 "1# 1#020$

%""% $%7"#!/2%%#%%# ; %#"/

5'-8$%#>##"/5'81%10$"

10 5'&8 % #" / 55(8 "#$>

#" / 55<1$% $% !"/2 # "0%$ 7

1#020$ 1#% >2 !12%$/$

0!#%"2 0#1$%0%@ ?1$/# !"$#"

02 1C# %$$7$" ##%# $ 8 "1#

$$"$/0!#%"2C%%"$"$#%/"%$

$#%#$"1"##!%+1#

. 0# "1 1/7 #"28 0#%

C$"$%7$$"$/"$"#1$6#%1C#

>## %# " #%"$0"# 0# #9"

1#020$ %""% ;)0$/" #" / 5-8

,%%##"/5&5<C#"1#/%%$$#"

$$#".$0#"1%#%!#$/$%#$$"

0#"1%?$"1 "1# >/ %/>/# %#% 92#

;< >$9$# ; < % $$"%

;,%%# #" / 5&5< "1# 00/2 %#

$$"% # # / ?0 %/$# $

"1#0$/"$ 0#"1 ;,%%# #" / 5&5<8

$2$### ;$B$0#" /55&8 0$ #"

/ 55&< $77##" $ $%"!#% ;$//#

5&5<%0$7$"$7"1#"1#0$/"$

0#"18 !/02 "#2 "1#"# 02

$!"# 1#"$ #/#0#" "1"

$"#0$""#"/21#"%"1#>/!

%%#"$//28 "1# $$"$/"$0#"1%#

>%# "1# /? 7 %#C"$ 7 0%%

;,%%# #" / 5&5< "1#0$/"$8 7

#90!/#8 / ?0 %/$# $% $B#"# $"

/%#""1#$1""$08"1#%>%#6#"

1# $ "#0!#"# $% 0#%# 70 "1#

!/02 "#2 1# $ "!"

//"$ $% >%# 1? "1# "#0!#"#

#"% " 0/ $# "1# 0#%#0#" $%

0# C# %#C#/ 1#" >#"%8 $$"

$/"$ 0#"1% " !# >#" " >#"

"

1# #"#%" ?> 7 "1#0$/"$

.$ 0#"1% $% "1#$ $C%$C##%%I "1#

0#%#0#" $% !#70# ?$"1 !/02

"#2"1#"#!!/2$ "1#"1#"# #6$#%

Page 31: Adrenoceptor Antagonists and Haemodynamics - Trepo

-

%!#$/ #9!#"$%#8 $" 02 $C/C#

0!/$"$% ; #" / 55-8#$

#" / 558 % #" / 55:< .0 >"1

"#1$/#"1$/!$"%7C$#?8"1#%#7

"1#%# 0#%#0#"0#"1% $% /$0$"# "

$"$//2$//!"$#"% #"$"1#2# $/"$

0#"1%#/#%%$C%$C#8%$##"$

"#"/C#$"#2$%###;##"

/((<

'(*(-#.*-,),#.&$,),(%'5+#$7*#+

'&%1&%

$

1# !/%# " 0#"1 ?% $$"$//2

#C#/!# % $C%$C# "#1$6# >%#

1#% $ $" "#$/ !#%%# ;*/

5&83AA>$555<,"#8$C%$C#7$#

!#%%# #$C# !/%# " 0#"1 1%

!"/2 %>%"$""# $"% $C%$C# "#!"8

%$#"1#.$!#%;10#8,$%C$//#8 8

<#C$#$%>/#"0$0$"1#$" "#$/

+!""#%?1#!/#7$#;01/F#"

/ 5''8 01/F #" / 55(8 )$%1/ #" /

55:<

#C#/ 0#/% " %%#%% 70 "1# !/%#

" 1C#>###C#/!# ;./$$ #" /

55:8 #""$#"/((<1#0!""$$%

7"#>%#"1###/#0#"%#!#%#"$"1#

0B !!#"$#% 7 " "#$/ %2%"#0@

"$ 1"#$%"$ $0!##Q(8?1$1 $%

20$ !!#"2 7 "1# " $0!#$

!/%"$/# "7/? 70 "1# C#"$/#8

=$#%%#/ 0!/$# ?8 ?1$1 $% "1#

>$/$"27"1#""#$/%2%"#0"%"#

#/%"$//28 !#$!1#/ #%$%"# !

;=#%"#17#"/5&8=#%%#/$#"/55-8

"#$!/% #" / 555< Q( ? #

/$#/2#!##""1#"#$/!#%%#8

! $% "$0# C2$C$>/# $% "1#

%0 7 Q( ! 1# >%$ 7"$/

!$$!/#7"1#"1## #/#0#"0#/$%"1"

$% $B#"# $" "1# =$#%%#/ 0!/$#

$ %2%"/#8 $" $% $%%$!"# $" "1#

!#$!1#2$$%"/#

1# 7$# !#%%# #$C# !/%# "

0#"1 1% >## 0!# ?$"1 2# $/"$

/"% 0#"1% $ 0># 7

%"$#%8?$"1 "$"2 #%/"% ;" #" /

55-8)$%1/#"/55&8$$%#"/55'8

B##"/55'8)0%#"/5558)"0

#" / 5558 $ #" / 5558 #$ #" /

((< 1# C/#% $ 1#/"12 !"$$!"%

$0#"##9#$%#?##-X-5/G0$

/?#?$"1"1#!/%#"0#"1"1?$"1

"1# #>#"1$ 0#"1 ;)"0 #" /

555<1##!$>$/$"27"1#!/%#"

0#"1 ?% /#/2 $7#$ " "1#

#>#"1$0#"1)$%1/#"/;55&<8"8

#!"# "1" $$"$//2 $//!"$#"% "1#!/%#

" 0#"1 / " %>%"$""# "1#

"1#0$/"$ #C# $7 "1# !/%# "

0#"1?% /$>"#?$"1 "1#0$/"$ "

"1#>#$$7 "1#0#%#0#"%)?#C#8

"1#!/%#"0#"1?%>/#"%1?"1#

Page 32: Adrenoceptor Antagonists and Haemodynamics - Trepo

-

$#"$71#%$$$#9@$5(R

7 "1# #$%8 "1# C/#% >2 >"1 0#"1%

1#$" "1#%0#$#"$"1#"1#

18 "1# %"2 7 )0% //##%

;555< "# 1#/"12 2 /"% %1?#

##0#" $ 0#%#0#" >#"?##

"1#!/%# "0#"1 "1#0$/"$

1# C/#% ?## 0#%# $ C$% >2

!%$"$%8 $/$ 1# ! "$/" 0# "1#

##"%"$#%?$"1 $" "#$/!/%#"

0#%#0#" %1? 0# !0$%$ >" %"$//

%0#?1" $%$%"#" #%/"% ;$ #" /

5558 ""$%#"/((-81B#"/((-<

;

#C#/ C$"$% 7 /"%!12 1C#

>## %1? " ## ?#// ?$"1 $C%$C#

0#"1% $ "1# 0#%#0#" 7

;3AA>$ 5558 )#"" H% ((<

%"1$ "%#%!1#/

#1$!12$%!!/$>/#7$"#0$""#"

#C/"$ 7 0># 7 1#020$

!0#"#%8 $/$ 8 8 />/

#$/ ?// 0"$8 !#/8 7"#/

C/C/$"#$"2;2#"/558+#/#"#"

/ 555< "$% 1#020$

%%#%%0#" $% !%%$>/# ?$"1 #%!1#/

*!!/# >2 %$ !># $%#"# $" "1#

#%!1%8 >" "1$% $% 7#%$>/# /2 ?$"1

$"$//2 $// 0!0$%# !"$#"% # "

"1#07">/##%%7"1#!>#;+#$#"

/ 558 2"1# =#>> 55<

*$%C"#% 7 /"%!12 $/#

!#" #!##2 "1# ## 7

##" #!%$"$$ 7 "1# !># ; 1//#2

$#((-8#((-<

+

<

0!## $!12 ; < "#1$6#% "

#"#0$# "1# 1C# >## C$/>/# %$#

"1# 5:(% "1#%# 0#"1%8 %""

/"#"$#"$%!!/$#">2$#

"0#%#C$"$% $#/#"$/ $0!##

1##/#"$#"$%!!/$#""1#>2?$"1

#"#/#"#%8"1#C/"###"#$%

0#%#>2"1#!$7#/#"#%!/#

>#"?## "1# #" #/#"#% 1#8

$0!## Q $"% C$"$ ∆Q #

//"# $ " 10O% /? 1#

#/#"$/$0!##%$%"%7#%$%"#

!$"# 0!#"%=1# "1# 7#6#2

7 /"#"$ #" $% ( ( )F8 "1#

!$"# 0!#" $% #/$$>/# "1#

#/#"$/$0!##7"1#"$%%#$%/%#"$"%

#%$%"$C$"28 ?1$1 $% ( ΩG0 7 >/8 :-

7 !/%08 &( 7 $0%/#8 & 7

/% (( 7 7" ;# 5'5<

$ " #/#0#"2 !$$!/# $

#/#"$$"28 3$1? /?8 #/#"$ #"

!%%#% "11 "1# "% ?$"1 /?#%"

$0!## 1%8 # "1# $"$%

#!$"# >C#8 "1# #/#"$ #" $%0$/2

Page 33: Adrenoceptor Antagonists and Haemodynamics - Trepo

--

$%"$>"# C$ "1# >/ C#%%#/% %2%"/#8

"1# "$ C/0# $#%#% >2 "1# 0" 7

"1## $% #"$ #/$# $ "1#

#/#"$/ #%$%"$C$"2 $0!## ∆Q8 "1#

#/"$>#"?##"1#%#!0#"#>#$

3=

=3

=

=

3

3 ∆=⇔∆= 8 ;-<

?1## $% "1# "$ C/0# B%" >#7# "1#

%#" 7 "1# %2%"/# Q $% "1# $%"/$

$0!##7 "1# #/#"$ 7$#/ $C/C#1$%

$% "1#>%##6"$ "1"1%>## #7$#

7 $77##" #/#"# 7$"$%8

#"$ 7"% 7 1#0"$"8 ##

>2?#$1"1C#/%>##$"#;3AA>$

#"/55&>8%1C$"F#"/((<

<

1## # %#C#/ $77##" /"$% 7 "1#

#/#"#% "1# "1$ $0!##0#"1

; )<8#7"1##/#"#%$%!/#""1#

"7"1##"1#"1#/#C#/7"1#

9$!1$ !#%% 1$% #/#"# 7$"$

0$/2 0#%#% "1# #/#"$/ $0!##

1#% $ !/02 "#2 "

;%1C$"F #" / ((< //8 " /#%" 7

$77##" #6"$% 7 ) 1C# >##

#C#/!# %# $ /$$/ %#""$%8 "1#

7$%" 7?1$1?% !>/$%1# >23>$#

//##% $ 5:: ;%1C$"F #" / ((<

1# "1$ $0!## 0#"1% 1C# >##

#C/"#?$#/28>" "1##%/"%?$"1"1#7$%"

##"$#C$#%?##"%$%"#";.//#

558 $B0#% #" / 555< 1# #?

##"$ #C$#% 1C# %1?# 0#

!0$%$ ##0#"?$"1 "1#0$/"$

$#" .$ 0#"1 ;Q$#/# #" / 5558

1/9 #" / (((8 $1 #" / ((8

#0 #" / ((8 *# ="# #" /

((-<

>&"

"1# 5&(%8 "1# ?1/# >2 $0!##

$!12 ; =< ?% $"#

;$%11#5&-<"1$%0#"18"1##"

#/#"#% # !/# #9"#0$"$#%8 B%"

!9$0/"?$%"%/#%;.$</"#

#/#"#%#!/#!9$0//27"1##"

#/#"#% $"$ " "1# $$/

#6"$ >2 $%11# ;5&-<8 3AA>$ #"

//##% ;55&><8 %/$ .$#0

;$//# #" / 55-8 %/$ .$#0

55< 1C# #C#/!# #6"$% 7

#"#0$"$?$"1 =

3AA>$ #" / ;55&8 55&>8 555< 1C#

C/$"# "1#$ /$"10 $ 0!$%%?$"1

"1#0$/"$8 %$0/"#%/2?$"1 >"1

"1#0$/"$ .$O% $#" 92#

0#"1 1# >$%#% >#"?## "1# C/#%

?## #/$$>/# "1# /$0$"% 7 ##0#"

0!>/# >#"?## "1# 0#"1% =

#%"$0"# 1#% $ 1# ! "$/"

#6"#/2 ;3AA>$ #" / 55&>< 1#

#!#">$/$"2 7 = ;(& /G0$< ?%

Page 34: Adrenoceptor Antagonists and Haemodynamics - Trepo

-

/#/2>#""#"1"1"7"1#0$/"$;(

/G0$<

*6 1# #" #/#"#% $ ?1/# >2

$0!## $!12 # !/# ?$%"%

/#%/"##/#"#%#!9$0//27"1##"

#/#"#%>8 ?:

1# #6"$ >2 %/$ .$#0

;$//# #" / 55-8 %/$ .$#0

55< 1% >## %1? " ## ?#// ?$"1

"1#0$/"$ $ !"$#"% ?$"1 "# 1#"

7$/#8 #%"$C# 1#" 7$/#8 2

"#2 $%#%#8 % ?#// % $ 2

"#2 >2!%% !#"$ ; ""# #" / ((8

%1C$"F #" / ((< %0# 7 "1#

%"$#%8 =1%"##%77$$#"/2?#//

?$"1"1#$C%$C#0#"1%;0177#"/(((<

)?#C#8 "1$% $% " /#%" !"/2 #9!/$# >2

"1# #/#"# 7$"$8 ?1$1 #% "

"//2#!#%#""1##"$#>2;3AA>$#"/

((<

2"

#$""$7>/#"%$$7$""$

C/C# $%77$$#2 $"$

!#$$ %1"% 02 %# C##%"$0"$

7 /%8 "$ $/""$8 #2%0

""$ # $"$% ?1## $0!##

0#"1% 1C# " >## C/$"# #$"1#

= ) //?0#%#0#" $

0"$$7"1#!"$#"$%#%"/#%%;%1C$"F

#"/((<

6

%$ #/#"#% !/# #8 0>$0

%"#$/#7"/78>$$0!##>#%#

"%%#%%"#$/+=>20#%$ "1# "$0#

#/2 >#"?## %$0/"#%/2 ## 7/?

!/%#% "1# $%"# >#"?## #$

%$"#%8 $# >#"?## "1# " 7 "

!!/$"#/ "#2 1#0#"1 1% >## %1?

" ## ?#// ?$"1 += 0#%# >2 "1#

/"% *!!/# 0#"1 ;3AA>$ #" /

((-<

Page 35: Adrenoceptor Antagonists and Haemodynamics - Trepo

-

2.1 α2.1 α2.1 α2.1 α8#7$,('+,1%'$34'+;*(67$&6.2.1.1 α2.1.1 α2.1.1 α2.1.1 α8#(%#6'(*.%.#45&<'.*(#(7

%#).&4'.*(

+F%$ ?% "1# 7$%" $ "1# 70$/2 7

#"% ?$"1 !$!#F$2/ 6$F/$# /#%

"%77$$"2"α ##!"%$%>"(((

7/ #"# "1 " α ###!"%

$$//28 !F%$ ?% %# %

"$12!#"#%$C# #" # " $"% #0>/#

C%$/"2 #77#" ;10 5'-<8 >" "1#

0$$$"$1%%1$7"#"//#C$"$/?#

$2 "" %20!"0% ;,< %%$"#

?$"1 >#$ !%""$ >%""$ ;)#/ #"

/ 5'-8 77$9 +##% 5'<

#F%$ 9F%$8 "1# /%# /%

7!F%$81C#>##%#$,!"$#"%

?$"1#%/"%0!>/#""1%#?$"1!F%$

;3!/#"/5583!/#"/55&8%B$$

(((8 =$/" #" / ((< 1#%# /%%$ α

"$%"% >$ " α ##!"% " /2 $

/?# $2 "" >" /% $ >/ C#%%#/%

1$% 7#6#"/2 >$% / $FF$#%%

"1%""$12!"#%$8#%!#$//2?1#$C#

" , !"$#"% ?$"1 !# #9$%"$

"$12!#"#%$C# 0#$"$ ;*BC

>## 5558 #?$ 2 5558

1$%1$//#%#"/((<

. $% %""//2 6$F/$#8 >" $"

$77#%70!F%$8"#F%$9F%$

>2"1#>%##7!$!#$$#0$#"2"1#

!#%##7$0$!!2/%!#

<% ;< ; Y ; "192!1#92<

#"12/0$Z !!2/< 0#"192>#F##

Page 36: Adrenoceptor Antagonists and Haemodynamics - Trepo

-:

%/!10$# 121/$#8 $% "1# 7$%"

/$$//2 %# α "$%"% ?$"1" $$"$/

$$"$ 7 12!#"#%$ ;>0% #" /

5583?>#55<

"1/7F%$ "0%/%$#%# $ "1#

"#"0#" 7 , %#%"$C# 7 >#$

!%""$ >%""$ 1$% $% 0%" "2!$//2

%#>2>#$!%""$12!#!/%$;+)<

/$# "1# /%%$ α "$%"%8 /7F%$

"0%/%$ # " #!"# " %#

"12!12/9$%8"1#"#"0#">#%""#

?$"1 "1# 0$"## %# ;# #2 55'8

*BC >## 5558 #?$

25558$1#/#"/((8*#"/

((8$1#/#/%#""#((<

$

1# >##7$$/ /$/ #77#"% 7 α

"$%"% # # " #"1/ #/9"$ C$

"1# >/# 7 α ##!"% $ "1#

#"1!%""#/7F%$"0%/%$

#/$#C# /?# $2 "" %20!"0% %

#77#"$C#/2%!F%$89F%$"#F%$8

>" 1C# /#%% $/"2 C#%# #77#"%

;*BC >## 5558 $1#/ #" /

((8=$/"#"/((>8=$/"#"/((-<

1# #!" 7 α "$%" %#/#"$C$"2

1% >## #/>"# " #%$># "1# "$ 7

>##7$$/ $2 #77#"% 0!# ?$"1

$C%/ C#%# #77#"% ;#%%

55'<1#!12%$/$/!10/$/

> 7 "1# %#/#"$C$"2 1% >##

?$#/2 $C#%"$"# $%%%#8 >" "1##

# %"$// 02 !# 6#%"$%I # "1# #9"

/#%7>/ >$>$#!##""$8"$%%#

%!#$7$77$$"2%""#%7"1###!"%

!10$#"$% # %"$// %/C#

;#%% #" / 55&8 *#>2# (((8

$0#%((8#1>((8

#1> 1?$ ((< C$## 7

#// "2!# %!#$7$77$$"2$%"1#7$$"1""1#

77$$"2 7 #"$ !F%$ #$C"$C# ?%

1$1# " "1# α ##!"% $ "$C#

!%""$ #//% 0!# " /# α

##!"%;#F$##"/(((<1%8

"$%%# %!#$7$ 77$$"2 %""# 7 "1# %0#

##!" #"2!# / ># !"#"$/

0/" 7 "$ ;#F$# #" /

(((8$0#%((<

0%/%$ $% "1# 7$%" α "$%"

#9!#%%$ ##!" %>"2!# %#/#"$C$"2@ $" 1%

0#"#/21$1#77$$"2 "α "1 "α8

$"#0#$"#77$$"2 "α* ;$1#/#"/

55:<1$% 77$$"2!7$/# $% /$0# ">#

$/ 7" #9!/$$ "1# !%""#

%#/#"$C$"2 7 "0%/%$ ;#1>

1?$ ((<8 >" %0# "1% %"#%% "1#

$0!"# 7 "1# !10$#"$ !""# 7

"1# ;1$#"/55'8$0#%

((8)#$#"/((<"1#"$%%#

%!#$7$ 77$$"2 %""# 7 α ##!"%

;#F$# #" / (((< !%%$>/#

Page 37: Adrenoceptor Antagonists and Haemodynamics - Trepo

-&

!10$#"$#9!/"$$%"1#7$$"1"

"0%/%$ %1?% "1# /?#%" /#C#/ 7 $C#%#

$%0 0 "1# 00/2 %# α

"$%"%;)#$#"/((<

"#0% 7 !10/$/ ##!"

%#/#"$C$"28 "1# /%%$ α "$%"%

/7F%$ # %>"2!# %#/#"$C# α

"$%"%8 $# "1#2 >/ // #"/2

#$%# "1## α %>"2!#% " >" "1#

%0# #9"#" ;,# 5558 $0#%

((8 #1> 1?$ ((<

1# #/"$C#/20$/$C%/#77#"%

7"$/ %#/#"$C$"2 >2 /7F%$ $%

#9!/$# #"$#/2 >2 $"% $%"$>"$ $ "1#

>2 ;#1> ((<@ $ $%/"# 10

"$%%#%8 /7F%$ $%!/2% 1$1#%" %#/#"$C$"2

"$ 7 "1# !%""# C# "1# C%/ "$%%#

;"$ < 0!# " "0%/%$ ;5(<8

9F%$;<"#F%$;5<;#"#"/

555<

1# ##%#% $ + *+ >2 /7F%$

1C#>##%$0$/0!>/#"#1"1#

?$"1 // "1# "1## 0#"# 70/"$%@ $

0%" %"$#%8 "1# + 1#% $ %!$#

%"$ !%$"$% 1C# >## %$$7$"8

"1# 09$0/ C## #"$% >#$

00) ;*BC >## 5558 $1#/

#"/((8#1>((8C3##>##"

/ ((8#1> 1?$ ((<1#

$7/##7/7F%$%!$#)1%>##

0#%"8 #C# "11 "12$

!/!$""$1C#>###!"#%C#%#

#"$% ;1#F 1! #" / (((8

$1#/ #" / ((8 #1> ((8

#1>1?$((<

1##77#"7"0%/%$(0#$/2

+*+1%>###$"1# %$$7$"

/$$//2$#/#C"8"1##70$"#

>#$ ! 7 ( 00) ; 1!!/# #" /

55:8 # #2 55'8 *BC >##

5558 $1#/ #" / ((8 #1>

1?$ ((<) 1% >## 7 #$"1# "

#0$"1#!# 0#$"$/#C#/"%1?

%0// !8 >" "12$ !/!$""$

# !%%$>/# C#%# #77#"% ;*BC

>##5558,##(((83/##"/((8

#1>1?$((<

77#"%7 "0%/%$ "#F%$ $$/

"/ "1%""$ "#%"$ 1C# >##

%"$# ?$"1 ( #/#/2 0"#%$C# 0/#

C/"##%"1#"0%/%$!8"1##?%

/2 # %>B#" ?1 #9!#$##

%20!"0"$"1%""$ #"$" /#%" #

" 7 "1# 7 !#70# "1%""$ "#%"%I

%#C# %>B#"% %1?# #"$ 7 " /#%"

( 00) $ + $ "1%"%$% 1#

C/"##% $ "1# "#F%$ ! #9!#$##

%$$7$"/2 0# 7#6#"/2 >"1

%20!"0"$ %20!"0"$ #"$% ;#

#2#"/55'<

1#?/##"1##77#"%7/7F%$

"0%/%$"1#$C%/!0#"#%

Page 38: Adrenoceptor Antagonists and Haemodynamics - Trepo

-'

#9#!")8+*+$%%#/$

% " /7F%$8 "1## # #!"% $"%

#77#"% 8 8 #%!$

$$#% #%!%#% += "#$/

0!/$#1C#">###!"#8#$"1#8

"1# #77#"% 7 /7F%$ "1# 1# ! "$/"

#%!%#%#?

1##77#"%7"0%/%$ 1C#

>##0#%#$%"2?1##"1####7

α >/# ?% %%#%%# ;17#% #" /

555< "1" %"28 1?#C#8 "1# %>B#"%

?## !#"#"#?$"1 α $%" !1#2/#!1$#

$7%$

$8

/>$C$/>$/$"27/7F%$$%>":R

9$0/ !/%0 #""$ ; 09< $%

#1# $ 5 1% #!#$ "1#

!#!"$%#!/%085(R7/7F%$

$%> "!"#$%?$"1#/$0$"$1/7 /$7#

;L< 7 5 1% 1#/"12 #/#/2 %>B#"%8

09 # # #""$ $

!/%0C#%%"$0#C#; <"$77#

%$$7$"/2 70 "1%# $ 2# /"%

>" ( R 7 /7F%$ $% #9#"#

1# $ $#8 ?1$/# "1# #%" $%

0#">/$%# $ "1# /$C# >2 2"10# +(

; +< #F20# -8 "1# $"$C#

0#">/$"#%#0%"/2#9#"#$7##%

0%/%$ $% ""//2>%>#70"1#%0//

$"#%"$# *# " "1# /? /#C#/ 7 7$%" !%%

0#">/$%08"1#>$C$/>$/$"2$%/%#"((

R 0%/%$ $ !/%0 $% /0%" #"$#/2

> "!"#$%=$"1 "1##!" !%/#% $

!# 0#"%8 "1# 09 $% #1# $ :

1%8"1#L $%( -1%*$%"$>"$

C/0#$%%0//8>"(/G>"5R7

"0%/%$ $% #9#"# 1# $ $#8

?1$/# "1#0B$"2 $%0#">/$%# $ "1# /$C#

>2 +-?$"1 "1#0#">/$"#% #9#"# $

$#

2.1.2 2.1.2 2.1.2 2.1.2 αααα8#(%#6'(*.%.

/#7α ##!"%?$"1"$%"%

%1 % 21$0>$# $#%#% %20!"1#"$

"7/? 70 "1# $1$>$"% "1#

#"$C# 7##> "1# #/#%# 7 70

"1# #C# #$%1$% /#% " "$C"$ 7

α 8 M M ##!"% ?$"1

%#6#" $#%# $)+ ;/>#

#" / 5'-< )?#C#8 α ##!"

"$%"%#"2#"$7#6#"/$$/%#

ββββ8#7$,('+,1%'$34'+;*(67$&6.'(8.,4,+%*-,=ββββ#(7ββββ>ββββ8#(%#6'(*.%.

$

1# β ##!" "$%"% 1C# ?

"#0#% /$$/ ""#"$ >#%# 7 "1#$

#77$2 $ "1# "#"0#" 7 12!#"#%$8

Page 39: Adrenoceptor Antagonists and Haemodynamics - Trepo

-5

#%"$C#1#"7$/#8#"$2"10$%

$%1#0$ 1#" $%#%# // /$$//2 %# β

"$%"%%1#"1#007#"#7>#$

0!#"$"$C# "$%"% " β ##!"%8

>" "1#2 ># $%"$$%1# # >2 "1#

7//?$ !!#"$#%@ #/"$C# 77$$"2 " β

β ##!"%8 77$$"2 " α ##!"%8

$"$%$ %20!"10$0#"$ "$C$"2 ;<8

// #%"1#"$ 0#0># %">$/$%$

"$C$"28 /$!$ %/>$/$"28 C%$/"2 #77#"%

!10$#"$ !!#"$#% ;)#%/#

55(8$#/%#"/55(8)770((<

+!//8 ;G< Y; #"12/#"12/<0$Z

- ; !1"1/#2/92< !!/8 ?% "1#

7$%" /$$//2 %# β "$%" ;/

"#!1#%5:<$"#0$%"1#0#/β

"$%"?$"1?1$1//"1#"1#β >/$

% # 0!#+!// $% #0$

0$9"# 7 #"$0#%I #%%#"$//2

/2 #"$0# "$C#% β >/$ 1#

%# 7 !!// 7 "1# "#"0#" 7

$ !#"$% 12!#"#%$ 1%

%>%""$//2 ##%#8 >" $" $% %# $ "1#

"#"0#" 7 !/!$""$%8 %#C#/ "2!#% 7

12"10$8 >#$ !%$"$/ "#08

12!#"12#%$% % !#C#"$C# $%"

0$$#

$

+!// 1% #6/ 77$$"2 " β β

##!"%+!//1%#77#""1%

0#0># %">$/$%$ "$C$"2 "1" #% "

># /$$/ %#6#$#% $ / %#

#$0#%8 >" !!// $% " %# %

!1"1/0$ #" # " #/ #%"1#%$

;,0 ((< +!// %1?% $#"

02$/#!#%%"#77#"%

)#020$ #77#"% 7 !!// #

%!!#%%$ 7 )8 8 8 +

02$/""$/$"2#%!#$//2 $ "1#%""#

7#/#C"#%20!"1#"$"%;C#%##"/

5&583#//##/#25'-8*1/755(8

)#%/#55(8%0#"/5583E1A##"

/ 55'8 #00# 55'8 )770 ((>8

3E1A# #" / ((< .//?# >2 "1#

#"$ 7 )8 02$/ 92#

#9!#$"# $% ##8 " ;0? #" /

55:< 1" "#0 0$$%""$ 7

!!// $#%#% # "

0!#%"2 #7/#9#% >/# 7

C%/β ##!"%;3E1A##"/((<

"1#/#8#"%""1#$$"$//#C#/

$ 0"#%$C# $$C$/% ;$0

*$/ 5''< #C# ##%#% $

12!#"#%$C##%;$P"#/#"/5''<

+!// ##%#% += ;3E1A# #" /

((< // "1# β ##!" "$%"%

#!#%% %$"$/ !#0#8 ##%#

%!"#% "# 7 #!/$%"$ 7 #"!$

!#0#%8 %/? "$ $ "1# "$

$ "1# #8 $#%# "1# #7"2

!#$7"1##;)770((><

Page 40: Adrenoceptor Antagonists and Haemodynamics - Trepo

(

$8

+!// $% /0%" 0!/#"#/2 >%>#

7"# / 0$$%""$8 >" "1# >$/$

C$/>$/$"2 $% /2 R # " 7$%"

!%% 0#">/$%0 1## $% #/"$

>#"?##%# !/%0 /#C#/ "1#!#"$

#77#" ;1 #" / 5&(8 Q#%" 31

=#%# 5&< >" 5( R 7 !!// $

!/%0 $% > " !"#$% 1# C/0# 7

$%"$>"$ $% /G8 09 $% 1$#C# $

'( ( 0$I L $% - 1 ;+?# #" / 558

3/#"/(((<

+!//$%9$"$C#/20#">/$%#"11

+:8 +*: + 58

9$"$$%7//?#>2B"$#"$%

+/20!1$%0 $ +*: #% " %##0 "

1C# /$$/ $0!/$"$% ;?$%$

/#?55&8H1%#"/(((83/#"/

(((8)#"/((-<

<

$0// 0/#"#8 ;< Y;8 $0#"12/#"12/<

0$Z - YY ; 0!1/$2/< 88 "1$$F/

- 2/Z92Z !!/ ;Q< >"##$"# ;@<

;%/"<8$% %#/#"$C#β "$%"$$//2

/2 %# $ / %# #$0#% 7 "1#

"#"0#"7$C%/$%#%#%;/21#"

/ 5&8 $>$# #" / 5&-81 #" /

5&85&:<8>""1##"%#$%0$/2%

/!#!"$%1##77$27!1"1/0$

"$0// $ "1# #"$ 7 $"/ !#%%#

1% >## !C# $ #" 0># 7 %"$#%

;)##/#"/5&58,#/#"/5'8%$"/

+/0 5'5<8 "$0// $% #"/2

%# ?/?$# % %" 0#$"$

$%"/0/12!#"#%$

$

$0//#%"1C#8$#"02$

#!#%%" #77#" 0#0># %">$/$%$

"$C$"2 ?#$1" >%#%8 $" $% ' : 0#

!"#"β "$%" "1!!// ;#7#/

#"/5'-8%$//$#%55<

!$//2 0$$%"## !1"1/0$ "$0//

##% "1# $"/ !#%%# ;+< >2

>/$"1#%20!"1#"$#C##$%$"1#

$/$2#!$"1#/$0/#$ "##%# $ "1#

!"$76#%10;#7#/#"/

5'-<

%!$"# 7 "1# "!$/ 0$$%""$8

!1"1/0$"$0//%#%%2%"#0$##$

β >/$ # " >%!"$ 70 "1# #2#

"11 "1# B"$C/ #!$"1#/$08 %/

0%8/$0/1#/%%"$"#%"$/

""$""1#%2%"#0$$/"$;*2/##"/

5'8 ,#$# #" / 5':8 F$# 0$"1

5''8 $ #" / 55-8 *$%"#$

%/ 55:8*$2 #" / 55'83"# #"

/((8$#"/((<#/70/"$%7

Page 41: Adrenoceptor Antagonists and Haemodynamics - Trepo

"$0// 1C#>###C#/!#?$"1 "1#/ "

## %2%"#0$ >%!"$ 8

#%!$/28 %2%"#0$ C#%# #77#"%8

?1$/# 0$"$$ "1# #6$C/#" "1#!#"$

"$C$"2 0!# ?$"1 C#"$/ /

70/"$%8%1%6#%%/"$

1# >%># 7"$ 7 !1"1/0$ "$0//

1% >## %1? " $# C$% %2%"#0$

##$ β >/$ #77#"% $ $/"2

!/02 %2%"#0%@ #%"$ ) 1%

##%# 70 #/$$>/# " : >!0 ?$"1

( (R6#%"$0//;*2/##"/5'8

,#$# #" / 5':8 F$# 0$"1 5''8

*$%"#$ #" / 5''8*$%"#$ %/

55:8 0#"%$ #" / 55&8 "#?" #" /

5558 "#?" #" / ((8 "#?" #" /

((>< 70 #/$$>/# " ' >!0 ?$"1

( ( R #/ 70/"$% ;*$%"#$

%/55:8"#?"#"/5558$#"/

((<1#C###"$%$"1#!#)

$#9#$%#1C#>##& >!0;6#%<

;*2/# #" / 5'8 ,#$# #" / 5':8 F$#

0$"1 5''8 *$%"#$ #" / 5''8

*$%"#$%/55:80#"%$#" /

55&8 "#?" #" / ((8 "#?" #" /

((>< 5 >!0 ;#/< ;*$%"#$

%/55:80#"%$#"/55&8"#?"

#"/555<

#$"1# 6#% #/ 70/"$% 7

"$0//1C##9#"#2"#?"12#77#"%

+ *+ ;F$# 0$"1 5''8

*$2#"/55'83"##"/((8$#"

/ ((8 "#?" #" / ((8 "#?" #" /

((><8 ?$"1 "1# #9#!"$ 7 %/$1"

#"$ $ "1#"/*+$!"$#"%

(R6#%#2#!%;)2#1#"/555<

% " !0#"#%8 "$0// 1% >##

%1? " %/$1"/2 %1"# "1# #"# 4

$"#C/ ;4< " %/? "$ C#"$/

"$;+$"#C/<$"$/" "#%" ;$

#" / ((< .//?$ $%"$//"$ 7 0

"$0// 0/#"# $ #1 #2#8 ) %"#

$#9 ;< 1C# ##%#8 %2%"#0$

C%/#%$%"#$#9;<1%$#%#

%$$7$"/2;1%1$#"/5'5<)?#C#8

"1# "#0!2 "$0// !% /2 "$

!!9$0"#/2([ "$0// $6#%

-( [ $ #/ 70/"$% ;07"#%O

0#"%<8 #77#"% 7 "1#%# %0// !%

8 8 "1# #%!#"$C# $$#%

1C# " >## #!"# /%8 "1# #77#" 7

"$0// "#$/ += $% ? %

#%/" 7 β >/#8 "1# C## #"$%

$ "1# !/02 !0#"#% !# #9!$"2

7/?;+.<1C#C$#70("&R8$

7# #9!$"2 7/? $ # %# ;.<

>#"?## ( - R 7 "1# $$/ C/#%

;*$%"#$ #" / 5''8 *$2 #" / 55'8

=/#"/(((83"##"/((<C#

#"1% 1C# >## #!"# # "

>1%"$"$ ;.7#/# #

5'<

Page 42: Adrenoceptor Antagonists and Haemodynamics - Trepo

"1#β ##!">/$>$$"$C$"2

%"$#% 73$/ //##% ;558 55-<8

"1# /?#%" "$0// !/%0 /#C#/?$"1 1#%

$)$%((G0/

$8

1# >$C$/>$/$"2 7 !1"1/0$ "$0// $

1#/"122C/"##%1%>##&'R$#

%"2 ;3"# #" / ((<8 >" "1#

#%!$ C/# $ #/#/2 /0

!"$#"% $% " ? % 0!$%8 "1#

>$C$/>$/$"2 7"# / 0$$%""$ 1%

/2>##' :R;%1$F$?5&'8

/ %1$2 5'8=$/% #" / 5'< >"

:(R7"$0//$!/%0$%!"#$ >L

$%>"'1%$#2#"$%%#% 1%$

!/%0 ;=$/% #" / 5'8 $ 3$/

55<8"1#C/0#7$%"$>"$$%>C#

/G $0// $% 0#">/$%# >2 +*:

;%## 7 #"$/%< $" $"$C# 0#">/$"#%

"1"##9#"#C$"1#$#2

ββββ8.,4,+%*-,#(%#6'(*.%.

$%!//8 0#"!//8 "#//

#>"// # 0 "1# β ##!"

"$%"%?$"1 #%%#"$//2 1$1# 77$$"2

" β "1 " β ##!"% 1#2 #

%0#"$0#% /% //# $%#/#"$C#8 %$#

β ##!"$%"1#0$β ##!"%>"2!#

$"1#1#"1#%#%#0%"/2%#$"1#

"#"0#"712!#"#%$$!#"$%

;)770((><8>""1#2?##"%"$#$

"1#!#%#""$/%

')3*(,7αααα8#(7ββββ8#7$,('+,1%'$34'+;*(67$&6.

#$-,7*4'4

C#$//8 ;G< Y5) >F/ ;< 2/92Z

- YY ; 0#"192!1#92Z#"12/0$Z

!!//<8 $% %>"2!# %#/#"$C# β

>/$ "1" /% "$%#% α

##!"%;$%"?55&<

C#$// $% %# " "#" $ !#"$%8

12!#"#%$ 1$ 1#" 7$/#

C#$// !%%#%%#% !"#"$//2 #/#C"

$//2 !!#"$#% ;# "$9$"8

"$!/$7#"$C# "$#"1#/$ "$%<

"1"027##1#>$/$"2"!"#"

"1#1#"C#%%#/%70"1#%#6##%7

%20!"1#"$ 12!#"$C"$ ;C$%1 #" /

55-8 30 #" / 558 /%# #" / 558

$%"?#"/55:8 1#"/55&8*#"

/55&<

$

C#$// #% " 1C# 0#0>#

%">$/$%$$7/##8$"#%"%#"1#

!#/"$7 "1#β ###!"%,

"#0 / 0$$%""$ 7 C#$// ; (

0$/2< 1% >## %1? "!# %#C#/

Page 43: Adrenoceptor Antagonists and Haemodynamics - Trepo

-

1#020$ #77#"%@ %$$7$" ##%#

$);$%"?#"/55:8 1#"/55&<

C$##77#"%$/?#$+;30#"/

558 /%# #" / 55<8 %$$7$"

#"$7;30#"/558/%##"

/55<8%$$7$" $#%# $ "1"

$%!>>/20!#%"2# " "1# /?#$

7);$$558/0#"/55<

#% " ! % /#/2 % ?$"1

!!// # " "1# C%$/"2 #77#" 7

C#$// ;)770 ((>< /%8 C#$//

#C#% += "#$/ 0!/$# $

!"$#"% ?$"1 12!#"#%$ ; "#/ #" /

558$%"?55&<

1# α ###!" 0#$"# C%$/"

"$ 7 C#$// "#>/#% "1#

#"$C#$"!$#77#"70M >/#8

"1% $0!C# "1# "# "/#>$/$"2 7 "1#

>2 C$$ "1# ! 7 $ "!"

;55<

$8

C#$// $% #0$ 0$9"# 7 "1#

#"$0#% ;J< ; < C#$// "1

70%>/α ##!"%8>"/2"1#;

< #"$0#>/%β ##!"% ;

55< C#$//$%#9"#%$C#/2>%>#7"#

/ 0$$%""$ ;C //#77 #" /

5'&<8 >" "1# >$/$ C$/>$/$"2 $% /2

!!9$0"#/2 R 7"# 7$%" !%%

0#">/$%0 ; 55< 09 $% 1$#C#

?$"1$ 1/0# 7 $%"$>"$ $% >"

/G8 5' 55 R 7 C#$// $%

!"#$ > $ !/%0 ;.##%"#$

77/ 558 # #" / 558 /10

/#55&8/$$.$55'<

C#$// $% 0#">/$%# $ "1# /$C#8

!#0$"/2 >2 "1# 2"10#% +*:

+ 58 $" "1## "$C# !1#/$

1292/"# #$C"$C#%8?1$1 !%%#%% /#

M ###!" "$%" "$C$"2

?# C%$/" "$C$"21# #$C"$C#% #

#9#"# C$ "1# >$/# $" "1# 7##% %

/$# %/7"# B"#% ;

558 .$%10 55'< /2 R 7

C#$// $% #9#"# 1# "11 "1#

$#2%;3$#0#"/((<

7"#/0$$%""$8 "1#L7C#$//

#%& (1 ! +*:0#">/$%#%8

"1#!/%0/#C#/$%#% -"$0#%1$1#"1$

#9"#%$C#0#">/$%#% C#$// $1$>$"% "1#

"#1/0$# #%!%# 7 "1# 10 1#"

>#2 "1# !/%0 #/$0$"$8 !>>/2

>#%#7$"%>$$"//%"#$%$"#7β

##!"%

#3,%#4'4

,>#"// $% "1# "1" 0!#"$"$C#/2

"$%#%>"1α β ##!"%1#

/$$//2 %# 70/"$% 7 />#"//

121/$# "$ 7 $77##"

%"##$%0#%8 // ?$"1 $77##" #/"$C#

Page 44: Adrenoceptor Antagonists and Haemodynamics - Trepo

"$C$"$#%"1#α 8β β ##!"%

;/ #" / 5'< ,>#"// $% $$"# 7

12!#"#%$12!#"#%$C##0##$#%

$&6,4*)*(#%*'(-*#+/%'+2$'),

*"%70"$#"$%#/%%$7$#%

#$"1# !1%# !1%# #"$% *$C#%#

2% 7 9$"$C# !1%# #"$% $/#

# 1292/"$8 #/2/"$

#1/#"$ // "1#%# #"$%8

92#"0$%$%#"#$""1#%>%""#

"1# 0! >#0#% 0# !/

%/>/#2!$//28!1%##"$/#%"

"1# /%% 7 !10/$/ "$C$"28 #C#

"11 "1## # #90!/#% 7 "$"$

#C# #1#0#" 7 "$C$"2 7 "1#%#

0#">/$"#%#"!0!"/2#9#"#$""1#

$#8"1#0#">/$"#%#%>B#""!1%#

#"$1#%#B"$#"$%#%/" $

"1# 70"$7C/#">>#"?## "1#

!#" 0! !1%# 0#">/$"#

##%/2#$C#/$$8%/7"#8

/""1$#8 0$ $% #""# 1$%

B"$#"#%1$1/2!/$%#0/#/#%

"1" # 0%" 7"# $"$C# # #9#"#

$" "1# $# 7##% ;=$/$% ((8

)$12((-<

1#!1%# #"$%#0%"/2"/2%#>2

2"10#+(; +<#F20#%$/$C#

$"#%"$#% 10%8 "1## # & ?

$77##""$C###%#$ +#F20#%

;#/% #" / ((< C# "11 02 7

"1#%# #F20#% # !>/# 7 0#">/$%$

%8 "1# #" 0B$"2 7 + 0#$"#

0#">/$%0 $ "/2%# >2 "1# +

%>70$/$#% +- ; :( R 7 "1# !1%#

#"$%<8 +*: ;( R< +

;5 (R<

1#$0!"7##"$C$"$$77#%0

"1#0B +#F20#%1#0%" $0!""

7 "1#+(#F20#%8 +-8#%"%##0

">#"#?"1/277#"#>2##0""$%

" "1# "1# #9"#0#8 +*:8 $0!""

0#">/$%# #%!#$//2 $ $C%/

!10/28 $% 1$1/2 !/20!1$ ?$"1

>" (( !1#"2!#% ;>/# -< ;C%

#//$ ((8 $#%" #" / ((< +*:

0#">/$%#% C#$//8 />#"//8 0#"!//8

!$//8 !!//8 "$0//8 /$$#8

#>$%6$#8 0$#8 7/#$$#8

/$$#8 $0$!$#8 $!0$# #"

$C$/% ?$"1 #"$ 0>$"$% 7 "1#

14$5//#/#%>#/%%$7$#$"$77##"

"#$#% $ " "1# ""/0#">/$%$

"$C$"2 7 "1# 0>$"$ 1#0%" "2!$/

/%%$7$"$ 0!$%#% 7 %"#%@ 7 "1#

/#C#/ 7 +*: "$C$"2 $% C#2 /? $/8

"1# $$C$/% # #7## " % !

0#">/$%#%8 ?1$/# $$C$/% ?$"1 7//2

7"$/ #F20# # //# #9"#%$C#

0#">/$%#% 1%# ?$"1 +*: "$C$"2

>#"?## ! #9"#%$C# # $"#0#$"#8

"1# $$C$/% ?$"1 !/$"#

Page 45: Adrenoceptor Antagonists and Haemodynamics - Trepo

0/"$!/$"# 7"$/ 14$5 ##% #

/" !$ 0#">/$%#% "1# /%%$7$"$

%1#0#% %$%" 7 - & "#$#% ;#/0

># ((8 +1$//$!% #" / ((8

+$010# + ((8 #" / ((8

+$010# + ((-8 #/0

>#((>8<

1#!/20!1$%0$ +#F20#%$%7#"

$0!"# $ C#%# #77#"%8 %$# !

0#">/$%#% # " "1# $% 7 1C$ 1$1#

!/%0 /#C#/% "1#"28 "1#

!/%0 /#C#/% $ /" !$ 0#">/$%#% #

7"# >#/? "1#!#"$ #% ;#/0

>#((><*#""1$%#"C$"$$

!/%0 /#C#/%8 #? 0! $

#C#/!0#" 02 #C# ># $%# $7

!/20!1$ +#F20# $% /#/2 $C/C#

$ "1# 0#">/$%0 ;+$010# +

((-<

#34,%"00 +*:0""$%@0""$7#6#$#%$ %$%%#6##%$#F20#"$C$"2

44,4,

+'7,

$,?&,(+/*(

#&+#.*#(.=@>

&%#%*'(7,.+$*1%*'( (</),#+%*-*%/

\ -: ?$/ "2!# 0/\ - ::V 8'(V %/$1"/2##%#\- ( 5V#/870#%1$7" #\ (& ':V8%!/$$#7#" #\ ( ###/#"$ #\: (5 &(&V#/870#%1$7" #\5 ' :- :#/ ##%#\( (( V ##%#9 ( *!/$"$0/"$!/$"$ $#%#

Page 46: Adrenoceptor Antagonists and Haemodynamics - Trepo

:

#$%

1# !!%# 7 "1# %"2 ?% " $C#%"$"# "1# #"$/# 1#020$ #77#"% 7 α β

##!">/$%#%!#$7$//28"1#%>%"$#%?###%$#"#7"1#

7//?$>B#"$C#%@

#C/"# ?1#"1# 7$# !#%%# #$C# !/%# " 0#"1 $% !!!$"# $

#%"$0"$1#020$#%!%#%"!%%$C#"1%"%$%

"#%""1#12!"1#%$%"1""1#α ##!">/$%/7F%$"0%/%$

"!#0#1#020$#77#"%$1# !"$/"

- 0!# "1# 1#020$ $7/##% 7 "0%/%$ ?$"1 "1# #77#"% 7 "1#

%#/#"$C#β "$%"!!//"1#0>$#α β "$%"C#$//

"#%""1#12!"1#%$%"1""1##$%#/"$>#"?##/?!/%0#""$%7"1#

%#/#"$C#β ##$"$%""$0//$C%/!0#"#%

#C/"#?1#"1#C$"$$"1##"2!#%767-0/"#)+

#%!%#%""$0//8"%%#%%"1#"$>"$7##"$!/20!1$%0714$5"

"1#!10$#"$%7!1"1/0$"$0//

Page 47: Adrenoceptor Antagonists and Haemodynamics - Trepo

! "

#$ $ % &' (

% '

$#) * *+

$ * , *+ -

# #

$# #

%** * $(,

*'. #/

%+ * $(,

* ' . # / #$#

. # / 0

# #

1#

# %234(' $

5/6

!

!# 7# #

809( 2$

# #$

#

#

!

# !#

. #/1#: #

# #

# 0$

!# #

Page 48: Adrenoceptor Antagonists and Haemodynamics - Trepo

'

"2 8 "?#"2 %#C# C/"##% ;

7#0/#%80/#%80##X2<?##

0$%#$"70#$"$!%

"28"1$"2 #C/"##%;&7#0/#%8

0/#%8 0# # X 2< ?##

0$%# $" "1## 0#$"$ !% -

7"1#%#1/#2>##$/#$"2

;%##<

"28#$1"##C/"##%;7#0/#%8:

0/#%80##-X2<?## 0$%#

$""?"#"0#"%#6#$#%

%&7/7,.*6(.#(7),#.&$,),(%

%,+2(*?&,.

// "1# "$/ #%$% ?## !!C# >2 "1#

"1$/ 00$""## 7 "1#)%!$"/*$%"$" 7

+$0$"$8"1#!"/7"2

?%!!C#>2"1#"1$/ 00$""##7

"1# )%!$"/ *$%"$" 7 !!%/8 ?##

?$""# $70# %#" ?% >"$# 70

#1 %>B#" !$ " "1# %"2 $$"$"$8 %

##%%$""#$"1#*#/"$7)#/%$$

%&7/

1# " 6$%$"$ ?% %""# 7"#

1#020$% 1 %">$/$%# $ %!$#

!%$"$"1#"$/"">/#?$"17"%!!"$

%$/#"/>"21##7"#8"1#">/#?%#!"

1$F"//2 7 "1# 0$ >#7# "$/"$

"1#">/#!":(°;-°G%<7(0$"#%;"$/"

!"$#"%< >#7# #"$ ;-]G%< "1# ">/# "

"1# %!$# !%$"$ 1# "$/" ?% #//#

#/$# $7 !#%2!# %2!# #C#/!#

;"$/"J!"$#"%<

?##0#%# >#" " >#" 1#

"$0# !#$% 7 -( :( % "# $" /2%$%

?## B%" >#7# /$7"$ ! "1# ">/#8 ?$"1$

7$C#0$"#% 7"# "1# /$7" !8 #0$"#

>#7# %#" ? /"#"1#8 "1## ?## (

0#%#0#"!#$%

$

+?%0#%# "$%/2?$"1.$!#%

;10#8 /#8 < $$"$%# >2

$ " %0!/$ "# 7 (( )F 1#

$ ##"#+7$/#?%? %0!/#

" (( )F %$ "/> %7"?# ;C#%$

8 "1=% 8 "$8

%%1%#""%8<#"7%"%7"?#;

$0#$/ %"0#""$ #%#1 $"8

0%"#08 1# #"1#/%< ?% %# "

//"# >#" " >#" #$C#

1#020$ !0#"#% >%#

/$#8"$0# C$>/#"1## #/#0#"#/7/?

0#/ ;=#%%#/$ #" / 55-< "1#

$$C$/1"#$%"$%7#1!"$#"@!/%#

"8 ##8 #8 1#$1" ?#$1"

C## #$%7 7 "1# "$0#

Page 49: Adrenoceptor Antagonists and Haemodynamics - Trepo

5

!#$% #%$># >C#?## //"# 7"#

$%$ "1# C/#% 0# % ! >2

#"7%"

+

?% 0#%# >2 %$ =

; $8 #/ (8 H #$/8

//$8 %"$< *$%!%>/# #/#"#%

;/# %#% "2!# (( 8 #$"#%" G8

^/%"2#8 *#0< ?## %# !$ 7

#/#"$//2 #"# #" #/#"#% ?%

!/# #9"#0$"$#%8 B%" !9$0/ "?$%"%

/#% /"# #/#"#% ?## !/#

!9$0/""1##"#/#"#%?$"10

$%"#>#"?##"1##"#%7"1##/#"#%

%&7*,.#(7

1# % $ "2 ;.$ < ?##

%#/#"$C# β "$%" !!// ;">/

+!/ (08$8.$/<8 %#/#"$C#

α β "$%" C#$// ;">/ $/

0081#8?$"F#/<8α

"$%" "0%/%$ !/#> ;">/G!%

/"%< "1# >/# 002 #%$8 "1#

%>B#"%"#$"1#!/#>"1#"?$#

2?$"1((0/7?"#7"1##2%@

< !/#>'0J'!0;_&<8

< !!// ( 0 ' 0 J !/#> '

!0;_&<8

-< !/#> ' 0 J C#$// 0 '

!07"?2%8C#$//0

' 0 J !/#> ' !0 %$# "1# "1$

2;_&<8

< "0%/%$ (08 ' 0 J !/#> '

!0;_:<

$"

$%

$

$

&'$

$"

$%

$

%

$

&

'$

*6 ./?%7"1#<"2><"2

"2 ?% !#/$0$2 "$/ " #%"$0"#

?1#"1# 00/2 %# α >/$ %

1C# 0#%>/# 1#020$ #77#"% 1#

$$"$/ " "1#$ /% $/# %#C#

!"$#"% ?$"1 α "$%" /7F%$ ;">/

#

3

Page 50: Adrenoceptor Antagonists and Haemodynamics - Trepo

(

`"/087$ 2"1#/>8.#<8#C#

"11 " !#%#"# ?$"1 "2 #%/"%

7"# "1# $"##%"$ #%/"% ?$"1 "0%/%$8

"1#"$/!!/"$?%#9!#""2

;.$><8?1## "1#%?##α "$%"

/7F%$ ;">/ `"/ 08 7$

2"1#/>8.#<8 "0%/%$ ;!%0$

( 08 01$ +10#"$/8 H!<8

!/#>;">/G!%/"%<1#"1## 2

#$0#7"1#$77##""#"0#"!%?%

%7//?%@

< !/#>'0J'!0;_<8

< "0%/%$ ( 0 ' 0 J !/#> '

!0;_(<8

-< /7F%$0'0J'!0;_(<

"1#0$;'0<7 "1#7"1 "#"0#"

2"1#%>B#"%""1#$/%"%#-

1 >#7# "1# >#$$ 7 "1# %!$# !# "$/"

#$7$C%/C$>/#%"1#

% /1/$ >#C##% ?## //?#

$ "1# "#"0#"8 "1# %>B#"%

7%"# C#$1" "$/ "1# %"2 !0#"#%

?####

1#%"$#%?##$#"$>/# >/$8

0$%# !/#> "//# 7%1$

#7# "1# "#"0#" ?% %""#8 "1#

7//?$"$%>%#/$##$%?##

"# 7"# "1# %>B#" 1 >## $ %!$#

!%$"$ 7 ( -(0$"#%@ >#" " >#"+8

*+8 +8 8 8 +=8 8

)1#"$/" ">/#?%$%#701$F"/

!%$"$ " !$1" :(] !%$"$ 7 '

0$"#%87"#?1$1$"?%/#"?$%

"1# %>B#"% 1 #%"# "1# 1$F"/ "$/"

">/# 7 7"1# : 0$"#%8 "1# !%" "$/"

!0#"#% ?## ## "1# 7"1

"#"0#" 28 " - 1% 7"# "1#

$#%"$ 7 "1# /%" %#8 $# ?1# "1#

% # ? " 1C# #77#"$C#

#""$% $ %#0 ;07"#P%

0#"%8 558 +?# #" / 558

"%%1$0 #" / 55'<8 "1# 1#020$

!0#"#% ?## 0#%# $ !$ "8

$ 7"# "1# "$/" !C"$ %

#%$># >C# *$ "1# "$/" "#%"8 "1#

%>B#"?% " //?# " %!#8 1#G%1#

?%//?#">#"1#?$"1""//#"#

:@

+ ?% ## >2 7$# >/ !#%%#

0#%#0#"0#"1;.$!#%-((8%#$#%

.`8 10#8 ,$%C$//#8 8 <

"//# >2 #9!#$## %# ?$"1

>1$/ 77 $ " "1# $C $

0#"1

?% 0#%# ?$"1 = ; $8

#/ (8 H #$/8 //$8 %"$<

?% //"# 70 + %

_+G 9'(8 ?##

"%70# " "1# #%!#"$C# $$#% >2

Page 51: Adrenoceptor Antagonists and Haemodynamics - Trepo

#/"$ "1#0" "1#>2%7##;<@

%"# $#9 ;_G<8 $ $#9

; _ G< %2%"#0$ C%/

#%$%"# $#9 ;_ 9 < .

+= 0#%#0#"8 $"$/ #/#"#%

#8 0>$0 %"#$ /#7" /7 ?##

%#

%&7/

1#%"2?%$#"$"?#"#%%$

0$%#8 >/# 0%#8 "? !#$

%%C# #%$ 1 %>B#"?% #C/"#

$7$C#C$%$"%877?1$1$/#1#

!"$/""#%"8 8%!$0#"28#9#$%#"#%"8#2#

#90$"$ $/$ 0#%#0#" 7 +8

>/ %0!/$ 70 "1# "#>$"/ C#$

7 "1# #"#0$"$ 7 1#0"$"

!/%0"$0//#""$

*$"1#%##$C$%$";%"C$%$"8.$:<8"1#

%>B#"% ?## 0$%# " # 7 "1# "?

"#"0#" %#6##% 1##7"#8 "1# !"$#"%

%""# - 2 $ /0 0#$"$

;# ! 7 F/0$# "1## "$0#% $/2<

!#$7//?#>27$C# 2?%1 "!#$

?$"1" + /?#$ "#"0#" >#7# "1#

C$%$"7"1#>%#/$#0#%#0#"%;C$%$"<

*$ "1# 7$%" 7 ?## "#"0#" !#$8

1/7 7 "1# !"$#"%?## "#"#?$"1 "$0//

( R 12#/ ;$0%8 "# 28

0!##8.$/<#$/28?$"1(5R

/%/"$ "?$#$/21#"1#1/7?%

"#"# ?$"1 6#% "$0// ( R ;7"

$0//8"#280!##8.$/< "?$#

$/2 12#/ C#1$/# # $/2

1##7"#8 "1#%>B#"%?## # #C/"#;-

C$%$"< $0#$"$ !#$ 7 - 2%

7//?#8$"?%%###>2?%1 "

!#$7 7$C#2%7"# "1#%#>%#/$#

0#%#0#"% ;"1 C$%$"<8 "1# !% %?$"1#

%"2 0#$"$% 7 "1# %# 7 ?##

"#"0#" !#$% "1" ?## 7//?# >2 #

0# %#" 7 !12%$/$ 0#%#0#"% ;"1

C$%$"<

! &

1# %>B#"% ?## %# " " %# 77#$#

"$$$%;77##8"#8/$%<

""%0#$"1#0$>#7##1%"2

%#%%$8>" "1#2?##C$%# "1C# /$1"

>#7%"

1# "$/" "#%" ?$"1 "$% +8

=0$"$?%%""#(0$7"#"1#

#/$C#2 7"# ( 0$ $ %!$#

!%$"$"%">$/$%#1#020$%1#7$%"

"#0$"#%"1#%>B#"?%%"$//#!"$%!$#

!%$"$8 7//?# >2 "%$"$ " 1# !

"$/" !%$"$ ;:(a< "1# "$/" ">/# 7 7$C#

0$"#% " 0$"#% 70 "1# %""8 "1#

%>B#" ?% $ "$/"# ? " %!$#

!%$"$ 7 "1# 7$C# 0$"#% )##8 "1#

""/ "$ 7 " 6$%$"$ ?% (

0$"#%

Page 52: Adrenoceptor Antagonists and Haemodynamics - Trepo

$"

$%

$$

($)$

*$)

+,-.

*$)

/,-(.

$$

($)$

*$)

+,-.

*$)

/,-(.

*6 ! ./? 7 "2 ?$"1 "? !#!"$% 7

!1"1/0$"$0//1#"?"2!#%7/$#%#!#%#""1#

"?!"$#"!%?$"1!!%#"#"0#"#%

%(17 )

.# #9!$"2 C/0# $ # %#

;.<?%0#%#$%"%!$0#"2

"#%" >" :( 0$"#% 7"# "1# $%"$//"$ 7

"1#

#"?## "1# %!$0#"2 #9#$%# "#%" "1#

%>B#" /$# ? $ %!$# !%$"$ 7 (

0$"#% 7 #$%""$ 7 #%"$ 1#

09$0/ #9#$%# "#%" >$2/# #0#"#

?$"1 #/#"$/ >#% ?% %""#

!!9$0"#/2 5( 0$"#% 7"# "1#

#/$C#2 *$ "1# #9#$%# "#%" /#

;% ,$< ?% 0#%# #C#2

0$"# + #C#2 "1$0$"# ;"1# "1$8

"1#%$9"1"1#$"10$"#<

(17

1# %$/?% /2%#?$"1=$ +

%7"?# ;>%/"#/$#%288.$/<

; # #" / 555<4 #"#"$ /$"10

0$7$# 70 #/%# Q##/#># ;5'-<

?%%#"#7$#!#%740!/#9#%

?$"127/#%%"10%1##7

>"$$ $%""#% $"#C/% ;<

1# $"#C/ 70"1#%""74?C# " "1#

!# ?% $"#"$C#/2 #7$#8 7//?# >2

%7"?# >%# ?C# !#9 ?C# #

#"#"$%#/#"$/$#?%#7$#>2B$$

Page 53: Adrenoceptor Antagonists and Haemodynamics - Trepo

-

"1# !$"% -(( 0% >#7# "1# %#"$C#

!#% $ "1# %$/ 1# # 7 ?C#

?% #7$# % "1# %%$ !$" 7 "#"

7$""#""1##%#$!"7#1?C#

"1#$%#/#"$/$#4$"#C/?%0#%#%

>%/"# "$0# $"#C/ % #"# 4

$"#C/ ;4< ?$"1 "1# 0#"1 7 )#%

;5'-<8 %$# $ "1$% %"2 "1# ) 1#%

>#"?## %!$# 1# ! !%$"$ ?##

%$$7$" $"$8 +?C#%?###"#"#

%"1#$!#9">"$+$"#C/80#%#7

"$ . "#1$/ #%%8 "$

C#"$/ "$ "$0# ;+ $"#C/< ?%

#7$# % $"#C/ >#"?## "1# !#9 7 +

?C#"1#!#7 "1#40!/#98"

% $"#C/ 70 "1# %"" 7 + ?C# " "1#

%""7"1#4?C#7"1#40!/#9

1#0#X*7 "1#8)84+

$"#C/?##//"#70%# #7$#(

%;0$"#%<!#$7##70#"!$>#"%>"1

$ %!$# $ 1# ! "$/"# !%$"$ 1#

%6# " 7 "1# 0# 7 "1# %0 7 "1#

%6#%7$77###%>#"?##B#"0/

" 0/ $"#C/% ;*< ?% /%

//"#$"1#%0#!#$%1#7$%"-(

%$1# !!%$"$?%/?2%#9/#70

"1# /2%$% >#%# 7 %""$$"2

%">/# 1#020$% 7"# "$/"$ !

$"$ " "1# #C/"$ 7 "1# >#" " >#"

C/#% 7 $ "$0# 0$8 %!#"/

#%"$0"$ 7 C$>$/$"2 $ 7#6#2

0$ ?% >"$# 70 "1# 7 0$"#

%""$2#$%$"1#%!$#$"1#1#

! "$/"# !%$"$8 %$ "1# !>/$%1#

#00#"$% 7 ) C$>$/$"2 ;%

.# 55:< 1# %!#"/ !?# 7 "1#

$"#C/ ?% //"# >2 7%" .$#

"%70"$ ; # #" / 555< 1# "$0#

%#$#%?##/$#/2$"#!/"#8#%0!/#

")F1#"1#2?##!%%#"11/?

!%% $0!/%# #%!%# 7$/"# ?$"1 " 77

7#6#2 7 (( )F8 /$#/2 #"##8

)$ 7$/"##7%".$# "%70#"

#%"$0"#!?#$%"$>"$ ;+#%% #" / 5'5<

"/ !?# ;C$#< ?% $C$# >2

$"#"$$""1##7#6#2>%@C#2/?

7#6#2 > ;,.< " ((()F (()F8

/?7#6#2>;,.<"(()F ()F

1$17#6#2>;).<"()F ((

)F1#$"#"#!?#%$"1#/?7#6#2

;,.< 1$1 7#6#2 ;).< >% ?##

#9!#%%#$0/$%#$"%;<$"$8

"1#"$,.G).?%//"#

$

#%>/%0!/#%70/?##"#B%"

>#7#(0$7"#0$$%""$7"1#

%"2!%$0//#""$%$!/%0

?## /2%# >2 %$ %#%$"$C#

$##!" %%2 ;3$/ #" / 55-< 1#

%#%$"$C$"2 7 "1# %%2 $% (( G0/8 ?$"1

$" $"# %%2C$"$7/#%%"1(

R

Page 54: Adrenoceptor Antagonists and Haemodynamics - Trepo

%&7/

1#/0!"$#"%$"1$%"$/#!#%#"#

%>! 7 "1# !"$#"% 7 "2 8

1##"1#%"27/??%#6/7"1#01#

1#/"12 C/"##% 1 %$0$/ %"2 %#

?$"1 "1## #9#!"$%@ 1#2 $ " "# 2

% $ "1# $ /00#$"$

!1%#%8 "1#2!!/$# "$0// 7/2 "?

$%"#77?##%$#1"#"0#"!#$

."1#0#8 "1# 2 7"# #1 C$%$" 7

1#020$ 0#%#0#"%8 "1# !/%0

#""$7 "$0//?%#"#0$#" 8

8-(0$"#%88888'

1%7"#$%"$//"$70#$"$

-)

6 7-

#0$*?% #9""# 70!#$!1#/

>/ /#2"#% %$ 00#$//2

C$/>/# $" $>"'=%""$

$ " "1# 07"#O% $%""$%

;4$# 8 )$/#8 #02< *

%0!/#%?## #"2!# >2 #0!/2$ "1# P

/#%# %%2 7/#$ //#/# %!#$7$

6!>#% ;,$C555<%$ "1#

+$%0 &5(() #6## *#"#"$

2%"#0;!!/$#$%2%"#0%8.%"# $"28 8

< 1# /#"$# %#6##% 7 !$0#%

!>#% %# $ "1# + ?## ##

70 !>/$%1# %#6##% #!%$"# $ "1#

# #/# ">%#%

%2"1#%$%# $ B"$ ?$"1 !!/$#

$%2%"#0%+ #"$"$$#0$

*8×$C#%/+ %"#$985((

7#1!$0#((7#1!>#?%

!#70#$5: ?#//!/"#%%$"1#%"

!"/$""/C/0#7µ/ !$"

7/#%## ?% 0#%# #"2!#

//$$#">2"1#//#/$$%$0$"$

/2%$%0/#7"#+ #%/"$$/#

$#"$7$"$ 7 "1## #"2!#% 7 >"1

67-!/20!1$%0%

14$5

+#%##7//#/#%14$5A14$5A

;>/#-<?%%%#%%#>2%#7O/#%#

%%2 1 #"$ %# 7 #0$

* ?% !#70# $ !/$"# %$

%" #"$ $"$% 1# ##"%

%# ?## !!/$# $%2%"#0% ;.%"# $"28

8 < +# *#C#/!# %%2 ##"%

;+*<+@-:- 7 "1#14$5A8

+@-(7"1#14$5A;,$C555<

0!/#%C$7"1#A"1#AC$"%?##

#"#%A

#%#2#(74*(6#(7.%#%*.%*+#4

#(#4/.,.

"2

Page 55: Adrenoceptor Antagonists and Haemodynamics - Trepo

" $0/"#%

C/#% #%"$0"# >2 !/%# " ;+ <

0#"1 = ;+ 8 + 8

8#%!#"$C#/2<?##0!#$

""1##00#"$%>2//"0

;5':<@ 1# C/#% 7 + ?## !/""#

$%""1##%!$C/#%7 1#

$77###%>#"?##"1#!$#C/#%?##

!/""#$%""1#C##7"1#%#!$#

C/#%$%>#"?##"1#0#"1%?%#7$#

% "1# 0# $77### >#"?## "1#

#%!$ C/#% 1# %0# /2%$%

?%/%!!/$#7 ,$0$"%7##0#"

?##//"#%$77###%7X*7"1#

0#%#0#" !$% 1# !##"#% 7

!"$#"%$?10"1#$%#!2$C/#%

>#"?## "1# 0#"1% ?% ?$"1$ ( R

;(5(b+ G b(<8(R8-(R8(R

(R?##//"#"#"O%!$#

"#%"?%%#$"1#/2%$%7!$#"

! C/# /#%% "1 (( ?% %$##

%$$7$"$//"1#%"$#%

1# >$% >#"?## "1# 0#"1% "1#

%" #C$"$ 7 >$% ?## //"#

%#!"#/27>"1"1#"$/" "1#"$/"J!

3 #%#

"1# #/"$C# 1#% 7 C/#% ?## 7

!"$/ $"##%"8 "1# 7$%" C/# 7 #1

%#" 7 "1## 0#%#0#"% ?% %$## %

(( R 1# "1# #/"$C# C/#% $ !#

#"%?##//"#7"1#%#"1$

0#%#0#"% 1# $%#!$#% $ "1#

%# "1$0#%#0#"%?## 1/#

%$0$//2 " "1# >%/"# $%#!$#%@ "1#

!##"#% 7 !"$#"% $ ?10 "1#

$%#!2 >#"?## "1#0#"1% ?% ?$"1$

( R8 ( R8 -( R8 ( R ( R ?##

//"#

1#1#% $+ ?##!/""#$%" "1#

1#% $ 1# #77#" 7 1# ! "$/"

?%!/""#7>"10#"1%

"$#%

#%X#$C# 1#%?$"1%

""1#>%#/$#8$#>#7#"1#"$/"!C"$8

?## 0!# ?$"1 "#" "#%" 7 !$#

C/#% %!!"# ?$"1 7#$ !%" 1

"#%" 1#% 70 "1# !# "#"0#" /#C#/%

%# >2 "1# "1%"%$% ?$"1$ "1# %"2

!?##/%"#%"#?$"1!$#&"#%"%$

"1# 7#$ "#%" *$77###% >#"?## "1#

!% ?## #C/"# ?$"1 #!#"#

8 %!!"# >2 "1# 7#$ "#%"

?1#2$!$ ?$%#0!$%%>#"?##

"1#!%;.$%5 (<

"2

#% X * # $C# 1# 1#% $

1#020$ !/02 !0#"#%

?## //"# % $77### >#"?## "1#

0#%#0#"%$"$0// "#"0#""

"1#>%#/$#1#">"16#%#/

Page 56: Adrenoceptor Antagonists and Haemodynamics - Trepo

:

70/"$%7 "$0//?##0>$#$#

"$0// #""$ C/#% ?## "

0//2 $%"$>"#8 !#0 $%"# 7

+#% #/"$ #77$$#"% ?$"1

%$$7$# /#C#/% ?## //"# 7 "1#

#/"$%1$!>#"?##"1#!/%0#""$

7 "$0// "1# 1#% 0#%# $

$/"2G!/02 !0#"#% 1#

%""#!/"%7 "1# "$0//#""$

$/"2G!/02 !0#"# $/# "1#

##%%$ /$#?$"15R7$## $"#C/

/$0$"%

"2

14$5& 1#14$5//#/#A?%

##0# 7"$/ //#/#% A8 A8 A

7"$/%0#%#7""/ +*:

"$C$"28 "1# !"$$!"% ?## /%%$7$# $"

"1## "#$#% $ " "1# 0># 7

7"$/ 14$5 //#/#%@ "1# $$C$/%

?$"1 F#8 # "? 7"$/ //#/#% #

#7##"%!;+<8$"#0#$"#;<

#9"#%$C# ;< 0#">/$%#%8 #%!#"$C#/2

;3$11#$# #" / ((< # 7 "1#

!"$$!"%$#!/$"#0/"$!/$"#

7"$/14$5//#/#%

. "1# 1#/"12 C/"##%8 "1#

!10$#"$!0#"#% 098"$0#" 09

;09<8 L ?## //"#

0!#>#"?##"1# "1## +*:"$C$"2

!% %$ /2%$% 7 C$# ;<

%#!"#/2 7 12#/ 6#% "$0//

!#!"$% +$?$%# !%" 1 0!$%%

?## !#70# %$ /#%" %$$7$"

$77###;,*<#"$70/"$!/#"#%"%

1##77#"%7#114$5!""1#)

1# 70 #%"$ " 09$0/ /#C#/ $

#9#$%# ?## 0!# ?$"1

%!!"#>2,*#"$

. "1# /0 !"$#"%8 "1# !/%0

#""$ " ( 0$"#% 7"# "1#

$%"$//"$?%0!#>#"?##"1#

!%8 %$ "#" "#%" 7

$#!##"%0!/#%

6& 7-& 1# /2

$#%7*7 !/20!1$%076

?## 0>$# $" # !8 #

10F2"#% " "1# /% 7 "1#

'*7 !/20!1$%08 /2$# $#%

?##0>$#7/2%$%%"7-8"1#

2"$# $#% 7 "1#<*1 !/20!1$%0

?## %$## % # !8 "120$#

10F2"#%%"1#"1#

1# #77#" 7 6 7-

!/20!1$%0% 7 "1# +8 *+ )

#%!%#%?##/2%#?$"1/$###%%$

%$#8##!/%0#""$7

"$0// % C$"#% 1# %$$7$"

$77###% ?## 7//?# ! ?$"1 !$?$%#

!%" 10!$%?$"1,*#"$1#

#""$ "1#%1/ 7 "1# %2%"#0$ M

0#$"# #77#"% $% !!9$0"#/2 (( G0/

Page 57: Adrenoceptor Antagonists and Haemodynamics - Trepo

&

;3$/#"/55<$#"1#$07"1#%"2

?% " #%"$0"# "1# #77#"% 7 6

7- !/20!1$%0% $ "$0//

"#"0#"8"1##""$C/#%>#/?((

G0/ ?## #9/# 70 "1# 6

7-/2%#%

Page 58: Adrenoceptor Antagonists and Haemodynamics - Trepo

'

')1#$*.'('5('(*(-#.*-,

),%2'7.*(%2,#..,..),(%'5 #(7

=>

1# C## C/#% $77##

>#"?##"1#0#"1%;!U(((<@"1#C/#%

>2 = # 70 - " &0/8 >" >2

"1#!/%#"0#"170"50/1#

>$% $>#"?## "1#0#"1%?%5X

0/ ;.$ &<8 "1# /$0$"% 7 ##0#" >#$ 5

'0/I"1###0#"!/"$%%1?$.$

' 1# !##"#% $ $77##" $%#!2

#%#$C#$>/#

1# C/#%>2 =#70("

'& /G0$8 >2 "1# !/%# " C/#%

70(":-/G0$1#>$%>#"?##"1#

0#"1%?% X /G0$8 "1# /$0$"% 7

##0#">#$ (&-'-/G0$

#34, 0/"$C# !##"#% 7 $%#!$#%

>#"?## %"# C/0# C/#% #C/"# >2 !/%#

" ;+ < 0#"1 $0!## $!12

; < *$%#!2 >#7# %/$ #7#% " "1# "$%

>#"?## !$# >%/"# + C/#% 1#

!##"#% ?$"1 %/$ # "1# $%#!$#% 7 "1#

%# "1$ !$# 0#%#0#"%8 ?1# "1# 7$%"

#% # %/# " (( R $" 8

68$"

*$%#!2

#;R< #7#%/$;R<

=$"1%/$;R<

( -:( ' ::-( - '-( :' 5( ' 5'

Page 59: Adrenoceptor Antagonists and Haemodynamics - Trepo

5

'*''

(

'*

(,

(0

''

(

$1

$ $' $

$(

$

$ $

1 '

1 ,2 2 0

1

$,

$ ,

$,

,

,

,

,

',

(,

0,

$ $3 $3 $3 4 43 43 43

!

*6 $% /$0$"% 7 ##0#" ;*< $ %"# C/0# ;< >#"?## ?1/# >2 $0!## $!12

; <!/%#"0#"1;+ <7//0#%#0#"%;//<%#!"#/27"$/" #"$C#; <"$/" !%$"$C#

;J<!"$#"%$"1#%!$#!%$"$;<87$C#0$"#%7"#"1#>#$$7"1#"$/";<>#7#"1##7"1#"$/";-<

1##%!$"C/#%#%1?>2#1!$"$" 8 68$"

,

,

',

0,

*,

,,

, , ', 0, *, ,,

$,

$ ,

$,

,

,

,

,

',

(,

0,

2,

, , (, 2, 1,

"!# !

!

*6,5%"#C/0#;<C/#%0#%#>2?1/# >2$0!##$!12; <!/""#$%""1#

!/%#"0#"1;+ <1#/$#7#6/$"2$%%1?*62%*$77###%70#%#C/#%; + <

!/""#$%""1#C##7"1#%#"?C/#%8; J+ <G1#C##/$0$"%7##0#";X*<#/%

%1?c ccJc#7#"d"$/" #"$C#dd"$/" !%$"$C#d!"$#"%8#%!#"$C#/2$" 8

68$"

Page 60: Adrenoceptor Antagonists and Haemodynamics - Trepo

:(

55,+%.'5'$#4#7$,(,$6*+

#(%#6'(*.%.'(2#,)'7/(#)*+.=9

>

# 7 "1# C/"##% #!"# 2 C#%#

#"$%$"1#"#"0#"!#$%

"1# #0>#" !%$"$ >#7# "1# !%%$C#

1# ! "$/"8 >"1 !!// C#$//

##%# + %$$7$"/2 0# "1

!/#> ;!U((<8 )0# "1 !/#>

"0%/%$ ;!U((< ;>/# <

+!// /% ##%# += 0# "1

!/#> ;!U((< 0%/%$ /7F%$

$ " 1# %$$7$"/2 2 7 "1#

C$>/#%0!#?$"1!/#>

1

1# 0%" !# 1#% $ "1#

$C%/ #%!%$C##%% " "1%"%$%

# $ #%!%#% ;.$% 5 (<8

?1$1?###0>/2##$1# !"$/"

!%$"$ $ "1# %>B#"% ?$"1 "0%/%$

/7F%$ 0!# ?$"1 "1# !# "#"0#"

#%!%#% ;!U((< 1# #%!%# C# ?$"1

!/#> $77## 70 "1" ?$"1 "0%/%$

;!U((< "## " $77# 70 "1" ?$"1

/7F%$ ;!U((< "1# !!// !8

"## " $#%# 70 "1# C/#

?$"1" "1# ;!_((< "1# "0%/%$

!8 "1# #%!%# C# " "1#

"1%"%$% $77## %$$7$"/2 70 "1" $

"1# !!// C#$// !%

;!U((<

$ %

$

$

$

$

$

&'

(

#

!

$=>A=>

$ %

$$

%$$

$$

$

$$

%$$

'

)*

#

*

!

$

A

A

=>

*6 B * $# 1#% ;0#% ± 8 _: &<

70 !# "#"0#" /#C#/% ;""# ( /$#< $ "1#

#%!%#% 7 1#" "# ;)< %2%"#0$ C%/

#%$%"# $#9 ;< " !%%$C# "1%"%$% $

"1# ' 0$ "$/" !C"$ "#%" 20>/%@ /%# $/#%

_ !/#>8 !# $/#% _ !!//8 %6#% _

C#$//8$0%_ "0%/%$+!≤((0!#

?$"1 !!// C#8 !≤(( 0!# ?$"1

C#$// C#8 ; < !≤( 0!# ?$"1 C#$//

C#8 \ !≤(( 0!# ?$"1 "1# C/# >#7# "1#

8;\<!≤(0!#?$"1"1#C/#>#7#"1#

;( C/#< $" 8

( 13

Page 61: Adrenoceptor Antagonists and Haemodynamics - Trepo

:

*$ "1# !%%$C# "1%"%$%8 + ?%

$$"$//2 ; 0$< ##%# 0# ?$"1

"0%/%$"1>#7#"1#;!U((<1#

"$0# %# C#% 7+ *+$ "8

1?#C#8 $77# %$$7$"/2 >#"?##

!!//8 C#$//8 "0%/%$

!/#>

#34, 0027"1#1#020$#77#"%7"1#"#%"#%1#?%%1?"1#$#"$7#77#"%;!b((<8

$!#"1#%#%$7((U!b((efd#"#%/7#77#"8#0!"2%!#"1""1#!0#"#?%"%%#%%#

$'1$#('4'4 *)'4'4 #$-,7*4'4 45&<'.*( #).&4'.*(

&1*(,1'.*%*'( ) g g g f f

+ g ;h< g f f

*+ f f f f f

f f f f f

f f f f f f f f f f+= g g f f f

,#78&1%*4% ) f g f h h+ f f f f g*+ ;h< f f f f f f f f f f g f h h ;h< h f g g+= f f f f f

:,$+*., ) g + f *+ f

#(7-#$*#3*4*%/ 4$"#C/ f +$"#/ f * f !#"/$$#% f

&4)'(#$/

5&(+%*'(

. f

)81#""#I+8%2%"/$"#$/!#%%#I*+8$%"/$"#$/!#%%#I8%"#$#9I 8$$#9I8%2%"#0$C%/#%$%"#$#9I+=8!/%#?C#C#/$"2I48) #"#$"#C/>#"?##"1#>#$$74?C#""1##7?C#I+8$"#C/>#"?##"1#!#97+?C#"1#!#I*80#%#7)C$>$/$"28%##-7#"$/%I.87##9!$"2C/0#$#%#

Page 62: Adrenoceptor Antagonists and Haemodynamics - Trepo

±

!

"# $ %&

' ! $ (#& !

) ! *

! ' ! + ', -

, .

+ / 0+1 2

. ! / 0+ 2 .

! 3 0+1 2 ! 4

0+1 4 0+ 2 ! ,

! +

3 "# ! 2

2 +1

2 !

+5+6+"#2 !

, .

2

0+1+ 3 , "# !

!

0+1

. 2 0+ 5+

+

& ! 2

' ,' '

+ %&

' !

,7 2 , 2

2 8 ' ,' ,

α+ 3 %& !

2!

'

! + 3

' 9:(+

!"#"$%#&!'&#(#!"

'"#"#") **&'"+,)&'!-

& ,

"# #+1 0+ 9:(

Page 63: Adrenoceptor Antagonists and Haemodynamics - Trepo

! " #

!!$%# &

'(

) *(

+ , - '.(

$%

$ / , -

' 0 1 0 02.

$ #

( # "! 3

"% &

$%

, '

!! -

#!

4 2 ," ,2 ,

,

) 5 $% -

"

! 6

53#,!

/7+28!

"' 01 0

- # $

# 4 "!

# # #

- 9- $ 9- 0

$

8 & $"%

:''1 (

# #"

- #% # ;.

,

,# #"

- ! / !

3$ " ;: ! ! 3

" (:

"0:

Page 64: Adrenoceptor Antagonists and Haemodynamics - Trepo

:

$ $ $% ,

- #!

$

$$

$∆∆ ∆∆

.

#!

C891C

$ $ $% ,

- # !

$

$

$

$

$

$

∆∆ ∆∆&'

/ (0

!

C8!91D

$ $ $% ,

- # !

$

$

$

$

$

$

∆∆ ∆∆&'

$.

(0

!

C8 91D

$ $ $% ,

- # !

$

$

$

$

$

$

∆∆ ∆∆&'

,$.

(0

!

C891C

$ $ $% ,

- # !

$

$

$

$

$

$

∆∆ ∆∆&'

0

0

(0

!

C891C

# 3

+ 7

*6 1# #77#" ;i< 7 "$0// /#C#/ !/%#?C#C#/$"2 ;+=< $ %!$#!%$"$>#7# "1#1# ! "$/" 1# #"/#% # "1# $77###>#"?## "1#C/#?$"1 "$0//0#$"$ "1#C/# " "1# >%#/$# ?$"1" 0#$"$ ,$###%%$/$#?$"15R7$##$"#C//$0$"% #/"$ #77$$#" # %1? $" 8

6:

*6!!#%%$7 "1#1#" "# ;)<% 7"$7 "$0//#""$" 70#%#0#"!$"%$ "1##9#$%# "#%"@ "1#1# ;i<< $ "1# %!$#!%$"$>#7# "1##9#$%#8><":(=""%8 <"(=""%8 <" "1#09$00/1##"/#%#"1#$77###>#"?##"1#C/#?$"1"$0//0#$"$"1#C/#""1#>%#/$#?$"1" 0#$"$ ,$# ##%%$ /$# ?$"1 5 R 7$## $"#C/ /$0$"% #/"$ #77$$#" # %1?$" 8 6:

Page 65: Adrenoceptor Antagonists and Haemodynamics - Trepo

:

*$"1#"#"0#"?$"16#%70/"$

7 "$0//8 L ;!U((< ;!U((<

$77##>#"?##"1# +*:"$C$"2!%8

09 "## " $77# ;!_((:< ;>/# :<

*$"1#12#/"#"0#"8 "1#!%$

" !#%#" 2 %""$%"$//2 %$$7$"

$77###% 1# #%!$ !/%0

#""$C#%#$.$-

"1#!$?$%#!%" 10!$%$"1#

"#"0#"?$"16#%(R"$0//8

!% $ " $77# 70 #1 "1# "

2 7 "1# //"# 7 C$>/#% 1# +

!!#%#"#1$1# 09"1;!_((<

;!_((< !% 09 $ " $77#

>#"?## "1# !%8 ?1$/# L ?% /#

;!U((< 1$1#;!_((!U((<

$+%"1$%%8#%!$/2

<14$5

)!

1#/"12C/"##%?$"16#%"$0//8"1#

#/#C"$ 7 ) 70 #%" " 09$0/ /#C#/

$#9#$%# "## "$77#>#"?##+%

%;!_((&585R7$##$"#C/

--&">!0<8+%%;!_((&:8

5 R 7$## $"#C/ - " ' >!0<

1# +*: "$C$"2 !% $ " $77#

70#1"1#$"#"0#"?$"1"$0//

12#/

<

:7"1#5!"$#"%?##%"1##%

%$$7$"$77###%>#"?##"1#!%

?###"#"# $ "1#!/%0 #""$% "

1

$ , 1 % 2 $

- 3 !

$

$$

$

$

$

$

#

!

45

6

$ , 1 % 2 $

- 3 !

$

$$

$

$

$

$

#

!

43)

6

*6!!#!#/@ #""$C#%7"1#"1##

+*: "$C$"2 !% 7"# $%"$//"$ 7 6#%

70/"$ 7 !1"1/0$ "$0// 1# " !$"%

!#%#"0#X*+ ;+<8 $"#0#$"# ;<

#9"#%$C# ;< 0#">/$%#% 1 F#8 # "?

7"$/ +*: //#/#%8 #%!#"$C#/2 ,?# !#/@

1#C#%?$"112#/70/"$7"$0//"#

"1#$77##"#""$%/#%$"1#!#/%

Page 66: Adrenoceptor Antagonists and Haemodynamics - Trepo

::

<6 7-

6$ !

"1# %!$# !%$"$ >#7# "1# 1# ! "$/"8

# 7 "1#%# !/20!1$%0% 1 %$$7$"

#77#"%)8+*+=1#"$/"$"1#

># ! " :(a8 "1# %>B#"% ?$"1 "? *

//#/#% 1 1$1# + ;!_((-< *+

;!U((< "1 "1# /2 $#% *$ "1#

09$0/ #9#$%# "#%"8 "1# %>B#"% ?$"1

//#/#% 7 7- 1 /?# *+ ;!_((<

"1"1#$#%

#34,!+10$#"$!0#"#%09$0/!/%0#""$ ; 09<8 "$0# " 09 ;09<8 #/$0$"$1/7 /$7#

;L< # # C# ; < # %1? 7 >"1 6#% 12#/ "#"0#"% #1 +*: "$C$"2

!+_!0#">/$%#%;7"$/14$5//#/#%<8_$"#0#$"#0#">/$%#%;#7"$///#/#<

_#9"#%$C#0#">/$%#%;"?7"$///#/#%<#8%"#C$"$;*<80$$0009$00C/#%#

$C#

$,#%),(% #$#),%,$ ,#( *( #:

6#%(R

09 + &5 ( :- 5

;G0/< &- (5 (' -

& (: (&5 '

09 + (- & :&

;1< :- (& ( &

(5 (&: ( &

L + : ('5 5 :&

;1< --( (' -&

-(& : 5& :('

+ ( : 5 -

;j1G0/< - -& '

'- : --5 5

)2#/(R

09 + (-( ((: (: (-

;G0/< (5 (5 (( (

(: ( (( (

09 + 5 (- :& &

;1< :( : ( &

(' : ( &

L + 5 (( - '&

;1< -'- (& -& (&

-& :& :&

+ - (5 &' '

;j1G0/< : ( ( (

(&' (&& (( &

Page 67: Adrenoceptor Antagonists and Haemodynamics - Trepo

!

:&

!

!&4.,+'(%'&$),%2'7*(%2,

#..,..),(%'52#,)'7/(#)*+.

$C%$C# 0#%#0#" 7 $%

$$%!#%>/# $0%" 1#020$ %"$#%8

%$#"#1$/#"1$/%#%"$""1#

%# 7 $C%$C# 0#"1% " $"$//2 $//

!"$#"% 1## # "? 0$ /"#"$C#% 7

$C%$C#"#1$6#%"1"#>/#"$%

%%#%%0#" 7 >#" " >#" @ !/%#

"0#"1 $0!## $!12

1# #/$>$/$"2 7 ?1/# >2 $0!##

$!12 ; =< 1% >## !C# $

0>#7%"$#%?$"1$77##"%"2#%$%

#6$!0#" ;3AA>$ #" / 55&83AA>$ #"

/55&>83AA>$#"/5558 ""##"/((8

%1C$"F #" / ((< 1# !/%# "

0#"1?/!"#"$//2>##C##%$#"%#

0# #$/2 C$/>/#8 >" $"% #/$>$/$"2

1% " >## #6"#/2 !C# # $

1# !"$/""#%"1##7#8"1#!#%#"%"$#%

?##%""#?$"1#C/"$7?1#"1#"1#

!/%# "0#"1 / %>%"$""# =

$7"1#1#020$"$/%

1# C/#%#%"$0"#>2"1#!/%#"

0#"1 ?## #/"$C#/2 /? 7 !12%$//2

"$C#%>B#"%;C##-5/G0$<8?1$/#"1#

C/#%>2$0!##$!12?##0#

!12%$/$/ ;C## ' /G0$< 1#%#

#%/"% # $ ##0#" ?$"1 "1%# 7

)"0 #" / ;555<8?1 %1?# "1"

C/#% >"$# >2 "1# !/%# " 0#"1

?## /?#"1"1#C/#%>2"1##>#"1$

0#"1 " %##0% "1" "1# !/%# "

0#"1##%"$0"#% %$$7$"/2

1#27"1#!/%#"0#"11%

>## !#%" $ !"$#"% ?$"1 %">/#

1#020$% ;*% "% #" / 558

Page 68: Adrenoceptor Antagonists and Haemodynamics - Trepo

:'

/>##"/55<1##7#8$"?%#9!#"#

"1""1#0#%#0#"%?/$77#0%"$"1#

!1%# 7 ;!#<%2!#8 >" "1# >$% >#"?##

"1#0#"1% "# " " ># /0%" #6/ $

"1# $77##" !1%#% 7 "1# "#%")?#C#8 "1#

$C#%$"2?%>#$"1#"$/"J!"$#"%;*

7 >$% 7 - /G0$ $ 0#%#0#"%<

"1 $ "1# "$/" !"$#"% ;* ('' /G0$<

;!U((<

3?/## 7 "1# >%/"# /#C#/ $ "$/"

">/# "#%"% $% $0!""8>#%# "1#/?>%/

02 ># "1# 7" %$ "1%""$

12!"#%$8 #%!#$//2 $ "1# #/#/2

#"$ 7 >$% $ "1# !/%# "

0#"1 ?$// " #/$0$"# "1# $%##0#"8

>#%# "1# /$0$"% 7 ##0#" # #/"$C#/2

/#8 !"$//2 $ %2!/ !"$#"%

."1#0#8 //"$ "1#>%$% 7

##% $% !>/#0"$ 02 #C#

/#"0#0#"#%

#%$# "1# >%/"# C/#%8 "1# >$/$"2 7 "1#

!/%#"0#"1"#7/#"1#%$

#1 !"$#" ?% %"$$%# =1# "1# >$%

>#"?## "1# 0#"1% ?% #/$0$"# >2

%/$ "1# 7$%" 0#%#0#" " (( R8 "1#

$77###>#"?## "1#0#"1% $ "1#%#

"1$0#%#0#"% $ " #9## (R

$::R7"1#%#%8?1$/#"1##%!$

#%/" ?$"1" "1# %/$ ?% /2 ' R "

$$"#% "1" "1# 0#"1% ## >#""# $

"$1#%$

#%#7$2$"1#!/%#"

0#"1 $% "1# #%"$0"$ 7 %2%"#0$

1#020$ !0#"#% "1# >%$% 7

//1"#$%"$%@"1#"$!/%#"$%

!!9$0"# >2 "1# " $ 7$#

)?#C#8 + $% #/"# >2 02 %2%"#0$

// 0#1$%0% % ?#// % >2 "#$/

?// !!#"$#% ;/!#! ((-8

((-><8 "1# 0!/$# 7 "#$#% C$#%

70#"#2""1#1$%02>#7/#%%

%$$7$# $ 1#/"12 2 !#!/#8 >" $

#/#/2 "1#%/#"$ !"$#"% "1# $$C$/

$77###% ># %$$7$" 1# "/

!#%%# "8 #%!#$//2 # %">/#

1#020$ $"$%8 02 C2

%$#>/2$$77##"!"%7"1#>2

"1# !%%$>/# %# 7 $2 $ "1#

!/%# " 0#"1 $% $1##"/2 /$# "

"1#!!9$0"$7"1#"$%% %#"$/

# >2 "1# !"$#"O% #8 %#98 1#$1"

?#$1" "1# %# 7 $/"# "8 "1#

#%/"$ C/#% ?$// ># %0//# "1 "1#

"#"!"8C$#C#%8C##%"$0"$"1#

"$#$#%#%"1# #700

$$0#"#!!9$0"$/#%"#7

( R $ "1# C/#8 %$# "1# %%

%#"$/ # # !!"$/ " "1#

%6#7"1#$0#"#

Page 69: Adrenoceptor Antagonists and Haemodynamics - Trepo

!

:5

!,%#*4,7*(54&,(+,'5'$#4

#7$,(,$6*+#(%#6'(*.%.'(

2#,)'7/(#)*+.

)#020$#77#"%7"1# %#/#"$C#β

"$%" !!// "1# 0>$# α

β "$%" C#$// 1C# >##

#9"#%$C#/2 %"$#8 #9#!" 7 #"$/#

?/## 7 "1# 1#020$ 1#% $

!%%$C# "1%"%$% 1# $C%/

1#% # " "1# α "$%"% /7F%$

"0%/%$#?/27+)

"1# ?/## "1# #77#"% $

$$#%+=$%!#9$%"#""1#

!#%#" "$/%8 "1#$C%$C# = #>/#

"1# %%#%%0#" 7 C$#"27 1#020$

!0#"#%$77$/""#%"$0"#"1#?$%#

(

"1# !!// C#$// !%8 "1#

>%#/$# + ) ##%# 0#/2

0!# ?$"1 !/#> "0%/%$8 %

#!"#!#C$%/2$02!!#%;C#%#

#" / 5&58 558 3E1A# #" /

55'8 ((< 1# >%#/$# $ "

1#%$$7$"/28?1$1$%$102?$"1

"1# %"$#% %1?$ "1"!!//#%"

1C# #%%#"$/ #"$C# $"!12 " #%"

;###"/55-83E1A##"/((<

"#$/ += $% 7"# %# % %"# "

0#%# "#$/ %"$77#%%8 $" 1% ##"/2

>##!!%# "># $#!##"!#$"

7 $C%/ 0"/$"2 $ 1$1 $%

$$C$/%@"1#7%"#"1#+=8"1#1$1#"1#

$% ;7 #" / ((8/1# #" / ((-<

/M "$%"%?$"1$77##"!7$/#%1C#

>## %1? " #$"1# ##%# ;>$%!//8

C#$//8 0#"!// !!//<

$#%#;#/$!//<+=;%0#"/558

$$558#/$#"/55-8/0#"

/558"#/#"/5583E1A##"/

55'8((< "1#!#%#""8 "1###%#

7+=?$"1!!//$%$#"8"1#

1# += C/#% ?$"1 C#$// $

$%8 ?$"1 "1# !#C$% %"$#% 1# /""#

02 ># # " "1# #/"$C#/2 /? %$F# 7 "1#

C#$//!

1##$77##"70/"$%7/7F%$1C#

>## 0#"#@ $$/ %" 70/"$

0 "1## "$0#% $/28 %%"$# #/#%#

70/"$ 0 "?$# $/28 !/#

#/#%# 70/"$ ( 0 # $/2 //

"1#%# 70/"$% 1C# /2 0$ +

#!#%% #77#"%@ $ 0%" %"$#%8 "1# +

1#%$%!$#%"$!%$"$%1C#

>## %$$7$"8 "1# 09$0/ C##

#"$%>#$00);$1#/#"/((<

0%/%$ 1% >## %# $ %#% $

70(0"('0#$/20%/%$

(0#$/2$%"1#0%"00%$8

%$# /# %#% >$ / C#%#

#"$%%1%$FF$#%%1$$"$% $!"

& R 7 "1# !"$#"% ;=$/" #" / ((-< 1#

#77#"7"0%/%$(0+*+

Page 70: Adrenoceptor Antagonists and Haemodynamics - Trepo

&(

1% >## /$$//2 $#/#C"8 ( 00)

; 1!!/##"/55:8##255'8$1#/#"

/ ((< /% $ "1# !#%#" %"$#%8 "1#

##%# 7 %!$# + *+ #0$#

!"$//2 1# ?$"1 /7F%$ 0

"?$#$/2"0%/%$(0#2

#0>#"!%$"$8"1#%20!"1#"$"$C$"2

7 α ##!"% $% /? ; 1!!/# #" /

55:8,#! #" / 55&<)##8 #C# ""/

>/# 7 α ##!"% ?/ /2 $#

0$ $C%/ #77#"% "%"8

%"$ ! 0#/2 "$C"#% "1#

%20!"1#"$ %2%"#08 8 %#6#"/28

C%/ α >/# >2 /%%$ "$%"%

%1 % !F%$8 9F%$ "#F%$

7"# %#% %20!"0"$ "1%""$

#"$%C#7$"$1%>###!"#?$"1

"1#%#α "$%"% ;#"% 558 1$%1$//#%

#"/((8#1>1?$((<

(

1#$C%/#%!%#% "/7F%$

"0%/%$ ?## #/"$C#/2 $708 "1#

"$C"$ 7 C%/ α ##!"% !

"1%"%$%?%/#/2$"#7##?$"1>2>"1

7 "1#0 1# C/"##% $ >"1 !%

#9!#$## %$$7$" 0# ! $

%2%"#0$ C%/ #%$%"# 0!# ?$"1

"1# !# 1# 1$% %#%"% "1" "1#

% # " !#/2 %#/#"$C# α

"$%"%1#!$"1#/?##+

' 00) - 00) $ "0%/%$

/7F%$!%8 #%!#"$C#/28 0!#?$"1

"1# 1# !$ " 0#$"$ 1# 0#

"# ##%# $+ $ "1# "0%/%$ !

/ 1C# /$$/ #/#C# $ "1# #/#/2

0#?$"1 >#$ !%""$ 12!#!/%$@ % "1#

!"$#"%%#/2$%#$"1#$1"#"

"$8"1#!$+/$#$FF$#%%

!%%$>/2 #C# 7$"$ 1$% 1% "//2

>## 0#"# % $7#6#" C#%#

#77#" 7 >"1 /7F%$ "0%/%$ $

0>/"2 !"$#"% ;#1> 1?$

((<

1# #/"$%1$! >#"?## "1# %# 7 α

"$%"% ;!F%$8 9F%$8 $0$8

"#F%$8 /7F%$ "0%/%$<

1$!G7#07"#%1%>####"/2%%#%%#

$ /#!!/"$ >%#%# "/%"2

;C##$#"/((-<1##%#1#%7

%%$"$ >#"?## 1$! 7"#% α

"$%"%8 ?1# "1# 0#$"$ ?% "#

7 $C%/ $%#%# )?#C#8 "1#

"#"0#" ?$"1 α "$%"% 7 !%""$

12!#!/%$ ?% " #/"# " $#%#

$%77"#%1$% $0!/$#% "1" "1#!$

+7$"1$%%"2?$"1"0%/%$$%"

/$$//2 %$$7$" % 7 "1# $%7 7//$8

"1""1#1#020$#%!%#"1# !

"$/" $ 1#/"12 C/"##% $77#% 70 "1" 7

#/#/2 0# 9"!/"$ "1# >%#C#

C%$/"2 #77#"% " "1# #/#/2 $% "

Page 71: Adrenoceptor Antagonists and Haemodynamics - Trepo

!

&

%"$1"7? >#%# 7 "$"$

0#1$%0%@ $ $% %%$"# ?$"1

#"$ $ "1# ##$ $7/##

!12%$/$/ !#%%#%8 "1$% ?/

""#"# "1# #%!%#% >%#C# ;$0#%

((< )?#C#8 "1# "0$

0!#%"2 0#1$%0% $ "1# #/#/2 #

"%#77$$#"%$"1#2;##255'<8

?1$1 / %# #C# 0# !#

1#020$#%!%#%?$"1"1#!#%##7

α >/#$#!"$#"%

1# ##%# $ + "$C"#% %20!"1#"$

>#7/#9 "1" #%/"% $ β β

##!" 0#$"# 0!#%"2 $#%#

$ ) 1$% #/"$C# "12$ ?% 7"1#

#1# >2 >"1 /7F%$ "0%/%$8

!>>/2 >#%# 7 $1$>$"#

C%%"$"$8 >#%# α >/#

#% " #%/" $ ">/# #"$C#

1"!$#77#"% "1#1#" ;#

$1#/555<!%%$C#1# ! "$/" $0!##%

C#% #"8 ?1$1 /#% " ##%# $

!#/ 8 % ?% /% 7 $ "1#

!#%#" %"$#%/7F%$ "0%/%$ $

" %$$7$"/2 1# "1# #%!%#

0!#?$"1 "1# !# "#"0#" !/#>

C/#%8>""1#%%$$7$"/2"$%#

"1###%#$ $"1#1# !"$/"%#%/"

7 "1# $#%# $)1%8 "1#/#!$

?% "#"# >2 "1# #/"$C#

$#%#$ 8?1$1#9!/$%?121#%$

+#%0//$%!$"#7"1#0#$1$>$"$

7C%%"$"$

0%/%$$77#% 70>"1!!//

C#$//% #%)#%!%#%

"!%%$C#"1%"%$%1#$77###>#"?##

!!//C#$//?%"%""$%"$//2

%$$7$" $ "#0% 7 2 7 "1# C$>/#%

0#%# 1%8 "1# α >/$ #77#" 7

C#$// $% " !!#" $ "1# "$/"

!C"$8 "1# 7//?% %0"1/2

"1# 1#020$ !7$/# 7 %#/#"$C#

β "$%"

!..'+*#%*'(3,%0,,(4'014#.)#

4,-,4.'5%*)'4'4#(72#,)'7/(#)*+.

# 7 "1# #/$# #!"% %1? %!#$7$

#/"$% >#"?## "1# /? !/%0

#""$ 7 "$0//

$/"2G!/02 $7/##8 #C# "11

%1#/"$1%>##%1?"#9$%"7

/"$0//;=$/%#"/5'<"1#"1#

18 / G $"C#% 0#"!//

!!//"!#%#"#/"$>#"?##

"1# $C%/ #77#"% !/%0

#""$;=$/%#"/5'8Q$#1#"/

((<1#%#7/$"$#%/"%?$"1$77##"

M ##!""$%"%$%#"1#$"##%"$

6#%"$?1#"1#"1#/?!/%0/#C#/%%#

>2 "!$/ "$0// 2 %%$"$ ?$"1

$C%/"$%

Page 72: Adrenoceptor Antagonists and Haemodynamics - Trepo

&

"28/0/12!#"#%$

!"$#"%?##%>B#"#"!%%$C#1# !"$/"8

8 >$2/# #0#"# #9#$%# "#%"

%!$0#"2 7 %%#%%0#" 7 #"$/#

1#020$1#%// "1#!"$#"%?##

"#"# ?$"1 >"1 6#% 12#/

70/"$% 7 "$0// %$ 0$%#8

>/# 0%# %%C# 0/"$#"# #%$

$# "1# %"2 ?% $0# " #%"$0"# "1#

6"$""$C# #/"$ >#"?## "$0//

#""$ "1# $C%/ #77#"%8

"1#""1#"?"#"0#"%?##0>$#8

8 "1##7"#8 "1# #/"$% >#"?## "1#

!/%0 /#C#/ 7 "$0// "1#

$/"2G!/02#77#"%?##//"#

1# "$0// !/%0 #""$% C$#

>#"?## #"#">/# ;U(( G0/<

G0/8?1$1$%$##0#"?$"1#/$#

%"$#%@ "1# C## !/%0 #""$ 7

"$0//7"#%$6#%%/"$1%C$#

>#"?## (: -' G0/ ;""$ 558

$3$/558*$%"#$%/

55:81## #" / ((83"# #" / ((8

$#"/((<8?1$/#7"#"1#!!/$"$7

"1##/70/"$$"1%>##( (&G0/

;*$%"#$ %/ 55:81## #" /

((8$#"/((<

1# !/%0 #""$ 7 "$0// ?%

#"#0$#(0$7"#"1#$%"$//"$8

?1$/# "1#"1%"%$%?% %""#/2(0$

"1# #9#$%# "#%" 5( 0$ 7"# "1#

1#%# "$0# $77###% 02 ># /$0$""$% "

"1# %"28 >"8 "1# "1# 18 "1# !/%0

/#C#/%7 "$0// #0$ #/"$C#/2 %">/#C#

"1# "$0#!#$ 70( " (0$"#% ;.$

-<

1# ### 7 ##$ M >/# $% 7"#

#0%""# >2 "1# #9"#" 7 #"$ $

09$00 )8 >#%# #%"$0"$ 7 M

>/#$%$77$/""/?#)/#C#/%#"

/?/#C#/%7M %20!"1#"$"$C$"2;H1%%

#1 5&:< 1# !#%#" " $%

%"/2%!!"$C#""1$%#!"@"1#1$1#

"1#)8"1##"#"1##/"$>#"?##"1#

!/%0 /#C#/ 7 "1# M >/$ #" "$0//

);.$ <

/"11 "1# $%# $) $%/#/2 %!!#%%#

!!"$"#/2 " "$0// #""$8 +

*+?##"%$$7$"/2#!##"

"$0// /#C#/8 ?1$1 $% $ ##0#" ?$"1

#/$# #%/"% ;3"# #" / ((8 $ #" /

((8 "#?" #" / ((8 "#?" #" /

((>< 1$% $% !>>/2 # " %77$$#"/2

%" >##!" "$C"# 0!#%"2

C%%"$"$ C$#"/28 1$1# !/%0

/#C#/% 7"# 0$$%""$ 7 "$0//

C#?#$1 "1#0!#%"20#1$%0%

/?# +8 %$# "1# / %# #$0#% ?$"1

!/%0/#C#/%7((G0/;."$//

#" / 5'8 =$/% #" / 5'< 1C#

%#%%7//2 >## %# % "$12!#"#%$C#

"#"0#";##"/5&8,10//#

.1/$15&<.//?$"1#!$)8

##%#8 ?1$/# "1# $ " #9#"

Page 73: Adrenoceptor Antagonists and Haemodynamics - Trepo

!

&-

"#?"12$7/##"1#""1#%#!/%0

/#C#/%

1# C%%"$"2 #77#" 7 "$0// ?%

#7/#"# $ "1# !%$"$C# #/"$ >#"?##

"1# #""$ $ "1# "$/"

"#%"1$%?%!>>/20%"/20!#%"2

#"$ # " "1# ""#"$ 7 )8 >"8

"1##"$//28 "1#>/#7 C%$/"2M

##!"% 0$1" /% !/2 !" $ $"

"1# M >/# #77#"8

>1%"$"$8 ?% " 7 $ "1$%

%"28?1$1 $% $ #"?$"1 %0#8>""

//8 7 "1# !#C$% %"$#% ;0#"%$ #" /

55&8 *$2 #" / 55'8 =/ #" /

(((83"# #" / ((< "1#!#%#" %"2

// "1#%# !#C$% #%8 !"$#"% ?$"1

? %"10 ?## #9/# 70 "$0//

#9!%#8 >" $77#$ !#C/## 7

%>/$$/ #C#%$>/# >%""$C# $?2%

$%#%# 0 "1# %"2 !!/"$% 02

#9!/$ "1# $77##" /#C#/% 7 !/02

%20!"0%;*$2#"/55'8=/#"/

(((< $0// ( R 6#% %/"$ ?%

"1# 70/"$ %# $ // "1# %"$#% ?$"1

!/02 #"$%8 >" "1# "/ !/%0

/#C#/%?##"6"$7$#

1# !#%#" " #C#/% "1# $"##%"$ C#/

7$$ "1" "1## $% $C#%# #/"$

>#"?##+="1#!/%0/#C#/7"$0//

#C# " "1#%# #""$% ?#// >#/? "1#

/#C#/%7"#0$$%""$1#/$$/

%#6##% 7 "1# 7$$ #0$ " >#

#9!/#

) C$>$/$"20$% "1# "0$ "$C$"2

"%0$""#""1#%$"$/#;+$#"/

5':< //2 0$$%"## M >/$ %

# ? " $#%# ) C$>$/$"2 # "

##%# %20!"1#"$ $#%#

!%20!"1#"$ 0/"$ ;+%%#" #" /

55:8 ,0!#" #" / ((-< "1# !#%#"

%"28 "1# 1#% $ ) C$>$/$"2 $ "

#/"#?$"1"$0//#""$$%!$"#7

"1#0##77#"%7"$0//)1$%$%$

##0#" ?$"1 #/$# #!"8 ?1## #/

6#% 70/"$% 7 "$0// $ "

1# %$$7$"/2 2 7 ) !0#"#%

;$ #" / ((< 1# !0#"#% +

$"#C/ 4 "$0# $ " %%$"# ?$"1

"$0// /#C#/ $8 "1#%# 7$$% #

!>>/2 # " "1# #/"$C#/2 /? !/%0

#""$%7"$0//

!2#$)#+'6,(,%*+.'5'12%2#4)*+

%*)'4'4

7"# / $#%"$ 7 "$0//8 "1#

!10$#"$ !0#"#% 09

1C# >## %$$7$"/2 1$1# "1# L

/# $ 14$5 +% "1 $ %

;"2 #" / 5'8 ,# #" / 5'5<

+# ) $ #9#$%# 1% >##

%$$7$"/2 /?# $+% "1 $%8?$"1

%$$7$"$77####%"$)+

Page 74: Adrenoceptor Antagonists and Haemodynamics - Trepo

&

;,#?$% #" / 5'8 / ##$"$ #" / 55(<

)?#C#8 "? !#C$% %"$#% ?$"1

!1"1/0$ "$0// 1C# 2$#/# 7/$"$

#%/"% "1# 7$%"7 "1#0;)!!##"/

55<8 / 0$$%""$

!9$//2 %# 1$1# !# !/%0

#""$% $ % "1 +%8 "1#

"1% /# "1" "1# C$"$ $ "1#

%2%"#0$ >%!"$ 7 / "$0//

"$>"#%""$0//!/%0/#C#/%0#"1

"1# +*: !1#"2!# "1# %"28

#9#$%#)7//?$"$0//#2#!%?%

## %$$7$"/2 0# $ "1# +% "1

%8 !/%0 "$0// #""$ ?%

1$1# $ +% ;#$ #" / 55< )?#C#8

"$0// ?% !!/$# $#"/2 " "1# %/

0% $ "1$% /""# %"28 " " "1#

%!!/$#?1#%#%/ "#"0#"

% "1# "1% "#8 "1$% 1# $ "1#

$%"$//"$"$#0%"!>>/2$#%#"1#

>$C$/>$/$"2 7 "$0//8 /#$ " #/#C"#

!/%0 #""$% 7 "$0// ?$"1 /#%%

$"#!#%/C$"$?$"1$#1!1#"2!#

1$%0#"1/$//$0$""$?%C$#$

"1#!#%#"%"2

1##"2!$#7$$"$%7+8

C2 " %0# #9"#" ;3$11#$# #" / ((8

Q$#1 #" / ((< . %$0!/$$"2 # "

"1# #/"$C#/2 /? 0># 7 %"2 %>B#"%8

?# /%%$7$# "1# $$C$/% ?$"1 (8

7"$/ 14$5 //#/#% % +%8 %

% #%/"% %1? "1" +*: "$C$"2

!$ 1% /# %%$"$ " "1#

!10$#"$ !0#"#% 098 L

8 >" /2 ?1# "$0// $% $C# %

6#% %/"$ 1# !/%0 #""$%

7 "$0// #0$ #%%#"$//2 /?# 7"#

12#/ "1 7"# 6#% !#!"$

"1#"1#18"1#/?#"1#"$0///#C#/%8"1#

/?# "1# +*: "$C$"202># %77$$#"

"0#">/$%#"1#1$%02#9!/$?12

"1# !10$#"$% 7 "$0// 12#/ $%

"#!##""1#14$5!

+#C$%%"$#%?$"1/0#"!//8"1#

M "$%" 0#">/$%# "11 +*:8

1C# >## %0#?1" $%$%"#" $ "1#

!10$#"$ $77###% >#"?##

$$C$/% ?$"1 7"$/ 14$5

//#/#%@ !/%0 #""$% 1C#

>## #$"1# #6/ >#"?## "1#!% ; #"

/((<1$1#$"1#$$C$/%?$"1/2

#7"$///#/#;32"1#C#"/55'<

"1# !#%#" "8 "1# $77###% $

!10$#"$ !0#"#% $ " #1

%""$%"$/ %$$7$# >#"?## % %

01#/"12C/"##%8#$"1#$ "1#

!/%0 #""$% 7 "$0// " 1 7"#

#/$C#2 0 /0 !"$#"% )

"1# %"2 !!/"$ >## >$#8 "1#

%$$7$#0$1"1C#>###1#

#7"1#%0"1#1#/"12C/"##%

%1?# 097'G0/ 7

j1G0/8 ?1$1 # " "1$ %#

1$1#%" $ "1# ?1/# %"2 !!/"$8

#%!#"$C#/2 ##" %"28 ?1## "1#

Page 75: Adrenoceptor Antagonists and Haemodynamics - Trepo

!

&

#/"$%1$! >#"?## 0#"!//

!10$#"$% +*: "$C$"2 ?##

#90$#;Q$#1#"/((<8%1#C$"$

?% #9!/$# >2 "1# %# 7 #"$ +*:

$1$>$"% )?#C#8 # 7 "1# !#%#"

C/"##% %# 0$"" %8 "1#

#C$"$%70##/!""#02>#"/#%"

!"/2 # " "2!$/ >$C$/>$/$"2 7

!1"1/0$ "$0// $ "1#%# $$C$/%/%8

7"$/14$5 //#/#% 7 7#6#$#%

>#/? R $ %$% ?## " #"#"#8

8 %#6#"/28 !%%$>/# $#% 7 "1%#

//#/#%?##0$%/%%$7$#"1$1# +*:

"$C$"2!

"##%"$/28 "1#$%#7)70"1#>%/ "

09$0/ /#C#/ "## " #!# "1#

14$5 !8 ?1# "1# 1#/"12 C/"##%

?##"#"#?$"16#%"$0//%/"$I"1#

$#%# $ ) 0 +% ?% :

>!0 /?# "1 0 % %8

#%!$/2 1# #%/"% ?$"1 12#/

1 "1# %0# "# 7 14$5 #!###

?$"1" #1$ %""$%"$/ %$$7$#%8

!>>/2 !"/2 # " "1# #/"$C#/2 /?

%0!/#%$F#1#%#7$$%1C##/#C# $

/$$/ !"$# >#%# 7 "1# #" 0>#

7 !#!/# "#"0#" ?$"1 !1"1/0$

"$0// "1# #/"$C#/2 1$1 !#C/## 7

+#"2!#@# (R0 %$%8

R0 "1#%$%8 ( 5R0

"1# 7$ 0#$% ;$#%" #" / ((<

#C#/ "1% 1C# /# "1" "1## #

%7#"2 #%% 7 /$$/ 14$5

#"2!$ $ B"$ ?$"1 M "$%"

"1#!2 ;Q$#1 #" / ((< )?#C#8 "1#

$C%/ #77#"% 7 "$0// %1/ >#

C$# ?1# "$0// $% %# % !1"1/0$

"#"0#"$#"1#%##77#"%##!##"

"1# 14$5 #"2!#8 ?$ "1# "/

#"2!# 0$1" ># C/>/# !"$//2 $

!"$#"%?1#9!#$##C#%##77#"%

1# 7"$/ $0!"# 7 "1#

!/20!1$%0 $ "1# β ##!" ##

6 1% >## %%#%%# $ %#C#/ %"$#%

?$"1 !"/2 $%$%"#" #%/"% +"$#"%

10F2%7"1#'*//#/#1C#%1?

#"# #"$ 7 $%"/$ "#$/ !#%%#

;*+< $ 0#"!// "#//

"#"0#"0!#?$"1 "1#C$"//#/#% $

%0# ;H1% #" / ((-8 7? #" /

((-<>""// ;P11#%%2#"/(((<

7 "1# !#C$% %"$#% "8 "1#

'*7 !/20!1$%0$"$77##"$"#

"1# + ) #%!%#% $ 2 7 "1#

0#%#0#"%$"$0//"#"0#"

% " "1#*7 !/20!1$%08 "1#*

10F2"#% 1C# %1? "# "?

%"##%!%#"0#"!//$ 1

2"$0# *+ 0!# ?$"1 7 * $#%

;H1% #" / ((-< "2 " "1$%8 "1#

!#%#" 7 * $#% 7# %"#

""#"$7+*+!%"$!

"1 * 10F2"#% $"$ " "1#

$77##"!12%$/$/#%$%;0>/"2C%

"1%""$+<8"1#!%%$>/##9!/"$%7

Page 76: Adrenoceptor Antagonists and Haemodynamics - Trepo

&:

"1# $77##" + #%!%#% # β %>"2!#

%#/#"$C$"2"1#!/%0#""$7"1#

"$%"%@ #"!// $% β %#/#"$C#

"$%"8?1$/# "$0//"$%#%>"1β

β ##!"% >"1 7 ?1$1 #

!#%#"$"1#101#"/%8"1#$77##"

!/%0#""$%02$#C2$β

#%!%#%8 "1# "$0// #""$%

7"#!1"1/0$0$$%""$##%%#"$//2

/?#"1$/%##$0#%."1#0#8

"1# "1# /? 0># 7 $$C$/% $ #1

#"2!# ! 02 "$>"# " "1#%#

$/%$C# 7$$% 1#%# 0#"% 02

/%#9!/$?12"1#2"%$#10F2"#%7

<*17##7-1/?#*+$

09$0/ #9#$%# "1 "1# $#%8 #C#

"110%"7 "1# "120$#$#%1>##

/%%$7$#%#%!#%"β >/#$

#/$# %"2 ;H$ #" / 555< 1#

0!#"$ #%/"% $ $77##" %"$#% $0!/2

"1""1##77#"%7"1#%"$#+%76

7- 02 " ># #" #1 "

#9!/$ %2%"#0"$//2 "1# $"#!#%/

$77###% $ "1# #%!%#% " β "$%"

"1#!2

! 4*(*+#4*)14*+#%*'(.#(75&%&$,

1$'.1,+%.

##" "#1/$/ C#% $ "1#

$C%$C# 0#%#0#" 7 1#020$%

!C$# 7 "1# !#%#" %%#%%0#" 7 0#

"# #9"#%$C# $C%/ %""%

"1 #/$# %" 7 "1# #? 7$$%

0!/#0#" "1# #9$%"$ ?/##8 %1 %

"1##/"$>#"?##)#""$

7"$0//#C#"/?!/%0/#C#/%1$%$%7

!"$//$$/C/#?1# +*:!

0#">/$%# ""#% /$$/ #9#$%# "#%" 7

"1# !1"1/0$ "$0// "#"0#" $% "

!##$C# "# $" "8 "1# )

#0$% /?# "1#9!#"#8?1$102 /#

" $%"$ 1#%8 ?

/%$%#C#0$%0#0#"

+#C$% #%"$ $% 1//## # >2

"1# #9!#"#/2 /# C%$/"2 #77#"% 7

/7F%$ "0%/%$ 0# 7 "1# +)

!"$#"% N "$%" "#"0#" /% %#

!1%!1$#%"#%# "2!# ;+*< $1$>$"%

7 ##"$ $%#% $# "1# +*

$1$>$"% %$/#7$/8 C#7$/ "/7$/

# /% ? " #/9 C%/ %0"1

0%/# ;+0#"/((<80$""%#

7 % 7 "1#%# "? /%%#% 02 !C#

#""#C%$/"$+1%"0#/2

##%# $ "1# !#C$% 7#? "$/% ?$"1

0$$%""$7 "1#%#%;#>1#"/

((8 3/# #" / ((<8 >" "1# C#

1#020$ !0#"#% 1C# " >##

%%#%%##? %"2 $%?"# " /$72

"1# #"$/# 1#020$ #77#"% 7

/7F%$ "0%/%$ $ "1##/#/2,

!"$#"%8/%?$"10$""%#7"1#

C%$/"2%8%1%+* $1$>$"%

Page 77: Adrenoceptor Antagonists and Haemodynamics - Trepo

&&

1#!/%#"0#"1%$$7$"/2##%"$0"#%"1#>%/"#C/#%7 $%!$#

!%$"$ 1# ! "$/" 0!# ?$"1 "1# ?1/# >2 $0!## $!12 "$

1#% "1# 0#"1% ## #/"$C#/2 ?#// 1##7#8 "1# 7$# !#%%# #$C# !/%# "

0#"1%##0%/2%$">/#7"$"1#$#"$7 1#%8"1%$0!##

$!12?%%#$"1#!#%#""#%"%

"1 /7F%$ "0%/%$ 1C# /# 1#020$ #77#"% $ "1# !%%$C# 1# ! "$/"

!C"$8$$"$"1""1#2#"!#/2%#/#"$C#N "$%"%1$%$%0%"%"$$/2

#C$#" $ "1# ##%# $ $#%# $ 1# #77#"% 0#%# 7 /7F%$

"0%/%$$" %$$7$"/2$77# 70#1"1#1#%#/#"$C$"27 "1#%#N "$%"%

02>#C##%"$0"#8$7/2+)#0#%#

0%/%$ /#/2 $77#% $ "1# 1#020$ #%!%#% 0!# ?$"1 !!//

C#$//1#/""#"?!#!"$//2#6/#%!%#%

1#!10$#"$%7!1"1/0$"$0//$%/#/2#!##""1#14$5#"2!#$#

"1## $% #/"$ >#"?## "1# !/%0 /#C#/ 7 "$0// %#C#/ 1#020$ #77#"%8

#%!#$//2)8 "1# +*:!0#">/$%#%02>#0#!# " %2%"#0$C#%##C#"%7

"$0//"1#9"#%$C#0#">/$%#%/"11)"#%"$#9#$%#$%C#%#/2#/"#""1#

!/%0/#C#/7"$0//8+$%#!"1##""1#0!#%"2$#%#$

1# !/20!1$%0% $ 6 7- 0/"# + *+ #%!%#% " !1"1/0$

"$0//8>""1#$#"$%7#77#"%#"%$%"#"?$"1#/$##%/"%

Page 78: Adrenoceptor Antagonists and Haemodynamics - Trepo

&'

"

=1$/# $%%#""$ %1/ #!#%#" "1# 1$#C#0#"% 7 $$C$/8 $"#"$?$"1 #"

0>#7!#!/#1%>##>%/"#/2#%%#"$/$%1!$"1$%"1#%$%

.$%"7#0%"8 1C# "1#!/#%# "#9"#02##!"$"#"02%!#C$%%!7$

3E1A#8 *8 !7 +/$ /$"/8 * #"# #9"#0#/2 7$#/2 %!!"$C#

"0%!1##?1##$"?%#%28#B2>/#!"$C#"?."1#0#8?%/?2%>/#"

"%"$2!0!"#9!#"00#"%%""$C#$"$$%0

2 "1%#%#C##"#$"7"1#$"$>"$$#%%!#$//28##"#0!1%$%#

"1# /#% 7 #"$$"3AA>$8*8 !7E$AB08*8 "1# "1% 702 7$%"

!## #C$#?#"$/#8$0#"$0#1?"!#!#%$#"$7$"$/#/%81C#$#$

/" 7 ?/## !#%!#"$C# $ "1# $%%%$% ?$"1 *% $"C /$"/ )#$/8*8

HE#!EE8*+$BHEC#"%"88$%$/2?/##7!#70$#%%#"$//2//

"1#"/0#%#0#"%"1$%"1#%$%$%>%#!I$"$%$77$/""#!$""1##9"#"71##$#%%

"#9#"#0/"$"#7"%%$"$0#/20#

+7#1,#1"$0E$8*8*$$"8+1*8?##$#!/#>/#$"1#!10##"$

7$#%%#%I2"!"$##1$1/2!!#$"#k/%8?$%1""1!7#%#8

*8*"#7,#8*87%1$"1##"2!$?/##/#9!#$##$

3/$% %"$""#" +7 / +A%"$8 *8 * $ =/$B$8 +1*8 #" 3$00

/0$$#0$8*8 H ,$18 8 # $/2 ?/## 7 #%#7/ $%%%$%

1# "$>"$ 7 !7 ) %$"/8 *8 ?% #%%#"$/ $ "1# #%#1 7 !1"1/0$

##!""$%"%

Page 79: Adrenoceptor Antagonists and Haemodynamics - Trepo

"

&5

0#"/2$#>"#"!7$%")!!#8*8#"$,$6C$%"8*87"$%

"1#!# #90$#%7"1$%"1#%$%7$C$$!""1"$0!C#"1#0%$!"

0C#2"#7/"//02?0"#%$"1#*#!"0#"7+10/$/$##%8$C#%$"2

70!##8*#!"0#"7 /$$/+12%$/280!##$C#%$"2)%!$"//%8?""

"# "1$% !!"$"2 " "1 "1# !#%#/% 7 02 !#C$% ?!/#% #%!#$//2 +%B$

)#/"1 #"#8 /$$ 7 #/2 " "1# +E$BE" )E0# #"/ )%!$"/ $ ," 7

>#$02C$#?7"1#0#$/7$#/C#0#$0!""/28$"1%>##B2"6$#02

#?$#$7$#%1$!%

"1#!$C"# %#" 7 /$7#8 "1## # /" 7 7$#%8 #C# "02 ">#0#8?10 0

>/$#"2!#"%$$H1C#>###9#0!/2$/2$%/$7"$702

/$7#8 1/2 #9!#%% " >/# !!#$"$ 7 "1" 2 %$%"#% $#8 H18

B 3$%C#8"1#>"1#%"%8+#?$"1"1#$70$/$#%#%#C#"#"1%

7//"1#!%"2#%

.$//28 ?" "$C#021#"7/ "1% "02#?$7#)# 7 /C#8 %!!" $%!$$

$%%%$%/%8"1%#%0#?%##9!#%%#"/C#/21$/#@"1#C$C$%1"#%

+$1/,$/B8"1####"$%%#13$12//7/#""$0#"1#?8

"12//7$%""$0#70"1#?"$%%#%7"0%"%$$7$#$/$7#

+%B$8.$/

H#((

0$#0$#

Page 80: Adrenoceptor Antagonists and Haemodynamics - Trepo

'(

,5,$,(+,.

>0%+81/0 #;55<@0%/%$8%#/#"$C#/!1 ##!""$%"@0$F#8"//#"$/$!"$#"%?$"1>#$!%""$P>%""$P;%20!"0"$+)<1#!#0%/%$"2!H/&:@- --:

18+$7%23$/C$#

;5&<@ 0!$%7$#77#"%7"$0//!!// /$+10/1#'@&' ':

18+$7%23$/C$#

;5&:<@*"$7$#77#"%7"$0//!!// /$+10/1#5@'

%#/8*8?#H8$0

81* 1#H;5'<@)#020$#/"$@$C#%"$"$>2%!#"//2%$%0H+12%$/5@)':& '&

%#/8*8>#/.81* 8

## 1#H;5'<@+?#%!#"0/2%$%71#""#7/""$@6"$""$C#!>#7>#" " >#"$C%/"/$##-@(

/06$%"8/#>#.8$/%"#$8 1#

8 1#` 8)%#8$ #$""*;5'5<@+C"$7>2$12!"#%$>2$%!"##/!$1"!%"#$

!"$#"%?$"1#9!/$#%2!#/H#-(@-: -

/ ##$"$8#$8,/#+#+

;55(<@1##77#"%7"$0//$"/!#%%##9#$%#1#""#$!#9"#%$C##>$%6$#0#">/$F#%"H /$+10/#%(@--5 -

#%%3;55'<@1##!"7

%#/#"$C$"2/--!!/@&

#%%38,#!)=2//$#

;55&<@+%""$/!1 ##!"%%#/#"$C$"2+%""#-(@(

#%# 3F#*,;55<@/#%

""%%/$"$% "#?2"#/$/"2"/#C+12%$/:@5- :

%H8 %"13;5':<@

1#/!1##!"%#"1#/$/#//%.#+@- -5

1H8$%?"18 ?"1#8

+$#28#$""8128=$/% =$/%;5'<@"2!$/>#" ##!">?$!2"#%%"#"7"$ >#%$"2%"#-(5@:- :

2/#"1H ;(((<@

/!1;<G/!1;,< ##!"

Page 81: Adrenoceptor Antagonists and Haemodynamics - Trepo

'

0#$"#%""$7$#%>"#%#%$%"#"#$#%H+10/9!1#5@:& :--

%08##"%8!1$H8,#"+8

+$#8$%8#",#C2;55<@%%#%%0#"7"#$/$%"#%$>$/$"2>2"0"$!/%#?C#C#/$"20#%#0#"/$"$/$$/!!/$"$%"$#%)2!#"#%$:@' 5(

%083#$1#/H 8$#`H7

;55<@77#"7>$%!//>/!#%%#"#$/1#020$%$%2%"#0$12!#"#%$0H $/:'@: :

#>18$""#/08FF8 $1

.8#%+=1$"#=;((<@$0/"#%0$$%""$7C#7$/"0%/%$#%"$#/$$//2%$$7$"12!"#%$$!"$#"%?$"1>#$!%""$12!#!/%$/2:@55' ((-I$%%%$((- ((

C/$8H#%*7FF/$ 1!

;55'<@4"$7$"$7/"#"$%$%""#7"$7#/%"$$"1#"#$/0#$)2!#"#%$-@&( &

$/#2H8.$"F#/*!!/#"#H

;55:<@77#"%7%""$"0$#C#%"$0/"$1#""#C$>$/$"20H+12%$/&(@)(' ('&

#,;5'5<@+$$!/#7$0!##

"#1$6##$/-@

#>83%18H%"#83$%"#%38

13))%>#;((<@##"#$/$%"#%$>$/$"2$%!#$"7$C%/$%#%#$!"$#"%7"##/"%!/""$H)2!#"#%(@&5 '

#""H;((-<@1##//@#$/+12%$/2 #////#/!!18!!(5 (:%=.,#%

#1#"*F+;((<@"1#/$/

7"$.0C%/>$/2"/$$/!!/$"$%0H $/5(@(, ',

#$8="10.8#+)8+$%8

"#$7"18)##$1H1/FH;((<@ 0!$%7#%!1#/*!!/#8!/%#"/2%$%8#/ "$0#!/02"#2"1#0$/"$7"1#"$%0#%#0#"7$"!"H $"1%#%"1'@' '5

#"%%38#/#81 #/#8

,$>/8%"0H8%"0,!,;((<@+/20!1$%0$"1#>#";< ##$##!"##12!#"#%$ $/"$(@'& 5(

#/8/$"F2H8%6#" #/8

,7""%"H,;55<@#" -##!" 0#$"#$#%#$"#%>/7/?$"1#H+10/9!1#:'@

#$8$/1*8#+8

+/$6#8 #//#+""#$;55<@? F"1#"# #/"#!/02C/C#$7#"$C##$"$%@%##!""#%$C# ##(@

##,#C2;55-<@ "/7

$"!"@ !/$7)#"/#%%#/%@+12%$/28!!5 (5%##,#C2%>2 #

##,#C2;55-><@#/"$

7"1#1#">#"@+12%$/28!!& -&%##,#C2%>2 #

Page 82: Adrenoceptor Antagonists and Haemodynamics - Trepo

'

/1#H8%08*B#8,7;555<@"$!/%#?C#C#/$"2%0#7$C%/$%$12!#"#%$C#!"$#"%)2!#"#%$--@ &

/1#H8+$#8#$+81$%H8

7,;55'<@ "$"#$/%"$77#%%%!#$"7$C%/// %#0"/$"2$# %"##/$%#%#)2!#"#%$-@&( &

/1#H878#$+8+$#8

1$%H,;((-<@"$!/%#?C#C#/$"2$#90"/$"2$# %"##/$%#%#3$#2":-@' ':(

/H="#!1#%H;5:<@

+10/27#?##$>#" ##!" >/$0!;#"1/$#<,#"@- -

/H/"0*;5':<@""$%"$/

0#"1%7%%#%%$##0#">#"?##"?0#"1%7/$$/0#%#0#",#"@-(& -(

0 8H#77$#%=>#/+=

;55-<@$$7"$/1"#$F"$7/!1 ##$##!"%>"2!#%!$C%/#"1#/$0H+10/9!1#:&@: --

C##+8"8+$8#

0#%3;55&<@>%##7/? 7#6#2C$>$/$"27%20!"1#"$#C#"$C$"2$%#C##1#"7$/# $/"$5@5

77$9 +##%,;5'<@/!1

>/#%$"1#"#"0#"7>#$!%""$12!#"!12@!12%$/$/>%$%#C$#?7"1#!>/#0/(@-(: -(

/!#!,;((-<@1#)#"%+0!@#$/+12%$/2 #////#/!!18!!(' --%=.,/!#!#%

/!#!,;((-><@$F"$7"1#

$C%/2%"#0@#$/+12%$/2 #////#/!!18!!- :%=.,/!#!#%

/!#!,;((-<@#/"$7"#$/

+#%%# $"!"@#$/+12%$/2 #////#/!!18!!- &%=.,/!#!#%

"2$#+8!#8%08"$#

8##"%8,//#2+,#";((<@"$%"$77#%%$%$#!##"!#$"7!$022#C#"%$12!#"#%$C#!"$#"%@/$"$/%"2)2!#"#%$-5@(

C#8/$$#8+"18.#H8

*28#1#$1*8%%>+8.C#/H8#H1#H+;((<@+%"$C/#71#""#C$>$/$"2$"$0#0$/2%$%$#%"$C#1#"7$/#H"#C /#"!12%$/@' '&

F$#*H0$"1;5''<@/

$C%/#%!%#""!$/"#//R"$0//(R$1#/"12C/"##%H!1"1/0/&@( (-

##)=82%1//281/F8"$

8=#1)#%1;55-<@)#""#C$>$/$"2$/"$"#1/0$##""$%$%"#2%""##9#$%#$1#/"12C/"##%)#"H&(@ 5

Page 83: Adrenoceptor Antagonists and Haemodynamics - Trepo

'-

$%"?;55&<@#1$%07"$7>#" >/$#"%$1#"7$/#0H $/'(@:, (,

$%"?8$/>#"8>10=8

0%3.8.?/#8)#%1>##83>)8138#%//)83##81%"#0;55:<@ C#$//!#%%# #/"#$0!C#0#"%$/#7"C#"$/7"$%C$C/$%>B#"%?$"11$1#"7$/# )C#%"$"% $/"$5@'(& ':

#;55<@#" >#"

##!"%$"1#101#"@!!#"$#%87"$8/"#"$%$1$1#"7$/#+10/#C-@(-

#$1#/ ;555<@

##$0%$$##!"%$"1#101#"+10/#C@: :5(

## 810%,8"$8)70

Q8H#%#H38%3*8=0>%%3 =$/0#H);55-<@77#"%7!!//!$//$"!"$#9"##!#$%7/? $"#%$"2!12%$/"$C$"20H $/&@'' 5

#8!#$1"C#2

;5&<@$0//@!#/$0$2#!"7$"%!10/$/!!#"$#%"1#!#"$#77$2$$12!#"#%$*%5@: &&

%$//$#%=;55<@/

>#" >/#%$/00#0#" /$$/!10/$/%!#"%*%$@('

%1#8#/#)8$/0#%3H8#//0!8

#H8*1#$8)2#+.8$1#/ 8%#/+#;((<@ C$C%"$#%"%!!"0B7"$//#7"1#/2-'5>#"

##!"!/20!1$%0$10%+10##"$%@55 (

2/*8$#>#* 8)$#>/#H+8,#

Q8,#7?$"FH8$#03+8/$77+877/8H##/#>;55<@"#"$/$7+10/20#/"#7##!"%+10/#C:@ -:

/7$#/+$%//H;55'<@

"#"$/$7+10/2` /%%$7$"$70%$$#"2/1/$###!"%+10/#C(@&5 5(

#""$ 8%"$+8/$++/"#

Q;((<@#" " >#"%"#C/0##%"$0"$70"$!#%%#?C#70$%$%"%@0!$%70#/%0H+12%$/)#" $+12%$/'@)'

1*H8 1380$%1$8/F

.)83%)831#81"8H%!#H81$#18,#%$H*8.+8*$#/%*8/#8 /#*81 1)=;55'<@/#//$8#0$1"#$F"$#9!#%%$7C#/10/!1 ##!"$%70%.,#""@&5 '-

1!!/# 8=2#/#HH8/$H8

#0$1%.8!0.>0%+;55:<@0%/%$8"1#7$%"!%""# %#/#"$C#/!1 ##!""$%"0#" /2%$%7"?0$F#8!/#> "//#80/"$#"#%"$#%$!"$#"%?$"1>#$!%""$>%""$;%20!"0"$+)<!#0%/%$"2!/5@ :&

1/98,%7# =/78$18

,0!#"8%?/ 00%%#8#""#8#2,%7#H

Page 84: Adrenoceptor Antagonists and Haemodynamics - Trepo

'

;(((<@#?$0!##$!1#C$#7"1# $C%$C##C/"$7$"!""#%"$#9#$%#@0!$%?$"1"1#c$#"c.$0#"1H!!/+12%$/'@-- -(

1#%%.80 /#%.;5&<@

7/##7$#/$!"%12"10$C$"$%71#"!#$$"1#"0H+12%$/'@&& &'(

1//#2+$#;((-<@%!1#/

*!!/#@$C%$C#$"!"0$"1$!12(@&:- &:5

1$%1$//#%8>#%"#$,8 1H83##

3H8$/#*11);((<@$"$"$7%#/#"$C#/!1 "$%""1#!2##712!"#%$ #/"#C#%##C#"%00#?$"1>#$!%""$12!#!/%$@#"%!#"$C#1"%"2 /$1#-@&& &-

/!10*##H;55&<@!"#$

>#"00%>$"%#C+10/9$/-&@:& (-

1H;55<@ $ %#6##%7

%0" 1#%$"1#+#$!1#2@0!##+#/@1#)#" $C%/2%"#0$#"$7$."$%8!!-:5 -&'%).FF8)>#8H#$%83"F)C#+#%%8#?

1H8.?/#8$%"?8 /$

=8$/>#"83$1/83##38,#B#0"#/8138+#88)/%/?,,%;55&<@7#"2#77$27C#$//$%#C##1#"7$/#1# C#$//)#".$/#"2!H .$/-@&- &5

/0>$8"8 C,8

#0%1$ 8 0!%8H

,!#%;((<@/#7"1#0#//>/"$12!#"#%$)2!#"#%$-'@5

/$#);55-<@""/

#/#0#"%7/!1%>$"%"1"$"#"?$"1>#"008##!"%8#77#"% #//&-@:- :

%.8H8*?%81?+38

"##)*8"$,;55(<@)#020$%""%$$"$//2$//!"$#"%?$"1?$"1""#1#"$%#%# 1#%"5'@(( (:

%.8H8 77##*2

;5'-<@C/"$7$1" 1#""1#"#$F"$$"1#$"$//2$//!"$#"?$"1""#02$/$7"$/H#-('@:- :&

%.8H8!#778*?%8

10% 8)#//.8H8=#*8*#%>$#%8/0,8==8 /$778./#%=H8H8$$//#")8%"#8#//02+8,2H3%=;55:<@1##77#"$C##%%7$1"1#""1#"#$F"$$"1#$$"$/#7$"$//2$//!"$#"%++C#%"$"%H&:@''5 '5&

#=)8)H8 %%083%#/

81C$#3>#*,;555<@)0#%!%#%"!$1""$/"@?$?#"/"0$$"#"$H+12%$/&;+"<@:& :'

""#8%1C$"F83/%$8 1#

H8$//#)8*##Q;((<@"#8$C%$C#"$%0$"$7$"!">2?1/# >2#/#"$/>$$0!## 1#%"@- (

""$%8##)$$%*H;((-<@

)#020$0$"$?$"1!/%# $#"$"!"

Page 85: Adrenoceptor Antagonists and Haemodynamics - Trepo

'

;+$ <$$"$/#"#%$C# $" #%5@-( -(&

$%138$%"#,8#%8=$1"

H8*%/$;((<@"$!/%# ?C#C#/$"2$"%#/"$%1$!"0"/$"2$$>#"#%/%#$"/##@$"#"#$#97C%/7"$D $/"$(:@(' (5(

*1/7 ;55(<@4/$"27/$7#G%>B#"$C#

%20!"0%$>#" >/#"#"0#"H+$0)#/"1 #!!/@&- '(

*/$%$1"#*;555<@/"$!/#

##%7#!#!"$#%"1#$##!"%@ #C/"$!12%$/2#%#%$@' ''

##2 ;55'<@ $C%/#77#"%7

/!1 >/#%%#7"1#"#"0#"7%20!"0"$+)@$0!"%7#"2?#// >#$/-!!/@' '

##2 8$1#/ 8?#H

#/;55'<@>/# >/$0!$%7"#F%$"0%/%$"1#$$77##"$/#77#"%0>/"2>/!#%%#"/"1%""$%"#%%"#%"$/--@' ''

*#>2#.;(((<@/!1>/#%@#//

#"##6/D/2:@( *#>2%#8*#?%)#6$H ;55<@

#/$#$1$>$"$7$%/$#/#%#@/#72/$+/ #//$/&'@&5 ':

*#1 8/#2 "";5'<@

%$#"$7$#C/"$7"1#"$%$%%20# $C%#%'@&: &

*#%//#%8$#%1.1?"FH;5&'<@

C$##7"1#!"$$!"$7>#"

##!"%$$%!#/$# $##$#/#%#70"$2%/$#%$C$"H+10/:-@

*#%%2 8$""#81$%/+8)C9`8

$100#+//$H,;((<@"1#/$/>#"- ##!"%0#$"#C%#/9"$71020$"#$#%"11$"$9$##"1#/$0 #!##"12!#!/$F"$ $/"$(@5' 5

*$.;((<@20!"1#"$#C%

%2%"#0"1#$#2$12!#"#%$ !$#!1/)2!#"#%@5& ((

*$%"#$3%/;55:<@

0!$%7"1##77#"%76#%#//!1"1/0$"$0//!##9#$%#!#70#$0$/# #0#0H!1"1/0/@-:& -&

*$%"#$38)!#%8%/8

3$%"$%3$%0#,;5''<@ 0!$%7"!$/"$0//C%>#"9//$!/02#9#$%#!#70#$1#/"12C/"##%"!1"1/0/; !#1<::@:- ::

*$.#%*;55-<@+#0#

0#1$%0%$$"$%%##C+12%$/@ &

*$2+8 %%#/% ?8$/

)$//0H;55'<@0$%#8"//#"$/7%!$0#"$1#%$#/#/2!#!/###$C$"$0//>#"9//%$$"$/"#"0#"7/0H!1"1/0/'@: 5

*$#.8*$#"FH2#H

;((<@$7#0!%"B"$//!1 ##$C%%"$"$$1#/"120# $/"$(:@-5 -

Page 86: Adrenoceptor Antagonists and Haemodynamics - Trepo

':

*$#.8$%#1H)8*$#"FH2#H;((><@+%" B"$//!1 ##!"%>%//$0>C%/"#$1#/"120#H+12%$/(@(- (

*BC>##;555<@0#"

/2%$%"1##77$2"/#>$/$"27/!1 ##!""$%"%$!"$#"%?$"1/?#$2""%20!"0%%#%"$C#7>#$!%""$>%""$/-:@ -

*1#"2H;55'<@>"2!#%77"$/

/!1 /!1 ##!"%H+10/-:@

*%"%+8 %"#+8##"+8*$#

H$% #%%#+;55<@Y "$%0$"$7$"!">2/2%$%7"1#!/%#"Z1/ #$%%'&@: &

*2/#=H8=#>#+##%);5'<@

77#"7"!$/"$0//0/#"##9#$%#!#70#1!1"1/0/(@& '

* H8,#+=%"77H;55&<@

C#$//#!!$%/7$"%!10/$/!!#"$#%"1#!#"$%#$$C%/$%#%*%@: '

* H8"1#%./%*;((<@

0%/%$@#C$#?7$"%!10/2"1#!#"$#77$2$"1#0#0#"7/?#$2""%20!"0%*%$5@- :

>#*,;5'-<@)0%$%12"10$

%$#97C/$"7/?H!!/+12%$/@5: 5::

>#*,;((-<@1#10#%!$"2

"#H+12%$/'@--5 -#"81#$#8//%%$8"?#$=

Q$#/#;555<@+%""#

%#/#"$C$"27/!1##!">/#%H/:;!!/<@--

#$8)#)=H;55<@

+10##"$#9!/"$7#9#%%$C#>#" >/#7//?$"$0//#2#!%+"#"$/7/ !1"1/0$$"#"$H&@: :-

$%#>#+8H77#1%"#*+

;5'<@ /$$/#C/"$0!#"!/02"#2"1#"#$F"$$"1#1#020$%%#%%0#"7$"$//2$//!"$#"% $" ##@5 -

/#CH8=$/#,8 1%%+$F$

;(((<@1#%20!"1#"$#C# $"#"$C#$"#7#>#"?##"?%!#%2%"#0%@"1#>$"1#$00#%2%"#0+10/#C@5 :-'

/ %1$2;5'<@%"$0"$7"1#

%2%"#0$>$C$/>$/$"27"$0//$0$!10**$%!%@5& (

0$#,8/$"%>#*;55<@

1#10>#"- ##!"@"1#%#17!12%$/$/7"$#%+10/$@- &

%%81$0$F8,6C$%".8

#%"0H#+;55<@*#0%""$7$C$C7"$/>#"- ##!"$0H /$C#%"5@-5

C%=#//$;((<@C$

"?%$$C$/$F#0#$$#?$"1!10#0$%"#5@: :'

.#$/;55'<@#/"/72

>/7/?H%#%-@' 5.##%"#$Q77/8H;55<@

C#$//8C#/0/"$!/#"$

Page 87: Adrenoceptor Antagonists and Haemodynamics - Trepo

'&

"$12!#"#%$C##"?$"1"$9$""$C$"2"1#!"#"$/702$/C%/!"#"$)#"H:!!/.@-'

./$$8*$*7#%""$$

;55:<@ 0!$%7/$#/$#70/"$%7"1#"1## #/#0#"?$#%%#/0#/0H+12%$/&@):: ::'

."$//H8 "$%+8,#7#>C#

$/"H;5'<@+10$#"$%7/"$0//%"$#>20%%70#"!12H /$+10/5@5- 5:

.7#/#.#.;5'<@

#%!$"2#77#"%7"$0///H#-@

.$%10=);55'<@ C#$///H

#--5@&5 &:.//#)*;55<@1#C/$$"27$

"!"0#%#0#">2"1$$0!##@0#" /2%$% /$C#%"#@(-

.#%%H %";5'(<@2!#%7

#C#%$"1##"#$#C%%2%"#0#%$##@ (

/$$#8+"18.#H8$%

8 $#*8%8C#8%%>+8.C#/8#H1#H+;(((<@*#!#%%#/?7#6#2!?#71#""#C$>$/$"2%$#!##"!#$"7%##"1$1$1#"7$/#)#"H@& '

=;((-<@1#"0$#C%

2%"#0@#C$#?70#$/!12%$/28!!: -!!/#"l,#8"07

=;((-><@ $C%/#/"2

0#1$%0%@#C$#?70#$/

!12%$/28!!55 :-!!/#"l,#8"07

"1$# 8,#>/$%83>F$,81H8

31$8$/8//$H,,##);55'<@1##"$C#$"!$#77#"7>#"- ##!"%"$0/"$$%0#$"#>2"$C"$7$"$9$#%2"1%#!"1?2$10C#"$/#H /$C#%"(@-&& -'

C$38 /+8#*81$

*1#"2H;55&<@/!1 ##!"%0#$"#""$/##%!%#%"#/$#$"1#10%!1#%C#$210$##>#%1+10/-@(:

$$%8"""8##//$8*/+%

,+%#"";55'<@Y $C%$C##C/"$7$"!">2/2%$%7!#$!1#/!#%%#!7$/#$!"$#"%#C#$$$"#%$C##Z$#C#%"#%$/:@:& &-

B#8)#38,00+810$"F 81$#/

8=#$#"#$1";55'<@ "$%8/#%%$C%$C#81#020$0$"$$$"#%$C##7"#$%#21 $C%:@ 5

/)8 1=8 1#808

1#$18H1%8+$/$2>#"FH;5'<@2"1#%$%0!$%7%0#$C%/!!#"$#%7"1#%"##$%0#%7/>#"//H# 1#0@-:- -&(

/>#8)//$%"#>#"%*

;5'-<@7/##721$0>$#>/!#%%#8"0$#7/#9#%8!/%0"#1/0$#%$10%)2!#"#%$@&& &&'

10;5'-<@ %$#"$%$"1#

/ "#0"#"0#"712!#"#%$ /$1#@ --

Page 88: Adrenoceptor Antagonists and Haemodynamics - Trepo

''

%%$8 ""#8#C//#8

,71$$;55'<@#7/#9"/7%20!"1#"$#C#"$C$"2$#%%#"$/%#212!#"#%$)2!#"#%$-@:' &

#$+8/1#H8+$#81$%H8

7,;((<@0!"7"$%"$77#%%""#"$%C$C/7!"$#"%$# %"##/7$/# $/"$(-@5'& 55

$0#%*;((<@%/

##!"%@!"#+10/#C-@-5 -:

$0#%8+$C4+##$;55&<@

/!1 ##!" 0#$"#!#B"$/#77#"%71/#"12//$$#$"1#$#%!1#%C#$H+10/9!1#'@-: --(

F$+10$";((<@

!1#0#71#" "#">/##8$"%#C/"$8!%"$C/# /#"!12%$/#C:@: :

)#%/#;55(<@+10/27>#"

>/#%@/%%$/%!#"%##"#C#/!0#"%H $C%+10/:!!/@ 5

)0$/"=.8#H=83$%0H

!/$;5-<@"$#%"1#$/"$."1#/2%$%7"1#$B#"$0#"171#%$1#020$%#!12%$/$/!"1/$$"$%0H+12%$/55@-

)0!#/ 8*/>#+ 80$"1+8C$,8

177H=8131?$*;((<@/"$7>/#/!1 ##$##!"%>"2!##9!#%%$>2>/#"/#">%""$H/:&@-

)$=12.H;((-<@)#!">$/$2."$@#$/+12%$/2 #////#/!!18!!5& ((%=.,#%

)0%+8=#%%#/$3)8+"".8H#%"!8

#C#H8#1#),$#%1"HH;555<@ "$%%"#C/0#0$"$>20#//$7/?70 $C%$C#0#%#0#"7"#$/!#%%#$10%#"1%""$%"#%% /$$;,<5&@5 -(

)2#18+1B%2+Q$00#0

;555<@#" >/##2#!%"/"#$/12!"#%$0H!1"1/0/'@-( -(5

)#= 4;55'<@ 1"#$%"$%

7##!"%$"1#10$/"#2@/$$/$0!/$"$%H1 $C%@-:

)#/)8#%%3;5'-<@

77#"%7!F%$$!"$#"%?$"1>#$!%""$>%""$H/-(@& &'

)##/ 8#8!#$1"C#2

;5&5<@$0//@#C$#?7$"%"1#!#"$#77$2$"1#"!$/"#"0#"7/0*%&@-'

)#$+8#!#/8 "#1$$1#/

;((<@6"$""$C#/2%$%7"$%0$C#%#$%0"?$/ "2!#%"$""$C#/2"$C#10%"#/!1 ##!"%210$##>#%1+10/-:-@- -5

)#""*H%;((<@ $C%$C#

$"!"0$"$"#%$C# $" #%(@(- ('

)$#>/#H+82/*8 /#*8$#>

* 8,#Q8,#7?$"FH8

Page 89: Adrenoceptor Antagonists and Haemodynamics - Trepo

'5

$#03+77/8H;55<@"#"$/$7+10/2`#00#"$70#/"#7/!1 ##!"%@%#%%!"#+10/#C&@:& &(

)$$% 8"#.?/

;5&-<@+%20!"1#"$"/7"1#1#"+10/#C@5

)$%?81$>"38)$#38#$8

>$3880"8$38H%B$0";55<@ /$87"$/#9!#%%$"$%%#$%"$>"$710/!1 ##!"%!/$#C$"%.,#""-:-@: :(

)$%1/8$#8?#1#>##8

)##)883$""/#),#;55&<@$C%$C#%%#%%0#"7$"!"$$"$//2$//!"$#"%>2/2%$%7"1#7$#>/!#%%#?C#70 $" ##@5(5 5

)$%1/8$#8)##)88

#8#$/#*8"1/$#),#;55:<@2#/$>$/$"27$C%$C#"$%7$#>/!#%%#0#%#0#"$$"$//2$//!"$#"% $" ##@:' :'5

),8)#*1#"2H;55'<@

C#%"$"$7"1#%>"2!#%7/!1 ##!"0#$"$!#B"$/$1$>$"$$""$0##>/"#9210$##>#%1+10/-&@:- :-5

)#%8/#*/$#*;5'-<@

F#""P%4#"$#C$#?#C$##"1"/$#4#"$71#"$%>#""#H0 // $/:5

)770;((<@ "#1/0$#%8

20!"10$0#"$*%8

##$##!""$%"%@0l$/0P%1#+10/$/%$%71#!#"$%8!! :'%H)0,,$0>$? )$//

)770;((><@ "#1/0$#%8

20!"10$0#"$*%8##$##!""$%"%@0l$/0P%1#+10/$/%$%71#!#"$%8!! :'%H)0,,$0>$? )$//

)7702/+;((<@1#

"0$0"$"#C%2%"#0%@0l$/0P%1#+10/$/%$%71#!#"$%8!! -%H)0,,$0>$? )$//

)7702/+;((><@1#

"0$0"$"#C%2%"#0%@0l$/0P%1#+10/$/%$%71#!#"$%8!! -%H)0,,$0>$? )$//

)770 8,#$"F8>#7 %%8

,1%#H3/"F3;((<@ 0!"$C#!10/2710>#" ##$##!"%>"2!#% 1"#$F"$7%">/2"%7#"###!"%$ )#//%210$##>#%1+10/-:5@ 5

)7#/"8>## 8`Q48##2#C8

>$*$#F;(((<@#!#!"$#% C#C$#?#!10/2-5@--& -:

)"08#%#>)!0

;555<@ $C%$C#$"!"%%#%%0#"$0#"##9#$%#@!/%#"0!#?$"1 #>#"1$ /$+12%$/5@-( -&

Page 90: Adrenoceptor Antagonists and Haemodynamics - Trepo

5(

) =8,$,8,$8,##),)H*;((-<@*%# #%!%##/"$%1$!%7!!//$ 1$#%#%>B#"%?$"1$77##" +*:#"2!#%H 1$#%%::@& :

)!!#83$/8,1#%38/0$#,

$%/;55<@2%"#0$>%!"$7/"$0//$!#9"#%$C#0#">/$F#%7#>$%6$#H/+10/&@'- '&

$B$082$8?8%H8.%#

83>2%1$?);55&<@ $"!"$/"$>/C/0#/2%$%>2!/%#2# #%$"0#"2H /$$"-@' '5

0$81%1$38.)$%1$"

;55&<@#%#0#"7$"!">2!/%#2##%$"0#"2%$$2$###@0!$%?$"1"1#"1#0$/"$0#"1#%"1#%$/2'&@': '

01778,#1#H),1/#$*;(((<@

$C%$C#?1/# >2#/#"$/>$$0!##$"!"$C%$C#"1#0$/"$$"!"$1$1 $%%$/!"$#"% $" ##'@' ''

01/F+8C"7%8#""#/%HH8C

#)#C#83#0#H=$#/$=;5''<@ "$% $C%$C#>/!#%%#0$"$@#/$>$/$"27.$!#%#C$#$"1#/%/C0#C# $C%#%@-5( -5&

01/F+8#""#/%HH8C##$#)8

=#%%#/$3)=$#/$=;55(<@ $C%$C#"$%7$#>/!#%%#0#%#0#"$"1%""$%"#%%0!#"$" "#$/!#%%# $C%#%@

#/0 >#;((<@+10##"$%@!!"$"27%7#0##77$$#"!10"1#!2H"##(@': ((

#/0 >#;((<@)0

0#">/$%$2"10#+(#F20#%@!!#"$#%!/20!1$%0%210$##>#%1+10/-:5@'5 (

#/0 >#;((><@

+10##"$%72"10#+($"%!!/$"$%$"1#!2@"1#!%"8!#%#"7"##%+10/$@5- ((

/>#8.%")8$##/H8)//#

+#"#3;55<@Y "$%0#%#0#"7$"!"?$"1!/%#"/2%$%Z#%"1#%$%"@5- ((

%1$F$?3;5&'<@ 0!$%

7$%!%$"$#77#"7"$0//!!//#9#$%#"12$H /$+10/@&

%#/8*F#H8,$#""8%1#2)8

1#$8 1$1$//$8 !#*8.12H8.$%1H8.H837"83%#/08,F% 8,#0%#.8H8"$H8,#*8+#"#%+8$/C#038#%% 8F#7/#H8=#$%%C ;((<@77#"7!/20!1$%07"1#>#";< ##$##!"#%!%#"#/%#7/>"#/$%"10"1//#200/@'- ':

H$)8)$$*810+8)!!#8

*$#% 8"?#$*8,/2**?H;555<@%%$"$7"1#;%</!1##?$"1#%%#"$/12!#"#%$#%!%#">#" >/#)2!#"#%$-@'

Page 91: Adrenoceptor Antagonists and Haemodynamics - Trepo

5

H1%H8)#$,8=/7##//$;(((<@ + +*: 1292/"#!!//>"1#"$%#91$>$"$/$77###%H+10/9!1#5@(55 (

H1%H8Q$#18+#""H82

+8$)+/2*.;((-<@#" ##$##!"!/20!1$%0%"$12!#"#%$C##%!%#"0#"!// /$+10/1#&@

H1%%#1 ;5&:<@ /$$/

!10$#"$%7>#" ###!"%>/#%*%++,@

3E1A#8/$"/83AA>$8B0

/$"/+;55'<@7/##7!"!$/8!!//8C#!0$/"#$/!/%#?C#C#/$"2"1#$C%/!0#"#%$1#/"12C/"##%"H /$+10/1#-:@'- '5

3E1A#8/$"/83AA>$8B0

/$"/+;((<@7/##%7%#/#"$C#8>#";< %#/#"$C#C%$/"2>#";< %#/#"$C#>#" >/#%"#$/!/%#?C#C#/$"2$0"#%$C#%>B#"%#+10/-@5

3$/8)!!#831C8)C/

+81#$$8$%//0$#,;55<@#" >/$#77#"%7"$0//"/?!/%0#""$% /$+10/1#5@- '

3$/831C8)!!#

$%/;55-<@1#/2%$%7!/%0$#"$%>#" ##!">$$ >/$"$C$"27"$0//7//?$$"%%0//$"C#%%#"H /$+10/1#9$/-@- -&

3!/8/3/%% ;55<@

#F%$9F%$$

0"#%$C#0#?$"1%20!"0"$!%""$%0@!$/"%"2"#"#0$#"1##77#"7%$#$0##77$2%7#"2/'@- '

3!/8#8#1$"%

+;55&<@1#"#"0#"7>#$!%""$12!#!/%$?$"1/!1>/#%$0#C#"1##7'(2#%H/'(@'& '&5

3!=;555<@%$"$/"">/#"

#C/"#%2!#0H#$-&@( :

3/*8,# C1H)

;(((<@,7"#"$#"?##,%!F/#+!//8+10$#"$7#"2%%#%%0#"H/7 /$$/+10/2(@-( -('

3"+H$1.;5&<@#%!$"2%$%

12"10$@$C%$C#0#%#7!%20!"1#"$$"/H!!/+12%$/-5@'( '(

3?>#3;55<@77$2%7#"27

"0%/%$$"1#"#"0#"7>#$!%""$12!#!/%$H/&:!!/@:- :&

3#//H##/#2,;5'-<@#"

##!">/$%@C#%##"$%$"#"$%+10/1#@- -:5

3#28,2 8082/$%%H8

,$1"0,"";5'&<@1#C/"$C$"20/$$#C%!#%%$#%!%#$"$%$%%20#@$0!/$"$%7#"/>0/$"2$"$%$%12!#%#%$"$C$"2 $C%#%@ (

3#"38!%"#$8 !#

H>?$"F*;5&<@ 1/$#$$#C"$7"1#$#10

Page 92: Adrenoceptor Antagonists and Haemodynamics - Trepo

5

C#"$/"$%2%"#0"0$#/#"!12%$/$#/"$% $/"$(@5' 5

C3##>#+8H$8C 1+

,C/3;((<@, "#0%7#"2#77$27# $/270/"$7/7F%$(0$!"$#"%?$"1%20!"0"$>#$!%""$12!#!/%$@!# />#/#9"#%$%"2/@ :

3$#08 81//#8.$/#

810$"38,#8=""#)817#%)H10;((<@ C#$//>""0#"!//##%>#" ##$#%!%$C##%%7"#0!/#"##/$0$"$70!/%0$C$C $/"$(5@-' -5(

3$11#$#H8)##%1 8#8#$%#/ 8

#$#8/00#8FC#"C8#$##8"%0//#H;((<@0!"7"1#/"!$0#">/$F##"2!#72"10#+(*:0#"!//!10$#"$%!1020$% /$+10/1#&:@-( -

3/#$#8$//#H+8$#H8H%%

H;5'&<@*##%#1#""#C$>$/$"2$"%%%$"$?$"1$#%#0"/$"27"#"#02$/$7"$0H $/5@: :

3/#8H%800$H8$"1#//

8#$8=#+##$;((<@"#"$>#"?##"1#!1%!1$#%"#%#$1$>$"8"/7$//!1 >/#%89F%$"0%/%$$1#/"120"#%$C#0#H/&@5- 5(

3AA>$;555<@ $C%$C#$"!"

#"#0$"$@%""#7"1#" !$#%"1#%$/@5 -

3AA>$83E1A#8$C$#B0;((-<@$0/"#% $C%$C#%%#%%0#"7"#$/%"$77#%%1#020$% C/$"$%"2 /$+12%$/."0$-@- -:

3AA>$83$#81/B0

;55&<@ $C%$C#0#%#0#"7$"!"@?1/# >2$0!##$!12$%$0/"#%0!$%?$"1"1#0$/"$$#"92#.$0#"1%"#%$C# ##-@- -&

3AA>$83$#3!!$#+;((<@

0!$%70#"1%7$"!"0#%#0#" $" ##5@(5

3AA>$83$#B0

;555<@ $"!">##/$>/20#%#$C%$C#/27"#2"#2>2!%%7"$!#"$ $" ##&@(:

3AA>$83$#8B0

%$"/H;55&><@=1/# >2$0!##$!12$"1#0#%#0#"7$"!" $" ##@&&5 &'

3"#H83$/$3;((<@

2%"#0$>$C$/>$/$"2$!/02#77#"%7(R"$0//#2#!%#7#%1 /$9!!1"1/0/(@-( -

32"1#C8/#8/1C83$C8

3#C81277 .$#%$##1;55'<@7/##7"1#2"10#+(*:\//#/#"1#!10$#"$%7"//# #/#%#0#"!//H /$+10/@:5 &

30)8# #%"#$H*8/%0$"1

,83$,81?"F8+#H8#$8%18)83"F

Page 93: Adrenoceptor Antagonists and Haemodynamics - Trepo

5-

*#"/;55<@*>/# >/$8!/#> "//#%"27"1#/ "#0#77$27C#$//$!"$#"%?$"1%#C##1$1#"7$/# $/"$5@55 (:

,C##8+$*8#%"$8"

8 !0//8.#>8.#$8.1$$8#00$8!%$1 8$$+8C#%$ >#//$.;((-<@1" "#01#""#C$>$/$"2%"/2!#$"%%#$#"1$1$1#"7$/#!"$#"% $/"$(&@: &(

,"";5'5<@"#$/!#%%#

$"H $/!!/@' '5,"";55<@,#"1/"$7

%/#+#70#@. "/$/?7"1#)#"@1#)#" $C%/2%"#0$#"$7$."$%8!!- -%).FF8)>#8H#$%83"F)C#+#%%8#?

,0+H;((<@2%"#0$C#%##77#"%7

>#" ##$>/#%@#C$## >%#%%#%%0#"0H!1"1/0/-@&5 &:(

,0!#"8C$%H8$%/$ H8)?$"F

,##.;((-<@77#"%7!!//#C#271#""#C$>$/$"27//?$"#02$/$7"$#/"$""0#$"1##" /#)#"""$/0H $/5@-&

,%8/8/$77H+8,#

.+?8H;5:&<@*$77##"$"$7##!"%2%"#0%"$C"#>2%20!"10$0#"$0$#%"#@5& 5'

,%8,#.+FF)H

;5:&><@*$77##"$"$7##!"%#%!%$C#"$%!"##/,$7#$:@ 5

,#Q;55&<@2#%%$#"1#

$%C#27!#%2!"$##!"%@!#%#"?/##7"#!#%!#"$C#%#%+10/$'@5 55

,#Q;555<@)$%"20#/"#

7/!1 ##!"%/-:!!/@ :

,%%#8)#$%##B%#+

;5&5<@$"0#"1%70#%#0#"7"$%%#>/7/?@)>7+12%$/28#"$@ $C%/2%"#08/8!! :-%H1#!1#.>>0#$+12%$/$/$#"28#"1#%8*

,#"8"2$#+8%08"$#8

,/98$F#,8*$0#"$##+##"%;((<@"$%"$77#%%$%$#!##"!#$"7// %#$C%/0"/$"2$12!#"#%$C#!"$#"%)2!#"#%$-&@-:

,#/ #8$!!$$802H8,#8

"H8*$##F %#C..;((-<@#1$%0%#/2$"1###$##%!%#"!12%$/#9#$%#H$/C#%":@'&5 ''

,#/+81#>3$!;5'<@

$0//@/ "#0 $0/"$#"#%"2 H!1"1/0/(@' -(

,##;(((<@0%/%$7"1#"#"0#"7

>#$!%""$12!#"!12+10"1#-@'' 55

,#$# 8#*=#>#+;5':<@

$C%/#77#"%7!1"1/0$"$0//"##(@5& 55

,#$#?#>#38%1#8)

#;((<@#" ##!"

Page 94: Adrenoceptor Antagonists and Haemodynamics - Trepo

5

!/20!1$%0%210$##>#%1+10/-:5@

,#8,#?$%8?,8#

80%2,8H%+=%).;5'5<@$0//0#">/$%0#>$%6$#9$"$!/20!1$%0@!!/"$%"2H /$+10/&@5 -

,#!)83!/83/$0>#8>/#2*.8

.?F2877#28#3*$%;55&<@*9F%$7>#$!%""$12!#!/%$@/ "#0#77$2%7#"2$12!#"#%$C#0"#%$C#!"$#"%1#/"$#"#"2!H/&@ -(

,#C$ 8//8"#8#%%

%%;((<@1#02$0 !"#"$C#/2 5C$"7"1#>#" ##$##!"#91$>$"%%"$""$C#"$C$"2$#%##%#%$"$F"$? #/"$H$/ 1#0&&@-(5 -(-

,#C2.8Q1`830H

$>0#,;55-<@77$27>#" ##$##!"%$%/?#"1"1"7>#" ##$##!"%+"/$5(@(&5' ('(

,#C2;5&<@20!"1#"$

!%20!"1#"$$"#"$%$"1#1#" $#%5@-&

,#C2;55&<@#/"/7$

7"$$//$##% /$#/:@&

,#C21?"F+H;55<@/

"/7"1#)#"@9!#$0#"/%$% /$$/0!/$"$%."808

,#=$"#%/;((<@0/

+12%$/27"1# $C%/

2%"#0@)%"P%1#)#"8!!'& %.%"#8=/#9#P#? )$//

,#?$%8,#8H%+8#

80%2,=%).;5'<@$0//"#//@#/"$%1$!%>#"?##9$"$!1#"2!#8!10$#"$%!1020$%H /$+10/5@-5 ---

,$,8###)83"%!/%*81$#/,8

0#H*8*""1+;55'<@ $C%$C#0#%#0#"%7"#$/%""#7"$@#!#">$/$"28$"##/"$%1$!%"$/%0!/#%$F# /$$;,<5@::5 :&5

,$#"";55<@."$/!!#"$#%7"1#

"10>#"- ##$##!"%@$77##"$/$%""$C"$7#0>$"##!"%$ 1$#%#10%"#C2#//%/+10/@:- :-&

,$#"";((-<@+/20!1$%0%7

##$##!"%@C$"$%"1#0#%%2**#C#1/@-& -:

,$#""8=#,8 7",,8)

=8)$"*8"%1 =/%1;55'<@1#/#:>#" ##$##!"!/20!1$%0C#%#/277#"%"1#"0#7#%"$C#1#"7$/#H /$C#%"(@- -5

,$H,8 1),8* 8,$8,$ =8

,$38= +8%#Q,$#=+;555<@, "#0>#" >/#"1#!2$0!C#%"0$#C%#/"$$C##%"$C#1#"7$/#@/$"$/1#""#C$>$/$"2%"20)#"H-&@:' ::

Page 95: Adrenoceptor Antagonists and Haemodynamics - Trepo

5

,$6C$%"8+C$$#+83/$+80$#H8E/$0E$8"$/3,$"$#,;5'5<@ $C%$C#0#"17"#%"$#/$/"2"/$0 $C%#%-@: &

,$"B8$/C#038"$%$38

!?*82/C$H=#$%%;((<@#" ##$##!"!/20!1$%0%1!/"2!#%#%%$"#?$"1$?2%12!##%!%$C##%%0%0$0# 1#%":@:: &

,$C3H;555<@//#/$$%$0$"$%$

7/#$!>#%"1#P/#%#%%2##"/@- 5

,10#$#;((<@1#%20!"1#"$#C%

%2%"#0/ "#0>/!#%%##/"$0H)2!#"#%@&

,10//#.1/$1*;5&<@

0!$%7"$0//!!//$#%%#"$/12!#"#%$0)#"H'5@-&

,8/1#H8+$#8#$+8

1$%H7;((<@"#$/?C##7/#"$%%C$C/$# %"##/7$/#)2!#"#%$-'@- -'

,#$;555<@7/##

7"#$/!/%##7/#"$C#?C#%%2%"/$>/!#%%#$7"$H)2!#"#%!!/&@- :

,>#H;55:<@+10/27

"%0$%%$$"1#"0$#C%%2%"#0@$"#"$C#%!#"%0$#%8#!#!"$#%8#%$#"$!1%!1"#80$$%$"$9$#+10/#C'@- &'

38=),#),;((<@

##"$>%$%70#">/$%00H)#/"12%"+105@(: (:5

#H8)/%1#$#*+8)$0"H8H8#0$>$%"#$);((<@#%#0#"7$"!"?$"1$2$###"%"#%7/#%##$/"$"#1$6##%"1#%$/2((@&: '-

? 38)##/0=

,;((<@+/%# ?C#C#/$"20#%#$#1#">#"%$"$#%#'@

#F$#H.8*/2 H8+#$$H*

"1H ;(((<@4"$""$C#$0$$/$C#10#//%#C#/%$"#////!1;< ##!"/$ >$$%$"#%H+10/9!1#5@- -

1B81>$#8#H8!1#H

$B$H;((-<@+/%#"/2%$%7$"!"0$"$$$%#27#$"/1#"$%#%##%"1/5&@'- ''

//$$8+$8,0>$. #""$

;55<@ $C%/#/#/"$#9!/#$"1#7#6#20$ $/"$'@' 5

//2H8+$#*8+$#8$#%"

8*/#38.,8#`,8$1% *8*"$ .1?$*;55'<@/!1 ##$##!"%>"2!#%$10#"%H/:(@5-& 5-

/#2H*8H##.H8. F$.

$%));5''<@/$"C%C/%2!#@!/#%2%"/#!C#>21# !"$/" %##!"#C$#?7$%$%8!"1!12%$/28"1#!2 /#C# /$H#@ '

$P"#/H8##$#)

1/#0!;5''<@*>#" >/#%#//2$#%#!#$!1#/C%/#%$%"#D#C$#?7"1#

Page 96: Adrenoceptor Antagonists and Haemodynamics - Trepo

5:

/$"#"##?>%#C"$%#>%/$"$%0H)2!#"#%@5 5:

*8 #//8,#%%$H,

%#H;55-<@ "1#"# $#!/02"#21#01##%/"$70!#0"19 H#%"1(@(:5 (&

?%#;((-<@20!"1#"$

#C#"$C$"2$12!"#%$"1%""$$"/##"+12%$/&&@-5 -:

%1//H;55<@+#$!1#/

1#0##!"%$C%/#/"$+12%$/#C&@- 5

%*8#H*8##,$#""

;555<@$ 7 7"$!/20!1$%0$ !"#$!/$0$7"1#10>#" ##$##!"H$/ 1#0&@:&( :&

"1$% H80%"8?%#8

11$38#C/%+%%#//=;55<@/#7 $C%$C#"$%>/!#%%#0$"$$"1##"#"$7"$%$%12!#%#%$"$C$"2 /$"#%@& 5

"%%1$0)830$0)8#$%1$8

=">#8)$1$%;55'<@+10$#"$%!/%0!"#$>$$7"0%/%$121/$#$"%8%810%*#">*$%!%:@(

*/*;5&<@/7/?$"#$#%

/8,"2H 8$/%H)8./#0$HH8

#2=H=;5'<@+10$#"$%>#" >/$#77#"%7"$0//$!#9"#%$C#

0#">/$F#%7#>$%6$ /$+10/1#-'@(5 -

"1+8,$,83"%!/%*

0#H*;((<@0!"7!12%$/!12%$/$/7"%"#$/7"$ /$9!+10/+12%$/'@( (&

C$%1*8 0!/$ $1%*$

;55-<@ C#$//#C$#?7$"%!1020$!10$#"$!!#"$#%8"1#!#"$#77$2*%@- '

##%=;((<@+"1!12%$/27

12!#"#%$$"1##/#/2#0$#!1/@: &(

#/$8$08*#/+$8"$08

=#/F#/*,#C#%H;55-<@"$%$#77#"7"$12!#"#%$C#"#"0#"?$"1$%$!$#0#"!///#"#2#0#"$#/%"$!!#"$#% /$+10/1#@&: '-

#2+.8>$ ##%8#%"##/#8

H#C$$%H8%1#1#.$%10#$%"#;55&<@%$$#/"$7"1#, "2!#/$0#"$$%/"#$022"#%,$7#$:(@- (

#"%.;55<@* $#"1%""$

12!"#%$$/#!"$#"%*%$:@5 '

$1#/ ;55<@#" ##$

##!"%@##!"*"7$/$/9!#$0#"%8!!5 %)*%H C##///$%)?8#?

$1#/ #/%#""#HH;((<@

77$2%7#"27"0%/%$$"1#"#"0#"7/$/$%#%#%9!#"!$+10"1#@ :(

Page 97: Adrenoceptor Antagonists and Haemodynamics - Trepo

5&

$1#/ 8./#22+;((<@=/?$##9!#$##?$"1/7F%$"0%/%$/2'@(' :

$1#/ 8>>#/81$38#7"1

.8""3!7/*;55:<@*%7"#"0#"7>#$!%""$12!#!/%$@77$$"20!$%"/#/!1 ##!"%>"2!#%$10!%""#H"+10/:@ '

$#/%H38$0!%+H,1#%$

;55(<@%1#0$)#"*$%#%#@+"1!12%$/2+10/$#0#"@ $C%/+10/28!!5- -(%"$C#+#%%8#?

$//#*P //1H+;((<@

##$#%!#"%7"1##%!%#"%"#%%#">/$%0@ (

$//#)8.$#08%/$8.$#0

8%#%1#$83##8"1,$;55-<@ $C%$C#>$$0!##0#%#0#"7$"!"@C/$"$%"2# 7###7"1#%#/)#"$#"2'

$/%"#$8#"$7#H8,#%%#H8/#>#

.8#$""*8$ #2#%=H;5'5<@ $%2%"/#@0$7#%""$7#//20#$"#12!"#%$ >2$H0 // $/@:: :-

$0*$/;5''<@2%"#0$

#$/1#020$!7$/#7$#"$%/!1 >#" >/#%#C$#?0!$"#1$#77#"%*%-!!/:@:( :5

/#+8>""88.38

C$0"18,$,8=#%"H%%#//.*;((<@ %#C"$7"1#$%"$0/"#77#"%7; < #!$#!1$#%%#5/2

/2-'5>#";< ##$##!"!/20!1$%0%$10$1""$0$C$"H0 // $/(@& '

C//#778#$773##>#

;5'&<@+10$#"$%>$C$/>$/$"27C#$//8C%$/"$>#" >/#H /$+10/--@ -

$""#83>F$,8.#81H8

"1$# //$H,;((<@!#/"$7>#";-< ##!"%/"##""$/##%!%#"$"!$0$#%$107$/$02$0 $/"$(-@:5 :

;55<@ /$$/!10$#"$%

!1020$%7C#$// /$+10$#":@-- -:

%1C$"F83/%$8$/8##Q

""#;((<@##"#C#/!0#"%$$"!"#"#0$"$>2>$$0!##@0!$%?$"1$C%$C#$"!"!"#"$/$C%/!!/$"$% !$ $/5@5 -&

2"1#=#>>;55<@

+#$!#"$C#!/%0C/0##9!%$##%"1#$$##7"0%/12!!#7%$$$%#21-(@- 5

#/%*8Q#/$* 8)7708/"$%

,H8=$)#>#"*=;((<@ 0!$%72"10#+(; +<##%70"1#0%#10#0#%8$/$0#/"##00#"$%7##%8!%###%/"#"$C# %!/$#C$"%+10##"$%@ '

#7#/)8"#/%+,$H);5'-<@

,>"2/$$/%"$#%"1#

Page 98: Adrenoceptor Antagonists and Haemodynamics - Trepo

5'

0#1$%07"$7"$0//C!1"1/0/'!!/@': 5

#?"8F#C#+#H*

;555<@"!$%20!"1#"$#%!%#%""1#$"2$7%$7>#" ##!"$%"@10$C$C%"2 $/"$55@( (&

$1/%==?%*;((<@

"#$/#/%"#?C##7/#"$0#""$7%2%"/$>/!#%%#@#/#"#$%#77#"%$0!/$"$%7"1#!2H $C%+10/1#:@

$H81C$#38%$"/)8

B08)"$ 3E1A#83$/8!83%#/3E1A#;((<@ $C%/#77#"%7!1"1/0$(R"$0//6#%%/"$(R"$0//12#/ /$+12%$/."0$@& &'

"#%).8"#,81H

"#%;5&'<@1#>#" ##!""//$#$#/#%#1"+1021#-@( -

/10) /#;55&<@C$"

$#"$7$"$7"1#102"10#+(#F20#%$C/C#$"1#0#">/$%07;J< ; < C#$//*#">*$%!%@5&( 5&&

/%#,8$/>#"8#/*82/

*8?$"F.*$%"?;55<@ C#$//$0!C#%/#7"C#"$/7"$%20!"0%$1$1#"7$/#@>/# >/$0$F#%"2H0 // $/@ -

!$#,);55'<@1#)#"+12%$/270

#//" $/"$,$!!$"" C#+>/$%1#%8+1$/#/!1$

T$Q8$8=#$%%H821$`$#*);55<@)#""#C$>$/$"2.#6#20$/2%$% $/ /$(@55 -&

P#;55<@"#$/0!/$#

?C##7/#"$1/ #$%%'!#-@ '

P11#%%238.8*$#% 8

1%"*?H;(((<@1#$ 7 7"$-'5C$"7"1#>#" ##!"#%"$7/##>/!#%%#1#""##%!%#">#" >/#$12!#"#%$C#%>B#"% /$$;,<55@-- -'

+$8,0>$.8FF#""$8$0/$8

./8+$FF$#//$+8#8/7""8*#//P"8+$/#"/;5':<@+?#%!#"//2%$%71#""#"#$/!#%%#C$>$/$"$#%%0#7%20!"1 C/$"#"$$0%$% $#%5@&' 5-

+"$8*$$#F$;(((<@

)?"0#%#>#7/#9%#%$"$C$"2@70"1#$C%//>"2"$/2/$7#H)2!#"#%'@& 5

+C$# *#7#;((<@1#$

>#" ##$%$//$#?/#7"1#+, #//$/&@

+#FH;5&'<@2#?C#%@1$%"2

0#"1/2"0#$@- +#$ 8H8./#0$H,"$3

;55<@%#%!1#/*!!/#$"!"0$"$@!#70#$"$#%""$C#%#2#%"1/&-@&( &(

+1$//$!%38##%"*,8#8,##H3

##=;((<@+"#"$//#7!10#0$%$#$C#%##"$%@%2%"#0"$#C$#?H':@&( &5

Page 99: Adrenoceptor Antagonists and Haemodynamics - Trepo

55

+$010#+3;((<@##"$

%%#!"$>$/$"2"C#%##"$%#%+10/$@5' -(

+$010#+3;((-<@

2"10#+(#F20#!/20!1$%0%C#%##"$%9$/25@- -

+/"*8H%H )#6$H ;55<@

/$$#$1$>$"%+ %#%$"$C#3J1#/%$0%#!#"$>#" #//%H+10/(@-' -5(

+#/#"H810$" 8#)8)$#.8

//177,$);555<@0!$%7"%#%!1#/#1$!1$*!!/#%%"1#"$C/C#"1#"1#0$/"$"#1$6#7#%"$0"$$"!"#%"1#%$@' -:

+08#//$8+08#$8

1$$,8*$#//$8C/$$.8*$$8$$8/C#""$#//$ ;((<@ $C%/!0#"#1#%$!"$#"%?$"1##"$/#2%7"$%$!# $1$>$"%@%"2?$"1%$/#7$/C#7$/H/@: :5

+0#F8/2H8 $//83"F

80*8*83$/>38# 81* 8 1#H#"/;5'<@%%#%%0#"7"0$7"$$10%>21#""#%!#"//2%$%0H+12%$/'@) -

+%%#".8 !$#`8,#1"+8H$//+8

$%%#/H+8)#"F#/8.$//#""#.8#00#=8$F#,,#)#F#2H;55:<@77#"%7>$%!//1#""#C$>$/$"2$1#"7$/#0H $/&&@: :&

+?#H8*H,#H

;55<@77#"%7%#%2;"#%$<#9!%#"7/!!//

>$C$/>$/$"2$!10**$%!%:@&5 '5

+#%%=)8./#2+8#/%2

#""#/$=;5'5<@0#$/#$!#%8.$#%70!#"/#"1%8!! 5& 0>$#$C#%$"2+#%%8 0>$#8/

+$#*8,#7?$"FH8 8

#?$"F*1?$*;55<@,/$F"$707"1##$%"$"/!1 ##$##!"%>"2!#%$10"$%%#%@$0!/$"$%710/!1 ##$!12%$/2/+10/@& &

+2"1.8"#$!/%8=#%"#17

#$%"#HH;55:<@#"17#"#0$$$%"$>"$7#7/#"$%$"#%$"1#"#$/%2%"#00H+12%$/&@)'(& '-

4$ 8##*8)#""$*

#7;(((<@#"#$/%2%"#00!/$##%"$0"#70!!#""#$/0!/$#$0#'@5 -(

$B0#%8.#%H81/"#H8

C#"%))##"1;555<@0#" /2%$%7"1####%7C/$"$"1$$0!##$!12 $" ##&@(- -

#38H#%81#=)8+#$*8

)%$ 8 1$.8 1#*8+""8/%1#8 >*8 9*8"%"#$*$%1;((<@!/20!1$%0$"1#>#"##$##!"$%%%$"#?$"1#%"$1#""#0H)0##"&(@5- 5

"1F*8?3830#,

,$#"";((<@0$$5!/20!1$%0%7"1#10>#" ##$##!"77#"$%"

Page 100: Adrenoceptor Antagonists and Haemodynamics - Trepo

((

!0"#"77$$H $C%+10/-5@ :(

8)#$#8#038=""#)8

=##8.#$7#/%1#1#;((<@77#"7"1# +*:#"2!#0#"!//0#">/$%0!#%$%"%$/ "#0"#"0#"+10##"$%@: &

#00#=H;55'<@1#%20!"1#"$#C%

%2%"#0$%1#0$1#"$%#%#)#"H5!!/.@.: &

$18,%7# =/78 1/98

*"#/#811#$"8%?/ 00%%#8,0!#"8#""#8#2,%7#H;((<@ $C%$C#$"!"#C/"$$09$0/!#%%$C##9#$%#"#%"8%$#?$0!##$!1#C$#H!!/+12%$/'@( (&

$18#. 8%1$

,%1#.;55(<@*$77##""$C"$7, $$#!"1?2>2>2$$8%#"$8/$$#$2"#$#%0H+12%$/5@)-- -5

$1#%;((-<@1#"0$

#C%2%"#0@#$/+12%$/2 #////#/!!18!!-&' -5'%=.,#%

$1#%;((-><@1#"0$

#C%2%"#0@#$/+12%$/2 #////#/!!18!!-&' -5'%=.,#%

$8+%%# 83#2/ 8,$#>/

)>>11H;555<@ "$%$"!"0#%#0#"@!/%#"/2%$%C%"1#0$/"$"#1$6#$$%$/!"$#"%H#%"1'@ -(

#1> ;((<@/7F%$@C#C$#?7!10$#"$%8%7#"28#77$27/$$//2%#/#"$C#/!1 >/#/2'@ :-I$%%%$:-

#1> 1?$*;((<@

/!1 ##$##!"%"1#$$1$>$"%$/?#$2""%20!"0%>#$!%""$12!#!/%$H/&@(5 (-

0,;((-<@$/%"$@

#$/+12%$/2 #////#/!!18!!'& %=.,#%

#`,8#?$"F*8"1H8.

,8 F"3,8*P0$8/ /#0)8+#8$1% *8=$"#%8$,1?$*;555<@>"2!#%!#$7$#/"$710C%//!1;< ##$##!"%>2C#%%#/>## $/"$((@--: --

28+#81$# )2#%*

$10H;55<@%#%!1#/!/%#?C#*!!/#0#%#0#"7$"!"$0BC%/%#2@0!$%?$"1"1#"1#0$/"$"#1$6#H#%"1:5@( (

78)#2#0#;((<@

"$!/%#?C#C#/$"2@$#!##"0#7$C%/$%0H#$" $/@5 5'

78)#2#0#;((><@

"$!/%#?C#C#/$"2@$#!##"0#7$C%/$%0H#$" $/@5 5'

#0=8$77#>1)!$#%%*

;((<@6$C/##7>$$0!##"1#0$/"$$0#%$$$#97"#$%#2H $"1%#%"1:@'

Page 101: Adrenoceptor Antagonists and Haemodynamics - Trepo

(

%#.;5'-<@#%$%"#@)#020$%$ $/2 //"$%"#!#""$%8!! :+##8#?

1#F 1!8$/8/78

$#//,.##F )#;(((<@7#"2#77$27%%"$# #/#%#/7F%$/?#$2""%20!"0%%#%"$C#7>#$!%""$12!#!/%$$-8(5!$%1!"$#"%#C/"#$##/!"$#/-&@ &

$/%H8P11#%%23

?H;((-<@#"#$"!$2/$+#%!%#%#C#>2#/$#"11-'5>#" ##!"%C#%%/2-'5>#" ##!"%$$%/"#10"$/02$0H+10/-'@-': -5

%#*8%%#//.*8,210H8>""

88.38,$,830H/#+;((-<@; < +&&$#%#%""$/#7#1%"#%#/9"$71002$/!#!"$%"11!!// #%$%""%""#7"1#>#" ##!"210$##>#%1+10/-:&@(

17#%.8.1/8=%0"18

101#)81$38##2 8+1$/$!!$1#/ ;555<@*$77##"$/C%//!1 ##!""$%0>2"0%/%$"#F%$H /$+10/&@:& &

1#")8)#%#)=8*$8$##

$77#"=;55'<@%%$"$>#"?##!/20!1$%0$"1#!"#$>#"-%>$"##/?##$#/#C"#$%"/$>/!#%%#/#C#/%)2!#"#%$-@( -

$>$#81$,8"C%$H8,# 8$%#*)"# ;5&-<@0#$C%/#77#"%7"$0//#?>#" ##$>/$#"1"+1021#(@&: 5-

1*8//%"#%H;5&(<@

+/%0!!///#C#/%$/"%?$"1>%#C"$%$71$/# /$+10/1#@ (

1+81#38"$H82/

)*=#$H;55<@ 0!$%7$77###%$"1#1#020$#%!%#"!%%$C#!%"/%"#%%$1#/"12%>B#"%#"#"1&(2#%/#%%"1-(2#%7#0H $/:&@( :

1##)8,##H8$%1/1

;((<@+/%0"$0//#""$%7"$0//0/#"#@"$0//#/ 70$%/"$;+ `<#$/2C#%%"$0//0/#"#!1"1/0$%/"$"?$#$/2*!1"1/0/(-@&- &5

1#8Q1)"#.;55<@

+#$!1#/C%/#77#"%7>#" -##$##!"%"$0/"$$%$%%H+10/9!1#:'@:: &-

1$0383$"F0$8#8)

F?;5'<@# #/"#1#%7>#7/#97"$8!/%0#!$#!1$#8>/!#%%#)2!#"#%$&@- &

1B$80"81$1383$28

%B$0"83$%1$0")8%1$08>"$%1$F?;((<@*$>#"#%0#//$"%8"$%"$77#%%8$C%/0"/$"2$# %"##/$%#%#H0#!1/@&

Page 102: Adrenoceptor Antagonists and Haemodynamics - Trepo

(

$#%"8H##%%8#10#)80%8"#H81$%C$$%;((<@+10#0$%#%!%#$$C%/$%#%+10#0$%@&&5 '(

/087C$8/H,8,#"

7;55<@77#"%7"$12!#"#%$C#%/#"#20!/$##"1H#&@: :'

/#$1"+;55<@/#7"1#>##!"

#7/#9#%$$/"2"/8?$"1!"$/#7###"12!#"#%$)2!#"#%$'@- -

0//38?*=,$#""

;((-<@+10/2!12%$/2710##$##!"!/20!1$%0%#C+10/9$/-@-'

0//38=#,8,#C$83$

,,$#"";((<@2#$%"$!/20!1$%0%7>#" /!1 ##$##!"%"1#$%7#%"$C#1#"7$/#/H#-&@-

0$"1HH8)1#% 8+"$H8#2H8

$%"$.>#"H;5'&<@1##77#"7#1#020$#%!%#"#!%"/%"#%%$0/0#H#"/@(:

7?8*$%128,8`$#)8

+%) 82#*=80$/#283$08=H"#$ ;((<@/!1 ##$##!"!/20!1$%0C%/#%!%# /$+10/1#&@-5

7?8*$%128%F"8`$#)8

3$08)$%+8+%) 82#*=8$8=H"#$ ;((-<@00>#" ##$##!"!/20!1$%0;-'5/2<77#"%>/!#%%##%!%#">#"

>/# /$+10/1#&-@-:: -&

C##$+ 8"+8>#"% 8*#

/%#""#HH8 !# ,#7#%);((-<@%#7/!1 >/#%"1#$%71$!G7#07"#%H"##@'

?$%$3/#?;55&<@0!"

7 +*:!0#">/$F#!1#"2!#!!//!10$#"$%#%!%#+10"1#!2&@-( -(

"#3;5'&<@+#%2!"$/!1

"##!"%#C+12%$/$1#0+10/(&@&- :

"%%);((<@##!"#7/#9

7"$0H+12%$/#/"# 0!+12%$/'-@' ':

"%%);((-<@)#""#C$>$/$"20H

+12%$/#/"# 0!+12%$/'@5& 5-

"#$7"18 1#8,C$2H8%%#

8%#8%%?810$"F=1/F);55<@ $/!1 ##!"#%$"$#%$$77##"000/$%!#$#%H+10/(&@' ''

"#$7"18*$#/%#=8C#,#2#)8

##8#2#=8#0H8%#8#$1810$"F=81/F)#"/;55><@##/!1 >#" ##!" 0#$"#!%$"$C#$"!$#77#"%$10# %"#1#"7$/#H+10/(@:- :5

"#$>H8 #/$8$#% ,1"$8

##%*$=;55<@1#!#"$$0!"7!/02"#2"1#"#$F"$$0#$/G%$/ 1#%"55@

Page 103: Adrenoceptor Antagonists and Haemodynamics - Trepo

(-

"#$!/%8#$%"#HH=#%"#17;55<@$0!/#"#?27#%"$0"$""/%#0#"/"#$/0!/$#@"1#!/%#!#%%#0#"1$0#@-5 -5&

"#$!/%8#$%"#HH=#%"#17

;55<@C/"$70#"1%7#%"$0"$7""/"#$/0!/$#0H+12%$/:'@)( '

"#$!/%8=#%"#17=#%"#17

;555<@"/"#$/$#"#%"1#7"1#/#0#"7"1#?$#%%#/0#/0H+12%$/&:@)' ''

"#?"= 8 "#"#?"H;555<@

2%"#0$>#" >/#?$"1#$/2#"$0/$0!"$ `H/+10/1#@ -

"#?"= 8"#?"H8 #""83>$/%

8?10%;((<@ 0!$%7"1#$C%/#77#"%7!%"#(R8"$0//(R!/#>$1#/"12/"%$#9#$%#%$"#0$//"#%""!1"1/0/'(@& &:

"#?"= 8"#?"HH%,

;((><@ $C%/#77#"%7"$0//0/#"#8>$0$$#>$0$$#G"$0//0/#"#$0$"""1#!2"!1"1/0/'(@&& '

"=H8$%1.8)$//#>#1"81/F)8

#2#3#0#H;55-<@$C%$C#$"!"0#%#0#">2"#$/!/%#/2%$%0!#?$"1$#"%#>#"1$H!!/+12%$/&@:'& :5-

/A7=//$;5&'<@77#"7

/?#>2#"$C#!#%%#100%/##C#%20!"1#"$"$C$"2H+12%$/&'@ -

C#%#,8)"/$! H#%#H

;5&5<@00#$"#1#020$

#77#"%7!!//8!"//8!$//8"#// '58(:$1#/"12C/"##%H /$+10/@- '

/$$.$.;55'<@ C#$//

$1$>$"$7/$!$!#9$"$#?"$9$"$C#0#1$%0.##$#%5@-&& -'&

1$3817#%.$1#/

;55'<@$##!"%%2/2%$%7"0%/%$"#F%$!10$#"$%H /$+10/@5

1C$#38,$"$#83AA>$

)"$$#H;((-<@"0$%#1#0%"""$0%#"@3/$$$#72%$/$B$%"!!$/EE#"$##8!!( -%C$BEC$81#8H)"$/#"/*#$08)#/%$$

1%1$8?%8$820

)83$188$$)20;5'5<@77#"7#F20#4(1#020$#%!%#"/"$0//H $C%+10/@: :'

%.#;55:<@)#""#C$>$/$"2@

%"%70#%#0#"8!12%$/$/$"#!#""$/$$/%#%.#7"1#!#$#"27 $/2"1#"10#$$#"27+$/#"!12%$/2 $/"$5-@(- (:

2/H8 *,82#% =>#

*,;55'<@#1$%0%#/2$C#2 /? 7#6#2 $"#C/%$//"$%$10% $/"$5'@&

#?$2+;555<@/!1

##$>/$%$"1#0#0#"7>#$!%""$12!#!/%$@$"#"$%?$"1

Page 104: Adrenoceptor Antagonists and Haemodynamics - Trepo

(

"$12!#"#%$C#"1#!2/2-@ (I$%%%$

$%11#;5&-<@Y#%#0#"7"1#

%"#>/C/0#>2$"#/1#07"1#10>2Z.$F$/Q10#1#C5@:

%/$.$#0;55<@

$C%$C#0#"1#C$#7//#"$0#%#0#"%#!#%#"$>2"$C$"2#"#0$$$#%!$"2!0#"#%7"1#10>2>%#!"1#0#%#0#"%//#"#+"#"8:58'58C'55

%B$$;(((<@ 0!$%7!F%$8

"#F%$"0%/%$$"1#"#"0#"7%20!"0"$>#$!%""$12!#!/%$@%1" "#0!#80$F#0/"$#"#%"2+)#$/1#!2"2!#$!%""$12!#!/%$"H/&@55 (

1%10$"H10+;5'&<@0!"

71#020$0$"$$0#$/$"#%$C##$" $" ##@'( '-

#;((-<@*!!/# >%#

1#020$0$"$@0$$0//2$C%$C#/"#"$C# /$%%#%@( -

#81?"F,8 1!0

#?$/#;((<@ '!/20!1$%07"1#!"#$>#";-< %>$""$12!#"#%$C##%!%#""1$F$#$#"$)2!#"#%$-&@&-5 &-

/218.$%H ?2H;5&<@

0!$%7#?>#"##$>/#;35(<!!//$0 /$+10/1#-@- -'

0#"%$)83"#?8038"%3;55&<@#0!/C$"$$"1##77#"%7!1"1/0$"$0//$C%/#%!$"27"$%$1#/"120#H /$+10/-&@' :-

""$;55<@*#/$C#27"$/0

%@/C%%2%"#0$>%!"$H/+10/(@-5 -&

%$"/H+/0;5'5<@, "#0

#C/"$7"$0//"!1"1/0/; !#1<:&@&- '

"#/,83/H8$#)

"$B#$#);55<@77#"%7"$12!#"#%$C##"%//"#$/$%"#%$>$/$"20!/$#)2!#"#%$:@- -

#7+)81/#2+/H=

;55:<@/2%$%7"1#"$C$"27/!1 ##!""$%"%$""H+10/'@55 -(

$F$,>%;55<@ %2!"$

$"#"$%"!#%2!"$/#C#/+#>$/-&@ :-

$,8/$ #/$/83$/8$%/

$3;55-<@+/%06#%10#""$%%2%"#0$#77#"%7"!$/>#"9//"$0//$0"!1"1/0/; !#1<&@( (:

$,3$/;55<@+/%0$#"$%

"$%""$C$"27"!$//"$0//$#/#/2!"$#"%#7#%1 /$9!!1"1/0/--@- -

=#,8 7",,8$18#%1*+8

Q##/+=8$#8>10=8 1#$# 8*=8,$#"";(((<@+/20!1$%0%7"1#>#";< ##$##!"#"#0$##9#$%#!$"2$!"$#"%

Page 105: Adrenoceptor Antagonists and Haemodynamics - Trepo

(

?$"11#"7$/# $#%':@'- '(

=#,8 7",,8Q##/+8$#8

"1F*8*=8,$#"";((<@+/20!1$%0%7"1#>#" ##$##!"!#$"#9#$%#!$"2$1#"7$/#0)#"H@'( ':

=/#+*8#$ ,#!);555<@

,/$F"$#9!#%%$7"1#/!1 8/!1/!1* ##!"%$12!#!/%"$ 12!#!/%"$10!%""#H/:@:- :(

=/8!#H10 ;(((<@

77#"%7/00#$"$%"1#$#%!$"2$"/!#%%#%""%7#?/2$%#/0!"$#"%H!1"1/0/'@&( &-

*#="#H8$//#=8#/,8

"*/",;((-<@0!##$!12@"1##9"C$"/%$"#1/2D 1#%"-@(' (--

=#>#.8#8/73*

;5'-<@>/%%$7$"$710>#" ##$##!"%0#$"$#$#/#%# /$9!)2!#"#%@ -'

=#%%H;55'<@/#/>%$%7##!"G

!"#$ !/$%#/#"$C$"2+10/1#'(@- :

=#%%#/$3)8H%#H8#""#/%HH

1##HH;55-<@ 0!""$7"$7/?70!#%%#$10%%$/$#8"1## #/#0#"0#/H!!/+12%$/&@:: &-

=#%"#178/F$$!#0+

;5&<@"$7$$/"#$/%2%"#07!0!$1#"%H!!/+12%$/-@&&: &'

=$03 /!10*;55<@

1#/#/"$>2!"#$%+12%$/#C&@': ''

=$$>#;(((<@#%#0#"7"#$/

0!/$#$C$C")#/"1#1/70&@55 ('

=$/$%;((<@1#*20$%7*

>%!"$8*$%"$>"$8/$0$"$@0l$/0P%1#+10/$/%$%71#!#"$%8!!- 5%H)0,,$0>$? )$//

=$/%=8.$=8H1%8)/0#%

8%$ 8)>#+*C$#%;5'<@$0//!!//@>$C$/>$/$"28!/%0#""$%8>#">/# /$+10/1#-@:&: :'

=$/"H8)?#=8"%*/

;((<@#F%$7>#$!%""$12!#!/%$ 1#*">%#2%"#C *((-'

=$/"H8*/"%;((-<@

0%/%$7>#$!%""$12!#!/%$ 1#*">%#2%"#C *((('

=$/"H8*/#/%*;((><@

0%/%$7"#"$/?#$2""%20!"0%0!"$>/#?$"1>#$!%""$>%""$@%2%"#0"$#C$#?7#77$2C#%##77#"%H/:&@&& '-

=2%%H /%);((<@1#/#7

"1##C%%2%"#0$12!#"#%$ )2!#"#%#!-@ :

0?)8#1$8)8)"

38$20;55:<@#"$C#1"!$#77#"7>#" >/#"1#!2##%02$/

Page 106: Adrenoceptor Antagonists and Haemodynamics - Trepo

(:

92##9!#$"#70#1$/? $/"$5@-( -

0F$83"$;5'<@

/!1 ##$$1$>$"$7$%/$%##"$C$$"#7###?$"12/$+##"$$"!#"$$%/#"%/+10/@:' :-

$. $ ;55<@ 0!/$#

1#%$!12%$/$/!"1/$/%""#%H)2!#"#%!!/(@- --

#,8=`8H,877/8H

.##%"#$Q;55<@ C#$//8#?C%$/"$>#" ##!">/#8$1$>$"%9$"$7/? #%$"2/$!!"#$%>2C%/%0"10%/##//%!#C#"%/#2"#1#%$"%0"10%/##//%H+10/9!1#&-@ 5

$//#*,;5&5<@ $>/!/

$0$@#C$#? $"#C*$0$@- :(

Q#%"31 =#%#H;5&<@#/"$

7!!//!/%0/#C#/">#" >/#$/"1#!2+10/2&@&' '

Q1)$#03+;555<@/!1

##!"%>"2!#%H+10/-&@: &:

Q$#/#*8""$,3#;555<@

0!$%7$"!"0#%#0#"%>2C%$"#0$""#">/%"1#0$/"$$0#1$/C#"$/"#!"$#"% 1#%":;%!!/<@'

Q$#18#$"#/%1##%,8#$8=/#

H8+/2*.8>#%"38,###H8+1$//$!%8#/7 H1%H;((<@+10$#"$% +*:#"2!#%"!#$"0#"!//C#%##C#"%#77$2$12!#"#%$ /$+10/1#&:@-:

Page 107: Adrenoceptor Antagonists and Haemodynamics - Trepo

(&

Page 108: Adrenoceptor Antagonists and Haemodynamics - Trepo

('